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Abstract
A primary challenge in embryology is to understand the factors that govern the development of
preimplantation (PI) embryos and how these factors relate to embryo viability in the field of in
vitro fertilization (IVF). This is particularly important as clinical policy moving towards single
embryo transfer (SET) has gained awareness to manage unprecedented numbers of multiple
births, such as twins and triplets, resulting from artificial reproductive techniques. Conditions
that correlate with developmental potential of candidate embryos are disputed in the field,
however, as the requisite data is difficult to obtain.
The metabolic profiles of embryos during in vitro culture have been suggested as a key indicator
of developmental potential, and approaches have been clinically implemented to select transfer
candidates which make the most efficient use of nutrients. Existing microdroplet analysis
techniques are accurate and suitable for non-invasive assessment of single embryos.
Unfortunately, the process of determining metabolite levels in nanoliters of culture media
through fluorometric assays is low-throughput and requires specialized expertise, hindering
widespread clinical use of these methods.
The goal of this thesis is to develop microfluidics-based approaches for improving metabolic
analysis of PI embryos and mammalian cells. This challenge necessitates two competencies:
methods for automating chemical assays and methods for supporting cell cultures, which can be
integrated with analysis. Contributions include a standalone platform for determining the
metabolite use of single embryos. Profiles may be acquired automatically, which reduces
significant technician hours and improves repeatability. Techniques are developed for
performing embryo culture in the smallest culture volumes to date in microfabricated
environments. Microfluidic approaches have enabled culture that outperforms the current state
of art approach based on cell count measurements. An integrated system is introduced, merging
analysis and culture competencies to perform metabolic profiling of separate cultures of
mammalian cells in parallel. Finally, new paradigms in microfluidic design are presented based
on the concept of vertically integrated architectures, suitable for overcoming density limitations
of microfluidic assays. A scalable analysis platform for refining embryo selection has been long
warranted and would enable pursuit of the difficult questions relating metabolism and embryo
viability as the clinical movement towards SET continues.
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Chapter One - Introduction
1.1 The Advent ofART
More than 130,000 assisted reproductive technology (ART) cycles are started annually in the
U.S, accounting for approximately 1% of total births'. The development of ART (referring to
any process by which oocytes, zygotes or embryos are manipulated to achieve pregnancy) allows
fertilization of the female egg cells with male sperm to be carried out in a laboratory setting. In a
process known as in vitro fertilization (IVF), pre-collected eggs are fertilized in a lab with sperm,
monitored over several days to assure proper preimplantation development, then transferred to
the target female's uterus through the cervix where it will expectantly implant in the uterine
lining and further develop into a fetus. IVF accounts for 99% of ART treatments in the U.S., and
is often used to achieve pregnancy if a prospective mother's fallopian tubes are damaged or
missing1 . The success of this procedure (measured by the number of live births per ART
attempt) is traditionally low, around -30%2, 3, which can be attributed in part to imperfect in
vitro culture conditions 4. This procedure can cost families several thousands of dollars for each
attempted cycle, so to ensure a birth many patients and/or clinics traditionally opt to transfer
multiple embryos to increase the probability of success. For 2005 in the U.S., the mean number
of embryos transferred ranged between 2.4 to 3.3, for women between the ages of 35 and 431, s
The impact of multiple births in the United States due to ART began to attract concern towards
the late 1980's, when it was necessary for the American Society of Reproductive medicine to
introduce guidelines for limiting multiple embryo transfer. Following the increases in
implantation rates, nearly half of the resulting pregnancies were twins, even when only two
embryos are transferred 5' 6. Of total births annually in the U.S., approximately 15% of twins,
50% of triplets and 30% of quadruplets (or higher order births) are the result of ART assisted
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pregnancies 5. As a result, in vitro embryo selection has been accepted as an effective direction
towards eliminating multiple births and thereby avoiding the serious problems associated with
such pregnancies 7 including pre-maturity, low birth weight, disability, and death. For twin
births, the relative increase in preterm delivery, cerebral palsy and infant death are respectively
five, four and six times more likely. For higher order births, potentials incidence of early births
occur nearly ten times more often, with cerebral palsy and infant death nearly 20 times more
likely overall1.
Interestingly, due a chance collision of science and demographics, the state of Massachusetts has
ranked first in the U.S. in multiple births for 2003-20068, 9. It is hypothesized that due to overall
higher levels of education, potential mothers are more likely to postpone motherhood in pursuit
of professional advancement following school. While the probability of having twins increases
slightly with a mother's age, the majority of these births may be related to ART, and multiple
embryo transfer . Accessibility of health insurance, and subsidies for assisted reproduction by
the state, make assisted pregnancies via IVF or other means a viable option. Further, the general
high level of education ensures families are not deterred from seeking reimbursement from often
confounding insurance systems. In Massachusetts, approximately 4.7% of pregnancies result in
multiple births (4.5% are twins), compared to a national average of 3.4% (3.2% twins)9. Affluent
neighborhoods surrounding Boston produce the highest percentage of multiple births (5.6%).
The states of New Jersey and Connecticut, with similar demographics of wealthy professionals,
are a close second and third in the rankings of multiple births. Unfortunately, multiple births do
not scale well economically and result in a disproportionate toll on social systems. Since twins
and triplets are born prematurely on average (born by -35 and -33 weeks, respectively),
additional observation is necessary in hospital wards. Multiple births accounted for 35% of
patient days in neonatal units in Boston in 2006 . Overall long terms costs to parents and social
systems can be even more substantial due to the risks involved in multiple births including
neurological and physical disabilities. These risks again stress the importance of pursuing the
practice of single embryo transfer for IVF.
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1.2 Embryo Metabolism and Selection
It is possible to have multiple fertilized eggs in an IVF cycle (typically 5-20, depending on the
age of the donor) from which to select the most promising candidate(s) for implantation.
Medications are often used in conjunction with egg collection from a donor or from the intended
parent to stimulate ovaries into producing multiple oocytes, which increases probability of
successful retrieval and laboratory fertilization+. The only certain method of preventing multiple
gestations is through single embryo transfer (SET) 1', which is a practice gaining much attention
in recent years 5 (for example, SET has already been standard policy since 2003 in Sweden). It is
thor>Urbanski</Author><Year>2006</Year><RecNum> 1</RecNum><record><rec-
ref-type name="Journal Article"> 17</ref-type><contributoDIN EN.CITE
Development of innovative selection metrics is very effective in both reducing multiple
pregnancies, and reducing the total numbers of embryos to be transferred. Traditionally,
cleavage rates of embryos in culture and qualitative morphology have been used exclusively for
selection. In recent years, however, it has been suggested that metabolism may be a superior
indicator of viability amongst morphologically identically embryos' 3' 14
There are several methods to measure the metabolism of cells. Many conventional techniques
typically involve damaging the cell in question, or necessitate the use of radio-labeled substrates
to target specific metabolic pathways1 5.Non-invasive assays therefore have the advantage of not
disturbing cell integrity or function, which is of foremost importance when studying
preimplantation embryos from a candidate pool. Non-invasive approaches, however, do have
limitations in the depth of data that can be obtained. Rather than targeting numerous specific
metabolic pathways, non-invasive assays provide a "black box" approach to infer glycolytic
activity of cells. To estimate the glycolytic activity in a cell, it is possible to assay samples of
used culture media to quantify both glucose consumed as well as lactate produced. Although
such an approach can give an indirect measure of glycolysis, it cannot exclude the possibility that
the lactate produced could have come from another source within the cell, likely from any
* The oocyte is the cell from which the unfertilized egg, or ovum, develops following a series of meiotic divisions.
When fertilized with a male's sperm, this cell is referred to as the zygote, which develops into the multi-cellular
embryo at cleavage. For nomenclature, refer to Figure 1.1.
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pyruvate generated from the metabolism of specific amino acids or from pyruvate taken up from
the surrounding medium, or from the use of endogenous glycogen 15 . Notwithstanding such
limitations, the ability to infer single cell metabolism using non-invasive procedures is a
powerful technique.
A direct approach to analyzing biological compounds in nano and picoliter volumes was
pioneered using specifically constructed glass micropipettes 16, and later modified by
embryologists during the investigation of the nucleotide content in single mouse oocytes and
embryos 7' 8. Micropipettes can be used to manually dispense volumes of sample and fluorescent
based reagent into droplets on microscope slides under mineral oil. After the fluids mix by
diffusion and the reaction proceeds to completion, the resulting fluorescence intensity is directly
proportional to the metabolite concentration in the media. Using this general approach of
combining metabolite specific enzyme cocktails with culture media, a variety of metabolites
concentrations such as glucose and lactate can be inferred' 8 . Complete details of the existing
assays and materials are reviewed in Chapter 2.
While very sensitive and capable of providing insights to the developmental process, there are
numerous drawbacks to this micropipette technique which has hindered widespread clinical
adoption. Performing the necessary fluorometric calibration and assays on many samples of
used embryo media takes a several technician-hours for each metabolite. The glass
micropipettes are custom made, and their volumes must be painstakingly calibrated prior to
assays. Manual manipulation of samples with glass micropipettes limits the opportunity for
automation, and precludes the possibility of integrating these assays in line with embryo culture.
Clinics that have developed innovative measurement techniques and implemented selection
metrics based on the quantifiable metabolic activity of candidate embryos have in turn delivered
significantly higher pregnancy rates 3' 13. Nevertheless, the correlation between metabolism of
preimplantation embryos and viability remains an open debate in the field due to the scarcity of
quantitative chemical data. A high-throughput tool would be an invaluable asset to understand
the metabolic factors that play the most important roles during the dynamic embryo culture
period.
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1.3 Suitability of Microfluidics
As the metabolite analysis process essentially involves repetitive steps of metering nanoliter
volumes, mixing an enzyme cocktail and performing fluorometric measurements, the process is
particularly suited for high-throughput automation in a microfluidic construct.
In recent years, microfluidics has demonstrated novel methods of studying and culturing cells.
Microfluidics is a continually growing field of biotechnology, where fluid samples in the
nanoliter to microliter range, may be manipulated in microfabricated channels in a manner
analogous to the control of electrical signals in a microprocessor to automate complex biological
and chemical laboratory procedures. Fluid flow at these small length scales is laminar, which
presents both advantages (precise fluid control, reduced sample volumes, ability to perform
biochemical processes in parallel, sample isolation) and certain tradeoffs (difficulties in fluid
transport, mixing and surface chemistry)19 when adapting this technology to miniaturize and
automate biological protocols. Simplifying the laborious process of cell culture has been of
particular interest in microfluidics, and recent research has delivered promising results and
improvements to this field 20-22. Within well-defined volumes comparable to the sample of
interest, media, nutrients or toxins may be precisely targeted to individual cells via diffusion or
advection, enabled by integrated valves and pumps. Microfluidic environments enable precise
and repeatable control of temperature, pH, culture volumes and fluid concentrations2 0' 23, 24
Existing metabolic profiling techniques are particularly cumbersome and laborious and have
gone unchanged for more than 20 years since their inception. For widespread adaptation in the
receptive ART community, it is desirable to standardize and automate the selection procedure
into a platform capable of carrying out the embryo culture and measurement procedures on
individual embryos. The growing field of microfluidics is well poised to fit this role, and offers
the potential to further improve the selection procedure in IVF.
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1.4 Scope of Thesis
To address the need of controlled culture environments and improve embryo health and
subsequent positive implantation rates, this thesis explores the development unique platforms of
software programmable microfluidic devices for both culturing embryos as well as quantifying
metabolite levels in the culture media. Such contributions, which will be of significant utility to
the embryologist and the field of assisted reproduction, represent a diverse set of challenges in
across biology, computer science and mechanical engineering.
This thesis is divided into four sections, each structured to elucidate contributions to the
engineering field. First, a microfluidic platform is introduced to enable automation of the current
micropipette metabolite assay. Next the methodology and systems for embryo culture in
microfluidic environments are developed. With the goal of tying together the assay and culture
techniques to a single platform, a microfluidic platform is invented in the third section which is
capable of real time metabolic profiling of several cell cultures in parallel. Finally, new
microfluidic design paradigms are conceived and implemented to extend device feature densities
and capabilities for cell based assays.
1.4.1 Non-invasive metabolic assessment of single cells
Non-invasive techniques have been pioneered by embryologists to assess the metabolic activity
of preimplantation embryos during IVF culture1 3' 16. While it is agreed upon that glycolytic rates
are correlated with developmental success, metabolic analyses for candidate selection for
implantation have not been widely adopted in the majority of clinics, as existing manual
measurement techniques are simply too cumbersome and low-throughput.
To address standalone metabolite analysis, Chapter Two introduces a high-throughput
microfluidic platform configured to automate the previously described enzyme based metabolic
assays. The complete analysis system consists of the microfluidic device and supporting
hardware, a fluorescence microscope equipped with a motorized shutter, a CCD camera which
may be externally triggered, as well as the software to coordinate and run analysis routines. The
sensitivity and repeatability of this platform is capable of measuring the metabolic activity of
single embryos by analyzing sub-microliter samples of their spent media.
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The microfluidic device consists of a flow channel network for loading and mixing inputs, as
well as a control channel layer for orchestrating the movement of fluid in the flow layer. These
devices are fabricated from the silicone elastomer polydimethylsiloxane (PDMS) using the well
established multilayer soft-lithography fabrication process25. Input reservoirs to the chip contain
all of the enzyme cocktails, calibration standards and a rinse buffer. Media samples for analysis
are loaded into the remaining ports. Rather than coordinating measurements in nanoliter
droplets, reactions and measurements are now completed on chip, in much less than a minute
each. These non-invasive microfluidic approaches offer potential benefits of sample throughput,
measurement repeatability and compatibility with existing cultures. As all measurements are
automated through software, it is straightforward to record data and create custom mixing
routines.
For the device to be of utility to clinical users, it is desirable to bring the microfluidic software
and instrumentation to a state where a non-microfluidic specialist is capable of loading and
analyzing samples without concern for the microfluidic details. To ensure the most accurate
assays with this approach, thorough calibration studies were undertaken. Operational features of
the microfluidic approach have been characterized, including minimum mixing times of enzyme
and sample, the volume of media required for every assay, and robust operating pressures.
Macro scale issues such as the device service life have also been examined. One of the key
challenges was to provide a robust solution to the problems of culture sample transfer and
loading. Additional considerations are also considered in the transition to a microfluidic
construct, such as modification the enzyme cocktails to improve mixing times and minimum
detectable fluorescent signal, which make the platform more attractive to IVF practitioners.
As a proof of utility of the microfluidic platform, spent culture media of individual
preimplantation mouse embryos were metabolically profiled in a non-invasive manner. Less
than 500 nl of collected media was required to infer the consumption of nutrients and production
of waste products for a single embryo. Assays could be completed automatically over several
hours using software routines, rather than requiring attended hours by a clinical technician
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working with glass micropipettes to manipulate nanoliter droplets. Routines for image
acquisition and data analysis also simplify the inconvenience of manual data logging.
The architectures and methods develop herein should also extend to analysis of other types of
cells beyond IVF, as well as generate interest in automating related analytical assays.
This is an important development as it may be used in conjunction with standard embryo culture
techniques, and may also be integrated with microfluidic culture in the future. Before that next
step is possible, however, the methods required for supporting embryo culture in microfluidic
environments must be improved. These challenges are the goal of Chapter Three.
1.4.2 Microfluidic Based Embryo Culture
Extending the reach of this work in developing a means to non-invasively measure the amount of
metabolites in culture media, methods are developed to enable embryo culture directly in
microfabricated devices. Tools which both enable a repeatable and systematic means of single
embryo culture, as well as the ability to later integrate microfluidic components to measure
metabolic activity of individual embryos, should be of significant interest to an embryologist.
With robust protocols for microfluidic culture, it will be possible to implement culture channels
in a modular manner upstream of the architectures required for microfluidic metabolite analysis.
In conventional embryo culture, embryos may be cultured in microdroplets of media, in small
groups of embryos in 1-20 tl of media in a Petri dish. To prevent evaporation, oil is simply
overlaid on the droplets. While straightforward, this technique does not enable automatic
methods for metabolite analysis to be integrated to the culture process. If it becomes possible to
culture preimplantation embryos on chip with integrated valves and pumps, then it will be
possible to develop complete culture systems with chemical measurement capability. To date,
no research group has attempted to culture embryos in isolated, defined volumes on chip.
The field of embryo culture for IVF applications is of particular challenge for microfluidics. In
contrast to many cells routinely cultured for research purposes, oocyte cells are particularly
valuable and their safe retrieval from culture systems is a primary concern. The length scales of
channels in microfluidic devices are generally in the 10 - 100 jtm range. As the secondary
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oocyte is the largest cell in the human body (100 pm in diameter, which can increase to -150
jim by the blastocyst stage), embryo samples can push the limits of volumes within a
microfluidic channel. For reference, the murine samples used in the present research have
typical oocyte and blastocyst diameters of -70 jm and -100 m, respectively. Microfluidic
systems must therefore be carefully designed to enable reliable sample loading and retrieval
when working within the constraints poised by conventional microfabrication techniques23' 25. In
addition to tight control over culture volumes, integrated microfluidics provide additional
protection for the valuable embryo from the surrounding lab environment and thermal
fluctuations. Potential avenues of this work enable studying the effects of single embryo culture
in sub-microliter volumes, which will be precisely created by microfabricating channels of
appropriate dimensions.
The surface area to fluid volume ratio also increases within miniaturization, which necessitates
the consideration of surface interaction, either due to the absorption of small molecules and
proteins from the culture media20' 23, or due to the diffusion of toxins from the device walls into
the culture chamber. Engineering appropriate systems and processes are key challenges in
consideration of potential implications of the interaction between the fluid environments on
sample development.
It has been hypothesized that numerous variables associated with laboratory culture systems
(including accumulation of metabolites, such as lactate and ammonia and depletions of necessary
nutrients, namely glucose and pyruvate) are related to the low yields of viable embryos in vitro.
In vivo, the female reproductive tract is constantly active, resulting in movement of the embryo
down towards the uterus as illustrated in Figure 1.1. This movement also washes the embryos
through constantly changing physiological conditions through the oviduct to the uterus,
maintaining a gradient for the supply of necessary nutrients and oxygen, and the removal of
waste products 26. As the in vivo environment is dynamic, it has thus been hypothesized that the
use of an active system may be beneficial for in vitro culture.
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High pyruvate
High lactate
Figure 1.1: Developmental stages (and nomenclature) of an embryo in vivo (image courtesy of
David K. Gardner and by Vitrolife AB, Sweden). For IVF, fertilization and the first three days oj
culture are performed in lab settings. More commonly over recent years, the culture is now
continued until day five (blastocyst stage) in vitro prior to implantation, due to the advance of
improved culture methods, which results in significantly higher pregnancy rates. The cleavage
rates (for example, the transition from two-cell to four-cell through day two) are well
characterized, and used as developmental markers in lab culture. Different embryo culture
media is often used after the eight cell stage to imitate the dynamic environment of the female
reproductive tract.
An embryo's metabolic requirements differ with developmental stage27 . The pre-compacted
embryo (prior to day 4) has a low metabolic activity and has a very limited capacity to utilize
glucose. During the first few days an embryo generates energy from low levels of oxidation of
pyruvate, lactate and amino acids. Approximately 95% of the zygote's energy is metabolized
through the citric acid cycle (commonly known as the TCA cycle), while glycolysis of glucose
accounts for only -4%4. Proliferation and compaction are also stimulated by the presence of
non-essential amino acids and EDTA2 8. In contrast, the embryo post-compaction (days 4 and 5)
has a higher metabolic activity. It uses glucose as the preferred nutrient and requires a wider
array of amino acids for cell proliferation and differentiation, as well as specific vitamins to
maintain oxidation28. By this time, aerobic glycolysis and the TCA cycle now account for about
45% each of the energy metabolized, with the remaining due to the pentose phosphate pathway4.
f
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In response to the known metabolic preferences of the preimplantation embryo, different media
formulations may be substituted across days of culture. The advent of sequential IVF media in
the past two decades has been very effective in supporting the development of viable human
embryos and blastocysts in clinical settings27' 29, 30. Standard microdroplet culture techniques,
however, are limited to providing homogeneous concentrations of metabolites to embryos.
Research to advance culture approaches would benefit from systems which are capable to more
closely replicating and sustaining physiological chemical gradients.
As culture volumes are reduced into the sub-microliter per embryo range, secreted autocrine (or
from neighboring samples, paracrine) growth factors are more concentrated and are believed to
enhance development during the preimplantation period3 1. Standardization of such procedures
and culture conditions is particularly important when comparing results from multiple cell
samples, and also allows researchers in separate laboratories to replicate procedures using their
own microfluidic platform. The advantage of using a microfabricated culture environment is to
mimic the biological environment through agitation or recirculation of media, which may in turn
be modeled from a mechanical and chemical standpoint. Techniques have been developed to
improve the culturing via software control and feedback driven culture protocols32' 33. Related
approaches in dynamic (continuous flow) perfusion culture are also reviewed in the context of
studying and isolating the interactions between different types of cells.
Two of the primary challenges in enabling microfluidic embryo culture to be addressed in
Chapter 3 are the issues of device preparation to prevent toxicity, and the development of
methods to accommodate loading and retrieval of large embryos. Unlike engineered somatic cell
lines used in routine biological research, gametes and embryos are particularly sensitive to their
surrounding environment23' 34, and are susceptible to poisoning by residual chemicals used to
fabricate devices 25. The second main challenge addressed is in developing a new type of channel
and valve system capable of accommodating such large samples. Conventional multilayer soft-
lithography devices use two layers of channels to form pneumatic valves integrated into the
PDMS chip. Such valves have traditionally been restricted to flow channels in the 10-50 pm
height range, and as such, are incompatible for accommodating embryos which are 100 pm or
greater in diameter. Microfluidic devices with deep valves for sealing culture chambers
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containing embryos will enable integration with microfluidic metabolite analysis, as well as
address outstanding questions to improve static culture. Culture within specific volumes of
media is necessary for our proposed method of embryo profiling by observing the uptake and
production of metabolic factors over time. In this work, the largest multilayer soft-lithography
valves to date are developed using a novel mold fabrication process, capable of sealing channels
greater than 150 jtm in height. These valves are compatible with standard control techniques and
allow the safe passage of embryos into culture chambers.
Until now, no microfluidic research groups have tackled closed-volume issues in microfluidic
embryo culture. While embryos have been cultured in open microchannel systems (not
containing valves) by other research groups, effective media volumes have been an order of
magnitude or two larger, and the devices are incompatible with our proposed methods of
metabolic screening. This research is the first to culture embryos in truly confined chambers on
chip, and irrefutably, in the smallest microfabricated volumes.
Microfluidic embryo culture will be applicable to pursue several open questions in the field of
embryology. For example, it would be of particular value to determine if there exists an optimal
volume for static culture, and whether that volume is limited by metabolite depletion. Also,
since the in vivo environment is dynamic, it could be assessed whether gentle agitation or
recirculation of media using integrated pumps improves overall culture. Regiments for
replenishing spent media could be automated and reduce the need to manipulate samples
manually.
1.4.3 Providing inline cell culture and metabolic profiling
Chapter Four describes the amalgamation of the engineering contributions introduced in
Chapters Two (detection) and Three (culture), by the development of a microfluidic platform for
integrated culture and metabolic analysis. Beyond simply incorporating these two functions on a
single device, a unique scalable architecture is presented which can perform non-invasive
metabolic assays on parallel nanoliter cultures of mammalian cells simultaneously. This
platform is a major step towards an integrated culture system which may manage and
metabolically assess several individual embryos in an automated manner.
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Key features of the of the microfluidic networks developed in Chapter Two are adapted to
automate metabolic assays on samples of spent culture media. It is necessary to locate this
functionality directly downstream from on chip culture chambers. To improve the functionality
of this platform and identify suitable operating conditions, this new device is run through a series
of calibration studies. These studies cover device operations such as sample metering, rotary
mixing for metabolic assays, as well as mixing for circulation of culture media over samples.
Rather than use embryos on this first generation system, mammalian cells lines are used as
model systems. Individual culture chambers are capable of hosting approximately 100 cells each
were designed into the chip. While these cells are more stable than murine embryos, it was still
necessary to use the lessons learned in Chapter Three to enable robust cell culture on chip.
Parametric cleaning and surface treatment studies were completed to determine the necessary
protocols which would allow adherent cells lines to thrive in these microfluidic chambers.
Results of these parametric studies would also be of interest to researchers sustaining subcultures
of cells and tissues in microfluidic environments.
This high-throughput platform with both culture and chemical detection functionality has several
implications in the fields of biological research. An integrated system can be used to implement
feedback driven culture, and upstream treatment of samples can be modified based on the current
metabolic measurements of samples. Robust systems for studying the metabolism of cells would
also be of interest to medical researchers. Cancerous cells exhibit unique metabolic profiles in
contrast to their normal state, which provides opportunities for identification and treatment. It
may be possible to use metabolic inhibitors to target cancer cells by shutting down their main
sources of energy, while healthy cells can adapt to alternative metabolic sources35 . Enabling a
systematic approach for quantifying the effectiveness of various cancer inhibitors on tissue and
cell lines (or even combinations of inhibitors for simultaneously addressing different metabolic
pathways) would be very powerful. Further, by using software driven routines it will be possible
to pursue to the optimization of culture conditions of various cell lines based on their metabolic
profiles.
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1.4.4 Extending the capabilities of microfluidic architectures
In Chapter Five, a new design paradigm known as vertically integrated microfluidics is
introduced and implemented to extend device feature densities for on chip assays. Vertically
integrated microfluidic architectures will also open new avenues of research in fields of
biotechnology including cell culture and protein crystallization, where sample density on chip is
of paramount importance.
The majority of microfluidic devices in modem research consist of either one, or two layers of
channels. Devices containing integrated MSL valves used throughout the thesis up to this point
are in the later group, where the first channel layer containing fluidic samples of interest is
regulated using a complimentary valve layer 25. The size of channels and valves is a function of
the samples to be studied. For example, mammalian cells with diameters of - 10 jLm,
necessitates that channels are probably 20 [tm or larger. As such, the number of parallel assays
completed in microfluidic constructs cannot necessarily be increased by miniaturization alone.
One way to alleviate this bottleneck is to increase the number of functional layers within a
microfluidic device. The most complex microfluidic architectures to date have demonstrated
1000 fluidic storage chambers with a single flow layer device, necessitating a stamp sized
footprint (- 25 mm x 25 mm). Assuming a constant feature size, to increase the total number of
features by ten-fold, would require a footprint of approximately 80 mm x 80 mm. Twenty-fold
more chambers would require a device footprint with a staggering 110 mm x 110 mm base.
Large areas significantly increase the likelihood for assembly defects, and the large field of view
complicates sample inspection. In this chapter, it is reasoned and demonstrated that a preferable
way to increase the number of features on a microfluidic devices is to add layers, akin to
performing biological research in a skyscraper as opposed to a bungalow.
Methods to independently address layers of microfluidic chambers are developed, which are key
to this technology. Vertical multiplexors allow a user to address one functional flow layer at a
time, while reducing the total control overhead. In this manner, experiments between layers
remain independent, while on chip resources such as reagents and control valves are provided by
common inputs.
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Optical techniques are reviewed, and the necessary conditions for monitoring samples in
overlapping layers independently are discussed. Unique manufacturing techniques are
developed to allow the fabrication of such complex systems. Limitations of existing thermal
assembly techniques have prohibited the previous development of such systems. If thermal
techniques had to be used, the assembly time scales linearly with the number of layers. As such,
a ten layer device would take at least ten times as long to manufacture. The last thing
microfluidic researchers desire is more time spent fabricating devices. A hybrid thermal-plasma
approach is devised, where the forgiving nature of thermal bonding is combined with the parallel
processing nature of plasma bonding. Complete details of these processes are provided in
Chapter Five.
With the conceptual nature of this work in place, applications of this powerful technique are
demonstrated. In the first set of applications, large scale fluidic storage arrays are implemented.
For a proof of principle, it is shown that vertical large scale integration (VLSI) can be used to
implement networks with 214 (= 16384) independently addressable storage chambers located
across eight flow layers, while necessitating a device footprint of only 25 mm x 25 mm. The
number of features can be increased by simply adding more layers.
Relating the implications to biological research, vertically integrated devices are then
implemented for cell based toxicity assays. Different architectures are developed for row &
column based toxicity assays36, as well as methods for addressing sub cultures on chip
independent from one another. The techniques and design principles pioneered herein will be of
interest to biologist and engineers working to automate demanding high-throughput applications
such as protein crystallization and drug discovery. The manufacturing techniques may also
provide inspiration to alleviate other aspects of microfluidic assembly carried out in the
microfluidic community.
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1.5 Research Outlook
It is of particular interest to use feedback driven agitation schemes in microfluidic systems,
which could be based on the metabolic activity of the present concentration of nutrients and
waste products, in relation to the metabolic activity. By studying embryo nutrition on chip, it
should possible to formulate more suitable culture conditions and develop non-invasive tests of
embryonic health prior to transfer 37. Microfluidics may present one of the most promising viable
options to readily adjust the culture conditions dynamically.
Non-invasive measurement techniques have become an integral method of embryo profiling for
SET, but the laborious and time consuming nature of existing tools restricts the amount of data
that can be gathered from the cells during the culture process. Current techniques for assaying
metabolites are sufficiently cumbersome that they are not useful clinically. Automatic, real time
metabolite monitoring may enable the ability to dynamically modify and optimize culture
conditions in vitro. High-throughput tools such as those introduced in this work will also help to
address the difficult questions relating metabolism and developmental potential of embryos.
Microfluidics offers the opportunity to adapt precise fluid metering and measurement techniques
to approach the limit of continuous and automatic monitoring of single embryo culture
conditions. This work to automate such procedures through novel methods should increase
effectiveness and practicality of non-invasive embryo selection to a broader audience in assisted
reproductive medicine. By combining single embryo culture and real time analysis functionality
into a single automated platform, parameters affecting embryo viability may be studied and
understood with unprecedented accuracy. As these tools work to improve the probability of
healthy pregnancy using SET and reduce the expected number of ART cycles per pregnancy,
they may reduce financial burden and disappointment of patients undergoing these procedures.
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Chapter Two - Non-invasive Microfluidic Metabolic
Profiling of Single Cells
2.1 Introduction
Metabolomics represents an important approach to studying functional biological systems, and
provides valuable complementary information to that obtained from gene and protein expression
studies. The development of new tools and techniques for the analysis of cellular metabolites
(specifically various nutrients and waste molecules generated by living cells) has found
important application in exploring directed evolution, drug toxicity and cancer38 ' 39
Metabolomic studies of single cells are advantageous because the complexities associated with
cellular heterogeneity can be avoided. For studies of organisms composed of a single or small
number of cells, such as embryos during early development, single cell sensitivity is an absolute
necessity.
There is also a strong impetus from the clinical field of assisted reproduction to develop non-
invasive methods for evaluating the health and developmental potential of embryos. The current
prevailing method for selecting embryos in clinical in vitro fertilization (IVF) programs is based
on physical characteristics identified through light microscopy. It is well recognized within the
clinical community that morphology is not only subjective but a relatively poor indicator of
developmental potential40. As a result, more than one embryo is often transferred to the uterus in
an IVF cycle, frequently leading to multifetal pregnancies which increase risks to the pregnancy,
the mother and the child41. In an effort to move toward single embryo transfer, a variety of non-
invasive approaches to assess embryonic developmental potential are being developed 42.
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One of the most intensely investigated biologic processes in early embryonic development is
metabolism. Studies over the last four decades have revealed that the early embryo undergoes
dramatic changes in its metabolism, switching from a low to a high basal metabolic rate43
Commensurate with this increase in metabolic activity is a switch in utilization of nutrients,
switching from a pyruvate to a glucose based metabolism (following Figure 1.1)43. These
metabolic changes are similar to those seen when a variety of cell types undergo cancerous
transformation 44. Furthermore, it has been demonstrated that situations in which embryonic
development is abnormal are associated with alterations in metabolism. Studies of murine
embryos have shown that those blastocysts with an elevated glycolytic rate have impaired
developmental potential 4. Energy metabolism may also serve as a biomarker for the
developmental potential of human embryos, but no appropriate prospective trials have been
performed to date45 . Much of the reason for the limited data on embryonic metabolism resides in
the challenges of measuring metabolites in the small volumes of media that are used for culturing
individual embryos.
The most common means of non-invasively assessing metabolism of embryos has been to
evaluate what embryos consume and produce through analysis of culture media. Several studies
have used fluorometric enzymatic assays to evaluate utilization of the energetic substrates,
specifically glucose, pyruvate and lactate. For these assays, the metabolite of interest is a
substrate for an enzymatic reaction that either consumes or produces NAD(P)H, which fluoresce
when in the reduced form. A number of important metabolites, including glucose, pyruvate,
lactate, citrate, and several amino acids can be readily assayed using NAD(P)H enzymatic
assays16.For example, pyruvate is assayed by measuring the consumption of NADH in the
lactate dehydrogenase-catalyzed reaction. Reactions are detailed further in section 2.2, and
Appendix A. Due to the very small samples, often in the sub-microliter range, these assays are
performed using constriction pipettes that can be calibrated to the low nanoliter range46' 47. The
drawbacks of this technology are that the method is incredibly labor intensive and pipette
construction is complex. Other recently developed approaches with promise for non-invasively
evaluating embryonic metabolism include the evaluation of oxygen consumption using a variety
of specialized oxygen probes, amino acid turnover using high-performance liquid
chromatography (HPLC), and metabolic profiling using various forms of spectroscopy 48 51. All
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of these studies seem to support the hypothesis that embryos with differing developmental
potential can be segregated by metabolic activity, yet much work remains to be done to
determine what specific markers should be evaluated and how they should be detected.
An array of microfabricated approaches have been previously developed with the shared goal of
studying cellular metabolism, many of which are technically more complex and may not be
suitable for routine clinical use. Electrochemical microphysiometers have been used for
monitoring changes glucose and lactate concentrations in cell cultures using both continuous 52
and discrete53 fluid flow approaches that necessitate larger sample volumes and are prone to
difficult calibration. Scanning electrochemical microscopy (SECM) has been demonstrated as a
non-invasive means for studying the metabolism of single cells, though probe fouling,
instrumentation as well as calibration can also be challenging. Through SECM, oxygen
consumption of single bovine embryos has been measured with relation to embryo viability54,
and custom probes for glucose and lactate have recently been used to generate two dimensional
concentration maps surrounding individual cancer cells55 . Picoliter chambers with integrated
electrodes have been used for the quantification of glucose and lactate changes of stimulated
single heart cells56' 57. In addition, devices have also been fabricated for monitoring changes in
glucose and lactate from cells attached to beads with NAD-linked enzyme assays58 . These
specialized methods exemplify the challenges involved in developing flexible systems that are
compatible and can be integrated with embryo culture.
These specialized methods exemplify the challenges involved in developing flexible systems that
are compatible and can be integrated with embryo culture. Continued advancement in this field
also conveys the desire and excitement of studying metabolism at a single cell level with a robust
system. With the goal of improving the ability to analyze media for substrates of energy
metabolism, an automated microfluidic platform for performing NAD(P)H-dependent enzymatic
assays has been developed. Development of such a system represents a multitude of mechanical
engineering challenges and the contributions described herein would be of particular interest to
researchers in the fields of both engineering design and metabolomics.
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2.2 Assay Background and Existing Clinical Protocols
There are several methods to measure the metabolism of cells. Many conventional techniques
typically involve damaging the cell in question, or necessitate the use of radio-labeled substrates.
Non-invasive assays therefore have the advantage of not disturbing cell integrity or function,
which is particularly important when studying preimplantation embryos from a candidate pool.
Non-invasive approaches however, do have limitations in the depth of data that can be obtained.
For example the use of radio-labeled substrates can assist in determining the relative activity of a
specific metabolic pathway, such as the use of [5- 3H] glucose to measure the activity of specific
pathways' .
Rather than targeting numerous specific metabolic pathways, non-invasive assays provide a
"black box" approach to infer glycolytic activity of cells. To estimate the glycolytic activity in a
cell, it is possible to quantify in the surrounding media, both glucose consumed as well as lactate
produced (glycolytic activity can be calculated on the basis that 1 mol glucose produces 2 mol
lactate, and is often expressed as a percentage 4). Although such an approach can give an indirect
measure of glycolysis, it cannot exclude the possibility that the lactate produced could have
come from another source within the cell, likely from any pyruvate generated from the
metabolism of specific amino acids or from pyruvate taken up from the surrounding medium, or
from the use of endogenous glycogen' 5. Blastocysts with elevated glycolytic activity during the
preimplantation period (with a lactate production beyond that which can be accounted for by
glucose consumption) presumably waste energy reserves4 , and are suggested to be less viable for
IVF transfer. It is proposed that these blastocysts are less likely to implant in (the relatively
oxygen deprived) lumen of the uterus due to premature exhaustion of their necessary glycogen
stores4. Notwithstanding the limitations to identify all sources of energy expenditures, the ability
to infer single cell metabolism using non-invasive procedures remains a powerful technique.
2.2.1 Microdroplet Assays
A direct approach to analyzing biological compounds in nano and picoliter volumes was
pioneered using specifically constructed glass micropipettes' 6 . Micropipettes were used to
manually dispense volumes of sample and fluorescent based reagent into droplets on microscope
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slides under mineral oil. An example of a custom fabricated glass micropipette is illustrated in
Figure 2.1.
Figure 2.1: A doubly constricted glass micropipette calibrated to dispense 1 nl samples (Image
courtesy of Mark T. Johnson and Fertility Labs ofColorado).
After the fluids mixed by diffusion and the reaction had gone to completion, the fluorescence
intensity of the droplets was measured directly under oil to quantify the product of the assay.
This simple micropipette assay was modified by embryologists during the investigation of the
nucleotide content in single mouse oocytes and embryos' 7' 18. Rather than using a fluorescent
reagent, the procedure was a miniaturized version of existing methods of enzymatic analysis in
which the nucleotides NADH and NADPH are generated or utilized in enzyme based reactions,
as described by Lowry46. These pyridine nucleotides are excited around 340 nm, and when the
reduced forms are excited with UV, they emit fluorescence at 450 nm and above (These
nucleotides fluoresce when excited where the oxidized forms, NAD+ and NADP+ do not).
Using this general approach of combining custom made enzyme cocktails with culture media, a
variety of metabolites and enzymes can be studied' 8 .Fluorometric assays for metabolites and
enzymes are based on the generation or utilization of the reduced pyridine nucleotides, NADH
and NADPH in coupled enzymatic reactions (See Appendix A).
The intensity of the measured product is related to nominal concentrations using calibration
standards for the metabolite of interest. Thus it is necessary to create calibration curves for every
metabolite prior to every assay (glucose, lactate, and pyruvate) over the range of interest. When
the details of the conventional measurement technique are briefly reviewed, the applicability to
automation through microfluidics becomes apparent.
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Fluorometric analysis of metabolites in culture media have been conventionally performed in 1-
20 nl droplets on microscope slides under heavy mineral oil to prevent evaporation. For each
assay, metabolite specific cocktail solutions are prepared in advance which contain a buffer and
all of the co-factors and enzymes needed for the reaction. The fluorescence of each droplet is
measured by quantifying fluorescent intensity when exciting the pyridine nucleotides in the
cocktail by a UV light source. This is done using an epi-fluorescent microscope equipped with a
DAPI filter set, a high numerical aperture objective, as well as a sensitive CCD camera or
photomultiplier tube to quantify fluorescent intensity.
To start the assays, 1-5 nl of media sample is added to the cocktail drop to initiate a reaction (the
volumes may differ based on the particular assay, but as a rule of thumb, 1 part of media sample
is mixed with 10 parts of enzyme cocktail). The drops on the slide are then left until the reaction
has gone to completion. As mixing occurs by diffusion only in these microdroplets, mixing can
take anywhere from several minutes to an hour. All droplet reactions are prepared in a serial
manner using a micropipette (sometimes attached to a micromanipulator) under a microscope.
The difference in fluorescence between the reagent cocktail drop before and after addition of the
sample should be linear within the concentrations to be assessed. It is necessary to measure a
range of calibration standards with known amounts of glucose, lactate and pyruvate for each
experiment to determine fluorescence range of the substrate. Acceptable linear regression values
for intensity vs. concentration curves are R2 > 0.99.
To perform metabolic assays on cells or embryos, clean drops of medium are prepared under oil
in a dish. Depending on the sample, droplets may be in the 50 - 1000 nl range (larger volumes
are typically used for human samples). Individual embryos are transferred from their original
group culture into these temporary incubation drops using small glass pipettes to minimize cross
contamination from previous media. Linear rates of uptake or production may be determined for
each cell by taking subsequent samples from the incubation pool at regular 30 - 60 minute
intervals. Control droplets which do not contain embryos are also often sampled in parallel to
account for any breakdown of media that may have occurred during this period. If the collected
aliquots of media are not to be analyzed immediately, they may be frozen, and measured at a
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later period. This is particularly helpful in the current research, as samples prepared in IVF
clinics may be analyzed offsite.
There are numerous drawbacks to the existing techniques. Performing the calibration and assays
often takes a period of several hours as measurements for each metabolite are performed in
triplicate in a clinical setting. The glass micropipettes are custom made, and their volumes must
be painstakingly calibrated using radio labeled techniques prior to use.
Shapes of the microdroplets are prone to change experiment to experiment, and the free surfaces
of droplets are dependent on the wetting properties of the glass, cocktail and oil. The curvature
of microdroplets also leads to variation in fluorescence imaging. It would be ideal to work with
identical volumes for every measurement, and to not have to mix nanoliter droplets manually in
order to obtain important metabolic information. As the metabolite analysis process essentially
involves repetitive steps of metering nanoliter volumes, mixing an enzyme cocktail and
performing a measurement, the process is particularly suited for high-throughput automation in a
microfluidic construct. As a benchmark to microfluidic based measurements, these conventional
microfluorometric assays were also performed in calibration studies for this chapter using doubly
constricted micropipettes4 7.
2.2.2 Enzymatic Assay Preparation
Metabolite specific enzyme cocktails were prepared following Leese and Barton' 8 and Gardner
and Leese 59. Complete recipes for the metabolic cocktails used, as well as additional assay
detailed are presented in Appendix A. The assay mechanisms for the metabolites of interest are
presented below based on Gardner and Leese. In the case of pyruvate, measurements are based
on the reduction in NADH. For lactate and glucose, fluorescence is due to the generation of the
pyridine nucleotides NADH and NADPH, respectively.
Pyruvate Assay:
Lactate Dehydrogenase
Pyruvate + NADH + H+ Lactate + NAD+
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Lactate Assay:
Lactate Dehydrogenase
Lactate + NAD+  Pyruvate + NADH+ + H+
Glucose Assay:
Step 1:
Hexokinase
Glucose + ATP - glucose-6-phosphate + ADP
Step 2:
Glucose-6-phosphate Dehydrogenase
Glucose-6-phosphate 6-phosphogluconate + NADPH + H+
Standards for glucose, lactate and pyruvate were prepared by adding known amounts of the
particular metabolite to either water or media formulations. Single use glucose and pyruvate
aliquots were stored at -800 C, and lactate cocktails were prepared fresh immediately prior to
experiments.
2.3 Experimental
2.3.1 Device Fabrication
Microfluidic detectors in the present study were prepared by the process of multilayer soft
lithography using PDMS 25 (Sylgard 184, Dow Coming). Devices were fabricated using the
bottom-actuated valve configuration suitable to closing deep aspect ratio channels 60 . A three
layer photoresist process was used to fabricate the flow mold on a silicon wafer. Briefly, a 20
jim thick layer of SU8 10 (Microchem) was first used to pattern input sieves near the device
interconnects, which prevented debris from entering the channel network. Next, a 50 jIm thick
layer of positive tone AZ 50 XT (Clariant) was aligned and patterned. After development, the
AZ was reflowed by placing the wafer on a hotplate at 1200 C to create channels with round cross
sections followed by a hard bake overnight at 130 0 C. Finally, a layer of 50 Pm thick SU8 50
was aligned to the existing AZ, and used to add new channels segments with rectangular cross
sections in the mixing chamber for fluorometric imaging. Sufficiently hard baking the base AZ
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layer made the resist impermeable to most developers and allowed subsequent processing with
SU8. The control wafer for the detector chip was created using two layers of 25 pm thick SU8
10. The second layer of SU8 was patterned over the base layer where valves were located. This
made it unnecessary to neck down the width of the control channels where the lines crossed flow
channels and enabled faster valve performance. Molds were treated with silane to facilitate
PDMS casting. The flow and control layers of the device were cast and thermally bonded at
800C using 5:1 and 20:1 PDMS, respectively. After curing of the two layer device for
approximately 36 hours, input ports were punched with biopsy tools and chips were cleaned
using ethanol and nitrogen. Individual detector chips were bonded to pre-cleaned 1 mm thick
glass slides using a 30 second air plasma treatment on target surfaces at low RF power
(Expanded Plasma Cleaner, Harrick Plasma, Ithaca, NY).
2.3.2 Embryo Culture and Sample Preparation
Female Fl hybrid (C57B1/6 X CBA) mice at 5 weeks' age were superovulated with 5 I.U.
pregnant mare's serum followed 48 hours later with 5 I.U. of human chorionic gonadotropin
(Sigma) and then immediately mated with Fl hybrid males. Zygotes were collected from the
oviducts 21 hours after mating and cultured individually in 1 ld microdroplets of embryo culture
media blanketed by paraffin oil in a Petri Dish. Every 24 hours, the embryos were transferred to
microdrops of fresh media and the dishes containing the spent media were frozen at -800 C until
assays were performed. In this non-invasive approach, sampling is not performed from droplets
containing embryos; rather pools of spent media are used for assays. Embryos were cultured in
modified G1 medium for the first two days and modified G2 medium for the second two days61
To facilitate metabolic analysis, the glucose and pyruvate concentrations were adjusted to 0.3
mM and lactate was omitted from the media. Media were supplemented with 5 mg/ml human
serum albumin prior to culture. All cultures were performed in an incubator at 370C with 5% 02
and 6% CO 2. Developmental progress of each embryo was assessed daily by examining the
morphology. Half of each spent media drop (500 nl) was transferred to a replicate plate and then
both sets of plates were frozen at -800 C until used for metabolic analysis.
Variations of this media sampling approach are also possible, always with the intention of
protecting samples. For example, if embryos were being cultured in larger volumes (-10-20 tl),
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it is possible to transfer samples to smaller temporary media droplets for predetermined amounts
of time before being returned to their original droplet. Again, this would be performed to assess
changes is metabolite levels per embryo per unit of time within these temporary droplets. By
using smaller volumes, changes in substrate concentrations are more dramatic and easy to detect.
2.3.3 Hardware and Automation
Parallel microfluidic workstations were developed both at M.I.T. and Fertility Laboratories of
Colorado. Open source JAVA based software platforms at both locations were used to
orchestrate all device operations, image acquisition and data analysis62
Microsolenoids were used to control the integrated multilayer soft-lithography valves, and were
controlled by JAVA software as previously described 62, 63. Typical operating pressures were 15
psig for the control valves, and 3 psig on sample and reagent inputs. Fluids were interfaced to
the device using Tygon tubing (500 pm ID, Cole-Parmer) and sterilized stainless steel pins (New
England Small Tube Corp).
The device was mounted on an Olympus IX-71 epifluorescent microscope equipped with a long
working distance 20X objective (NA = 0.45), a neutral density filter (ND 0.25), a Sutter Smart
Shutter and a Prior motorized stage. Fluorescent reaction products were imaged through a DAPI
(340 nm/420 nm, EX/EM) filter set. The objective was focused on a microchannel with a
rectangular cross section within the mixing section of the chip for image acquisition.
A cooled CCD camera (Apogee Alta U2000) was externally triggered using JAVA and custom
scripts through MicroCCD (Diffraction Limited). 16-bit grayscale images were captured for
every sample measurement using an exposure time of 0.5 seconds at 2 x 2 binning and a CCD
temperature of 00 C. The shutter was synchronized with image acquisition to prevent
photobleaching of reaction products prior to measurements. ImageJ (NIH) routines were
integrated into the JAVA control software to analyze acquired images in real time. Area
averaged background intensity on the chip was subtracted from fluorescence intensity in the
microchannel for each measurement.
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Calibration standards with known amounts of glucose, lactate and pyruvate diluted in G1 or G2
culture media were used to generate calibration curves to relate measured fluorescent intensity to
metabolite concentration. It was possible to use standards containing known amounts of all three
metabolites in the same stock, which reduced the number of required fluid inputs to the device.
Metabolite specificity of enzyme cocktails was ensured through calibration studies. Calibration
curves were highly linear in the range of 0-1 mM for the metabolites glucose, lactate and
pyruvate, consistent with the values expected physiologically in embryo culture media.
Detection limits were estimated to be below 10 pM for the three metabolites of interest using the
current imaging settings, although it is straightforward to use a variety of methods such as longer
camera exposures or deeper detection channels to provide more signal, if it becomes necessary to
extend fluorometric limits in future work. Linear regression values on calibration curves
typically exceeded R2 = 0.999 (in conventional microdroplet assays, R2 > 0.99 on five point
calibration curves are considered sufficient). In additional calibration trials, linearity was
obtained in the 1-5 pM range, is indicative of a very high signal to noise ratio when imaging in
microfabricated channels. Standards were interspersed alongside media samples on chip during
analysis routines for fluorometric calibration. Slope and intercept values for fluorometric
calibration of each metabolite were updated continuously over the course of routines to account
for any changes in background light levels, or degradation of enzyme.
2.4 Detector Design and Performance
The microfluidic detector device consists of a flow channel network for loading and mixing
inputs, as well as a control channel layer for orchestrating the movement of samples and
reagents. Input reservoirs to the chip contain all of the enzyme cocktails, rinse buffer, and ports
for loading multiple media samples for analysis. A schematic of the microfluidic detector is
shown in Figure 2.2.
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Figure 2.2: Schematic of the microfluidic metabolite detector fabricated using multilayer soft
lithography. Red and blue features denote control and flow layers ofPDMS, respectively. Six
fluid inputs are reserved for supply of enzyme cocktails and wash buffers, while ten inputs are
used for loading media samples and calibration standards. To perform assays, samples of
culture media are metered into the central mixing ring and combined with a metabolite specific
cocktail. A fluorometric measurement is recorded after complete mixing (camera field of view
denoted in purple). Finally, the mixer contents are washed prior to the next assay.
Initial studies were performed with calibration standards to establish the fluorometric sensitivity
of the microfluidic detector, which relies on the detection of UV-excited pyridine nucleotides,
NADH and NADPH, in enzyme coupled reactions. Inlet and outlet channels on the rotary mixer
were arranged to prepare -1:10 compositions of media samples to enzyme cocktails, and samples
were mixed using a rotary peristaltic scheme64 . To facilitate uniform fluorescence signals,
detection channels of rectangular cross section were included in line with the rounded channels
containing valves.
Figure 2.3 demonstrates the high degree of linearity obtained when sampling dilute NADH
standards in 50 gim tall channels. The results of these fluorometric assays with dilute standards,
ensures that the optical depth of the channels is sufficient. The field of view imaged covers a
channel volume of approximately 2.2 nl. While taller channels were previously tested, 50 tpm tall
channels provided an acceptable balance between sample volume consumed and reliable
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fluorescent signal-to-noise ratio. Rather than performing measurements in inconvenient oil
covered nanoliter droplets, reactions are now completed serially in a fixed channel network.
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Figure 2.3: Example calibration curves and corresponding microchannel images. (a) Assessment
of device sensitivity with dilute NADH. (b) Typical metabolite calibration curves and typical
microchannel images demonstrates linearity of the microfluidic detector. Scale bars indicate
100 nm.
The amount of embryo media per sample available for assays is extremely limited, driving the
need to consume minimal sample per assay to enable replicate measurements. In light of these
considerations, a peristaltic pumping scheme regulated the amount of media consumed when
transporting media samples from the input wells into the mixing ring65. Sample flowrates were
calibrated at a variety of pumping duty cycles (over 10 minute averages) to determine the
minimum achievable loading time. Input flowrates were approximately -0.5 jl/s without active
regulation, which reinforces the necessity of this metering approach. While the flow of samples
was regulated, regular pressure driven flow was used on reagents and wash buffers to minimize
loading time. The on-chip metering sequence and measured flowrates are illustrated in Figure
2.4 (For the interested reader, movies of the metering and mixing operation are available at
http://pubs.acs.org).
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Figure 2.4: Peristaltic metering is used to regulate the amount of valuable sample consumed per
assay. (a) Three valves, outlined in blue, are actuated in sequence to meter samples into the
mixing ring. The path of a sample through the upper left of the mixer is illustrated with red food
dye in frames (i) - (iii). (b) Enzyme cocktail (presented with yellow food dye) is loaded through
the opposite path of the ring prior to the mixing operation. Scale bar indicates 500 Imn. (c) Theflowrate of samples into the mixing ring was calibrated to determine the optimal loading rates
and required sample volume. Each data point represents a 10 minute average at an input
pressure of 3 psig.
Every measurement requires metering a volume of media sample, and subsequently actively
mixing it with an enzyme cocktail. To increase the throughput of the detector chip, optimization
studies were also completed for both metering and mixing operations. The results of the
throughput studies are presented in Figure 2.5. Using glucose standards as mock inputs, the
linearity of calibration curves was assessed as a function of the amount of sample consumed. It
was found that curves were dependent only on the total volume of sample metered, and not on
the rate of metering. While the sample segment of the mixing circuit accommodates only 4 nl, it
was found necessary to meter more than this volume from the input channels to ensure the
greatest level of linearity due to Taylor dispersion during transport and potential cross
contamination in shared input channels. Figure 2.5 (a) illustrates that at least 15 nl of media per
assay should be used to ensure complete filling of the 4 nl chamber. To compensate for any
device to device variances, 20 n1 was metered for each assay which takes approximately eight
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seconds based on the flowrate calibration. The minimum volumes required for sampling are in
excellent agreement with the volume of the channel between the sample multiplexor and the
mixing ring, also illustrated in Figure 2.5. The can serve as a simple design guideline for
estimating minimum sample volumes when scaling up to more complex devices in the future
(such as those developed in Chapter 4).
A similar optimization study was performed to determine the minimum required mixing time.
The rate limiting process of the mixing operation was both a function of mechanical mixing and
the rate of the enzyme reaction after fluids have been fully mixed. Maximum linearity was
obtained in approximately 20 seconds of mixing for the three duty cycles tested. By contrast,
conventional microdroplet assays are completed by diffusive mixing alone, which imposes a
delay of at least several minutes per sample prior to imaging1 3. In addition to the metering and
mixing operations, injection of cocktail and image acquisition each required approximately one
second each. The mixing ring was also flushed with water between successive measurements,
which resulted in a total operating time ofjust over 30 seconds per assay. Complete runs
consisting of ten replicate measurements of ten samples (including calibration standards) with
three metabolites could be completed unattended in less than three hours. For more complex
experiments, the architecture may be scaled to accommodate additional enzymes and sample
input lines.
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Figure 2.5: Optimization of microfluidic metering and mixing operations. (a) Four point glucose
calibration curves were prepared under a variety of conditions. The linear R2 regression of
calibration curves is presented as a function of sample volume assayed. Linearity is independent
for sample volumes greater than 15 nl, and metering rates follow from Figure 2.4. (b) The
minimum metered volume for samples corresponds closely with the nominal path volume
between the sample multiplexor and the mixing ring. (c) Linear regressions as a function of
rotary mixing time with enzyme cocktail prior tofluorometric imaging. Based on these
calibrations, 20 nl of sample is metered for every assay, and actively mixed for 20 seconds with
cocktail.
2.4.1 Detection Accuracy and Repeatability
It was observed that the fluorescence measurements of repeated samples would decline over
several hours after chip setup. The pyruvate assay was most susceptible, presumably due to
photobleaching or oxidation of the NADH present in the cocktail. Microfluidic routines,
therefore, were written to ensure frequent calibration of all three metabolites, and values for
slope and intercept of linear curves were updated continuously. Culture sample measurements
were referenced using interspersed standards loaded onto chip, such to minimize inaccuracy due
to diminished signal. A replicate run was discarded if the calibration curve did not exceed R
2 
=
0.99. The high-throughput performance of the system allowed many (typically ten or more)
replicate measurements to be performed for each sample and metabolite to ensure consistency.
The ability to calibrate continuously and perform unattended replicate measurements on samples
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represents distinct advantages of the microfluidic approach in contrast to the manual droplet
technique.
Parallel analysis of mock samples was completed with standards containing known
concentrations of glucose, lactate and pyruvate to assess accuracy and repeatability of
fluorometric measurements. The data presented in Figure 2.6 shows very good agreement
between nominal and measured values, with accuracy on ten replicate measurements typically
within 5%, and standard deviations of approximately 20 gM across these three metabolites.
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Figure 2.6: Calibration curves to demonstrate repeatability often samples measured in parallel,
with sample types A, B and C, based in water, G1 media and G2 media, respectively. Black
columns indicate expected concentrations for each metabolite. Error bars represent the
standard deviation on ten replicate measurements.
In addition, calibration measurements were carried out using the same device for several
consecutive days to evaluate service life of the device. No significant variation in accuracy or
repeatability was observed over several days of operations, provided the device was cleaned and
dried after use as demonstrated in Figure 2.7. This further reduces setup time for a metabolic
profiling of cells in a lab setting, since control lines do not have to be reconnected to a fresh
device for every experiment. Detectors were typically replaced every couple of days depending
on whether any debris was accidentally introduced to the device.
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Figure 2. 7: Device repeatability and service life study. Media-based standards containing
known amounts of glucose, lactate and pyruvate were analyzed on separate days using the same
device, which was cleaned after each run using water and ethanol before being dried with
nitrogen. Sieve channels on the fluid input ports also significantly reduced debris from entering
and clogging channels. Device to device repeatability was also confirmed when standardizing
sample loading protocols and operating pressures.
Microfluidic experiments were also performed relative to manual microdroplet assays to enable
direct comparisons between approaches (with thanks to Becky Hamilton of Fertility Labs of
Colorado). The glass pipettes were rinsed in acetone between each sample to prevent cross-
contamination. Figure 2.8 presents the results of glucose assays completed on ten water and
media based samples using both a micropipette and the detector. As evident by the comparison
to expected values, both methods produced accurate measurements. With reagents and the
enzyme cocktail already prepared, however, microdroplet measurements require approximately
three hours of continuously manned time to perform a calibration curve and measure ten samples
in triplicate. By contrast, the microfluidic device generated measurements at a rate of -30
seconds per point, unattended. In routine clinical settings involving multiple metabolites and
multiple samples, these differences in labor compound quickly. Automated image acquisition
and analysis also avoids the inconveniences in manual data logging.
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Figure 2.8: There is good agreement in accuracy between the conventional microdroplet and
present microfluidic analysis for a number of calibration standards with known amounts of
glucose. Samples A] -A4 are water based standards, while standards B and C are based on
types Gi and G2 sequential embryo media, respectively. Error bars represent one standard
deviation on three measurements for the microdroplet technique and ten measurements for the
microfluidic device.
2.4.2 Management of Sub-Microliter Samples
In any lab setting, metering and handling of sub-microliter samples is not a trivial matter. This is
particularly true in the present research where it would be desirable to perform chemical
measurements in replicate for each of three markers (glucose, lactate and pyruvate), from a total
media sample of only several hundred nanoliters. As such, losing any media sample prior to
analysis is a critical concern. With these issues in mind, two different strategies have been
devised for loading media to a microfluidic chip. In the first approach, it is possible can adapt
the use of the custom glass micropipettes used in embryo culture for carefully loading samples <
0.5 gl directly to channels in the chip rather than using microbore tubing. On chip pumps may
be used for drawing samples from this larger volume to perform metabolite measurements. The
advantage of this approach is that no modification of the media is required and this technique
may be preferred if the culture is being performed next to the microfluidic workstation.
Unfortunately, the glass pipettes are very fragile and are custom made. Loading would have to
be performed under a microscope for each sample, which slows down the entire assay process.
In case of operator or software error during the metering process, the very small sample may
accidentally be blown through the channels before all required analysis are completed (flowrates
in channels during sample loading can approach several hundred nl/s). Devices employing this
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loading technique were designed and fabricated, but the tedious nature of sample loading negated
many of the advantages of a high-throughput tool.
In a second proposed approach, it is possible to pre-dilute culture samples to the microliter range
to alleviate difficulties in manual fluid transfer. For example, if media samples and calibration
standards are diluted with a buffer solution by a factor of ten, it will now be possible to transfer
working volumes of -5 tl or greater. Initial sensitivity experiments demonstrated that the
signal-to-noise ratio when performing measurements in microchannels is still adequate when
standards have been diluted by ten times. Physiological concentrations of glucose expected are
in the 0.1-0.5 mM range 14. If samples are pre-diluted by a factor of ten, we expect to have
metabolite levels between 0.01-0.05 mM. In the fluorometric assays, we further dilute this
sample with 10 parts of enzyme cocktail, which indicates we require reliable signal in the 1-5
IM range. Based on these assumptions, fluorescence calibrations of NAD(P)H in the pM range
were performed to assess this approach. Highly linear curves (R2 > 0.999 over five points)
suggest the feasibility of this dilution technique and indicate that performing such assays in well-
defined microchannels is significantly more sensitive than the microdroplet format. While the
drawback of this methodology is that samples must be pre-diluted, it alleviates difficulties in
transferring and loading sub-microliter samples and allows standard microfluidic tubing and
ports to be used.
It was particularly important to avoid transferring any of the mineral oil (used to blanket and
prevent evaporation of the culture samples) into the detector. Narrow gel loading round pipette
tips (-0.5 mm OD) were found to be ideal for transferring fluid from the oil covered samples
directly into segments of Tygon tubing that would be connected to the microfluidic device. This
technique was found to be suitable for preventing the introduction of mineral oil into the
microfluidic circuit. The loading sequence for pre-diluted samples is presented in Figure 2.9.
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Figure 2.9: Sample loading sequence. (a, b) Pre-collected embryo media samples are stored in
a Petri dish (35 mm) under oil to prevent evaporation. (c) A gel loadingpipette tip is
recommendedfor transfer of individual media samples (typically 1-5 Id working volume) directly
into a length of 500 pm ID Tygon tubing. (d) The end of the tubing may be cut to prevent the
carryover of any oil prior to adding a sterilized pin. (e) All samples and reagent lines are
connected to a detector chip which already is connected to control manifold, then (f) mounted on
an inverted microscope for the experiment.
2.5 Metabolic Analysis ofsingle murine embryos
As a proof of principle of our microfluidic detector, we performed metabolic profiling of ten
morphologically similar murine embryos in a parallel manner. It was particularly important to
avoid transferring any of the mineral oil (used to blanket and prevent evaporation of the culture
samples) into the detector. Difficulties in loading sub-microliter media samples from Petri dishes
to the chip were circumvented by employing the sample dilution scheme introduced in the
previous section to increase the working volume of fluid. All 500 nl sample droplets were
diluted to 5 il with DI water, and allowed to mix by diffusion. The use of gel loading pipette tips
allowed transfer of these aqueous samples from under the oil to the tubing without carryover of
oil. Total time required to load 10 samples into the device was approximately 10 minutes.
Calibration standards and reference media samples which did not contain embryos were also
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treated in a similar manner to ensure consistency in the loading and measurement process. Prior
detection trials at a variety of metabolite dilutions beyond the expected physiological range were
completed to ensure reliable sensitivity when employing this loading scheme.
Individual aliquots of spent culture media that had contained single embryos for 24 hours, as
well as reference media that did not contain embryos, were both analyzed to ascertain the
difference in concentrations of glucose, lactate and pyruvate. In all cases, measurements were
non-invasive since assays were performed only spent media aliquots which had contained a
single embryo for a limited amount of time. Embryos are transferred to fresh media droplets
daily prior to media collection, which maintains sample integrity and viability. Media samples
from day four were selected for analysis as the embryos are particularly active during this
preimplantation period. Each measurement was performed ten times, with calibrations
completed automatically for each replicate in approximately three hours.
The heterogeneity in nutrient utilization amongst similar day four embryos is apparent as
presented in Figure 2.10. Overall, the measured values are in good agreement with reported
literature values13. Expected metabolism of glucose, lactate and pyruvate are in the range of -5,
+5 and -1 pmol/embryo/hr for murine embryos 4' 13,18 (+ and - denote production and
consumption, respectively). Experimental measured values (+ s.d.) of nutrient utilization for this
embryo population are -4.82 + 1.40, +5.70 + 2.13 and -0.92 ± 0.76 respectively.
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Figure 2.10: Metabolic profiles obtained from ten murine embryos, labeled a through j. Results
are from day 4 of culture, and are presented relative to original G2 media (analyzed in parallel
with culture samples) to ascertain the changes in metabolite levels due to embryo activity.
Individual embryos were cultured in 1pl of medium G2for 48h prior to analysis. Heterogeneity
in metabolism becomes apparent amongst morphologically similar embryos. Error bars indicate
one standard deviation. The mean values for this population are represented by x, with dashed
lines for visualization.
These data serve to support the utility of a microfluidic detector in a research or clinical setting.
Since this assay approach is non-invasive, the integrity of delicate cells is never compromised. It
is not unreasonable to consider evaluating hundreds of samples with only a few devices. This
would be well within the range required for a large experimental or clinical study. It is also
possible to include additional enzymatic assays. A large number of molecules can be detected
using three or fewer enzymatic reactions. Other substrates of particular interest that could be
measured include asparagine, glutamine and alanine, several of the amino acids that have been
shown to identify human or murine embryos with better developmental potential48' 49. With a few
modifications, we anticipate that the throughput of the device could be even further enhanced.
The number of input ports could be doubled or quadrupled with the addition of just two or four
additional control lines added to the multiplexor, respectively66. It would also be possible to
design a device with several mixing circuits so that the measurements could be performed in
parallel. Such a device would either need to be designed so that the detector bins are within the
same field of vision, or a motorized stage would be used to image several distinct locations on
the device.
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A further step toward automation will occur when this analytic device is placed in line with a
culture system as this would eliminate manual handling of spent culture media. Furthermore, it
should greatly reduce the volume required for these assays. Several groups have made
considerable progress in culturing embryos in microfluidic devices6 7' 68. One concern that will
need to be addressed with using NAD(P)H-based assays is that a high energy excitation
illumination is required (wavelengths in the ultraviolet spectrum). It will be necessary to shield
embryos from exposure to the ultraviolet light, potentially using carbon black doped PDMS69 or
separating microfluidic components 7 . Alternatively, enzymatic assays that produce products
that fluoresce at lower energy excitation could be used7
While embryologists may adapt to microfluidic approaches in the future as advancements in cell
screening36, 72 and embryo culture continually evolve23, 26, 6 8 , 73, the majority of embryo culture
will take place in microdroplet formats for the coming years, particularly in regulated clinical
settings. For these reasons a standalone, non-invasive microfluidic metabolite detector is an
important development as it may be used in conjunction with standard embryo culture
techniques. Our microfluidic approach alleviates the issues involved with electrochemical
instrumentation and enables high-throughput fluorometric measurements with single embryo
sensitivity.
The two principal barriers to widespread adoption of this system are the availability of devices
and the need for a fluorescent microscope with imaging capabilities. With the widespread
dissemination of lithographic equipment and the growing interest in soft lithography, it is likely
that facilities to produce these devices will become more prevalent. Software is currently being
developed that will expedite and improve microfluidic device design74. Once the molds for a
particular device are made, the costs of producing casts are quite nominal. Many IVF centers
have high quality microscopes with imaging systems for micromanipulation of gametes and
embryos. In the future, it is quite likely that the device will have integrated illumination and
detection capabilities. The remainder of the equipment to run the devices is anticipated to cost
less than $3000, making this technology very competitive in terms of up-front costs as compared
to spectroscopic or chromatographic equipment required for other analytic approaches.
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2.6 Conclusions and Contributions
The objective of this multifaceted work was to develop an automated system for non-invasively
evaluating metabolism of single embryos. While several techniques have been developed for
culturing embryos in microchannel environments, none have addressed the challenge of using
these devices to assess embryonic metabolism. By combining the sensitivity and automation
enabled by microfluidics with previously characterized enzyme-linked assays, a practical tool
has been developed that should have applications to many types of cell culture. The utility of
this platform was demonstrated by measuring metabolite profiles of individual murine embryos.
With variations of the approaches introduced in this research, a large scale clinical trial to pursue
the relationship between metabolism and developmental potential should be within reach.
As all microfluidic measurements are automated through software, it is straightforward to record
data and create custom assay routines. Optimization of these assays and enzyme cocktails
should improve throughput further making such measurements more attractive to other
embryologists. With measurement accuracy on par with existing micropipette methods, the
microfluidic approach provides repeatability, scalability, and most importantly, the ability to
perform assays unattended. Since it is non-invasive, the microfluidic detector is also compatible
with any format of cell culture, the mechanics of which can be integrated downstream of other
culture devices for closed-loop analysis.
High-throughput tools such as those introduced in this work would be an invaluable asset to
understand the specific metabolic factors that play the most important roles during the dynamic
embryo culture period, and offer a tractable means to elucidate the relationship with
developmental potential. While the three of the most common metabolites have been
demonstrated in the present study, non-invasive fluorometric techniques can be expanded to
include additional metabolites of interest.
Looking forward, it would be desirable to standardize and automate the assay procedure to an
integrated culture platform capable of carrying out the metabolic measurements on individual
embryos and other cells in parallel for the entire culture period. A better understanding of
embryonic metabolism is likely to improve the probability of a healthy pregnancy following
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single embryo transfer, ultimately leading to reduced numbers of IVF cycles per pregnancy and
reduced incidence of multifetal pregnancies. These advances would lessen the financial burden
and improve the experience of patients undergoing assisted reproduction.
The methods introduced in this chapter should also extend to analysis of other types of cells
beyond IVF, as well as generate interest in automating related analytical assays. This
independent detector device is an important development as it may be used in conjunction with
standard embryo culture techniques, and may also be integrated with microfluidic culture in the
future. Before that next step is possible, however, the methods required for supporting embryo
culture in microfluidic constructs must be improved. These challenges are the goal of Chapter
Three.
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Chapter Three - Microfluidic Embryo Culture
3.1 Introduction
The desire to culture various cell lines and tissues in microfabricated environments has been one
of the driving forces to improve the design of microfluidic devices over the past decade. In turn,
devices which become more robust through iterative design and experimentation offer the
opportunity to gain insights to biological samples with unprecedented control of chemistry,
environment and repeatability.
Relative to conventional Petri dishes, unforeseen difficulties can arise when culturing delicate
tissues in micron scale chambers, reflective of the interplay of very high surface area to volume
(SAV) ratios surrounding samples, which increases dramatically with miniaturization 22 . This
high SAV ratio can be exploited for studying new surface treatments and rapidly culturing
bacteria and cells on complex surfaces. Conversely, increased interaction with surrounding,
artificial environments can be fatal to sensitive samples if care is not taken to prevent chemical
contamination, evaporation, or depletion of nutrients. These are key considerations in moving
forward to improve the embryo culture process in such at way that can be incorporated with
microfluidic analysis systems.
3.1.1 Culture Background and Considerations
As overviewed in the previous chapter, the predominant current method of culturing embryos in
clinical settings is by using microdroplets. Following conception, zygotes are carefully placed in
pre-equilibrated pools of media in a Petri dish that have been blanketed in a light mineral oil to
prevent evaporation. Embryos may be cultured individually, or in small groups provided there is
sufficient media volume to prevent starvation. The media volumes are generally in the 10-20 pt
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range, with evidence that smaller volumes and larger group numbers are beneficial for culture7 .
The culture takes place in incubators which are maintained at 370 C and are supplied with tri-gas
(typically 5-7% 02, 5-6% CO2 and remainder N2) to mimic the fallopian environment.
Development and optimization of sequential media for embryos, to further replicate temporal
changes in nutrient levels in vivo, is in itself an involved research area 27' 29, 30, 76. The general
strategy is to use a high glucose media for the first two days over culture, followed by an
exchange with a lower glucose media for the following days to reflect the needs of the
developing embryo27 (following Figure 1.1). Actual compositions of the media are quite
complex and in many cases are protected by commercial vendors28
Additional protocols have been empirically developed to improve the culture process of
environmentally sensitive embryos. In fertility labs that have implemented stringent quality
control programs, all raw materials such as Petri dishes and pipettes are contact tested on a
shipment by shipment basis with samples at the clinic before they may be used for human
embryo culture76. For example, a surprising one-quarter to one-third of sterilized Petri dishes are
found to be incapable of supporting embryos based on the quality guidelines in place at the
Fertility Laboratories of Colorado, in which case the entire batch must be discarded (MTJ,
personal communication). The number of times in which an incubator door is opened during
embryo culture is also carefully monitored, since subtle atmospheric lead to cumulative damage
and hinders sample development. As such, to prevent adverse effects to others' samples many
small, separate chambers are preferred over only a few large incubators. The list of incremental
improvements in culture continues on and on, and while these may seem tedious or trivial, these
convey the attention necessary to enable consistent culture of zygotes to the blastocyst stage.
Overall, these improvements have played a major role in improving pregnancy rates of IVF over
the past two decades.
3.1.2 Motivation and Goals
Building on the ability to perform microfluorometric metabolic measurements on pre-collected
aliquots of spent embryo media, the next logical step would be to remove the need to manually
transfer samples to a microfluidic detector. If it were possible to both culture and profile
embryos on a single platform in an automated manner, the clinical implications in IVF by
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reduction of labor and increase in quantitative data for implantation decisions would be
profound.
With that in mind, the process of culturing embryos using microfluidics is a challenge that has
been approached by a limited number of research groups. Even in conventional culture, embryos
are particularly sensitive to their surrounding environment and subtle changes in temperature or
oxygen levels can be detrimental to development. With proper engineering and process design,
microfluidics offers the potential to shield embryos from these adverse environmental changes
and automate steps in the culture process, such as the changeover of media.
In this chapter, we develop the microfluidic expertise necessary to culture embryos, directly from
zygotes all way to day five, to the blastocyst stage. Unique engineering challenges are
addressed, including the methods of loading and retrieval, and the difficulties in surface
contamination. In contrast to previous work in the field, where embryos have been cultured in
millimeter scale channels with continuous perfusion of media, successful culture protocols are
demonstrated for the first time in truly confined sub-microliter media volumes by the integration
of large scale microfluidic valves. Development and implementation of these culture protocols
will enable the scalability to study multiple embryos in parallel and the ability to collect precise
amounts of culture media for downstream metabolic profiling on a single device.
It has been hypothesized that numerous variables associated with laboratory culture systems
(including accumulation of metabolites, such as lactate and ammonia and depletions of necessary
nutrients, namely glucose and pyruvate) are related to the low yields of viable embryos in vitro.
In vivo, the female reproductive tract is constantly active, resulting in movement of the embryo
down towards the uterus. This movement also washes the embryos through constantly changing
physiological conditions through the oviduct to the uterus, maintaining a gradient for the supply
of necessary nutrients and oxygen, and the removal of waste products 26. As the in vivo
environment is dynamic, it has thus been hypothesized that the use of an active system may be
beneficial for in vitro culture. Microfluidic techniques have already been demonstrated to
improve bacteria and cell culture via similar recirculation and pumping protocols32' 33
-55-
An preimplantation embryo's metabolic requirements evolve during the five day developmental
stage . In response to these known preferences, different formulations of media are desirable for
different days of culture. Standard microdroplet culture techniques, however, are limited to
providing homogeneous concentrations of metabolites to embryos. With microdroplet culture, it
is presently necessary to pick up embryos manually and place them into new droplets of fresh
media in response to metabolic preferences. Continued efforts to improve culture conditions
would benefit from devices which are capable of reproducing physiological chemical gradients.
In the past, no microfluidic groups have tackled closed-volume issues in microfluidic embryo
culture. This research will be the first to culture embryos in truly confined media volumes on
chip. Culture within specific volumes of media is necessary for our proposed method of embryo
profiling by observing the uptake and production of metabolic factors over time. It is believed
that in the future, microfluidics may the preferred approach for embryo culture suitable to
spatially and temporally replicate in vivo conditions, while enabling the capability providing real
time feedback on developmental progress and viability.
3.2 Related Research
3.2.1 Embryos in Microfabricated Environments
Several groups have taken initial steps to demonstrate embryo culture in microfabricated systems
with varying degrees of success, all on the premise that these systems will become superior for
replicating the in vivo environment. In most cases, the microfabricated systems resemble more
of an open cavity, as opposed to a closed channel. As such, these approaches whether or not
they are capable of supporting embryo culture, may not be suitable for integration with the
method of fluorometric metabolite analysis introduced in the previous chapter. When culture
volumes are reduced into the sub-microliter per embryo range, secreted growth factors are more
concentrated and are believed to enhance development during the preimplantation period31' 75
Standardization of such procedures and culture conditions is particularly important when
comparing results from multiple cell samples, and also allows researchers in separate
laboratories to replicate procedures using their own microfluidic platform.
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Potential advantages of perfusion or recirculation of media for embryo culture have been
discussed, but only a limited number of detailed experiments have been completed with culture
conditions that are difficult to compare. In a study by Lim et al, it was observed that an
increased fraction of bovine embryos successfully developed to the blastocyst stage when
perfusion was used only in the first day of culture77. Overall, development rates using the
dynamic environment were significantly lower than that observed in static systems, and in many
cases mouse embryos were arrested by the four cell stage.
The Beebe research group has pioneered much of the early work in static microfluidic embryo
culture. They have characterized embryo compatibility with many materials commonly used in
microfabrication including silicon, borosilicate glass, chromium, gold, as well as PDMS78 .
While claiming that Sylgard 184 PDMS was not found to inhibit embryo development, they
acknowledge difficulties with surface interactions and suggest that for widespread adoption of
microfluidic culture systems will benefit from development of alternative biocompatible
materials7 9. They have developed several devices to microchannel embryo culture, including
devices fabricated with combinations of silicon/borosilicate, or PDMS/borosilicate. In the later
case (with borosilicate glass channels mounted on top of a PDMS bottom) they observed that
nearly 80% of embryos developed to the blastocyst stage, compared with only 50-60% of control
samples in 30 pl droplets. The devices were reasonably large for "microfabricated" systems,
with channels containing 0.5 ml of static media (including the input wells). Beebe states that the
"effective" volume of these systems is actually of the order of microliters per embryo, by
diffusion and high surface area to volume argumentsso. Unfortunately, these claims neglect the
fact that culture periods for embryos are on the order of days and even when limited by diffusion,
nutrients or toxins can be transported from distant channels. The group has also admitted that
some of their observed benefits (consistently faster cleavage and higher blastocyst rates) of static
microchannel culture could be magnified by sub-optimal aspects of their microdroplet culture
techniques sl . In any case, this thorough groundwork in microchannel culture supports the
potential benefits of transitioning from microdroplet methods.
Interesting perfusion culture results were obtained by Hickman et al, in using a large glass
channel to continually flow media over a group of preimplantation mouse embryos26 . In the
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absence of flow, cleavage rates between the microfluidic embryos and control samples using
traditional culture methods were similar. As flow was introduced, developmental rates
accelerated initially (from two to four cell stages), but were ultimately hindered by the use of
flow rates in the range of 1 to 5 [l / hr in a channel with dimensions of 1000 [tm by 250 pm.
Unfortunately, the exact conditions of this setup were not well described, since the experimental
protocols described would imply average perfusion velocities of only -1 tm/s (non-embryo
continuous cell culture studies have been successful at local velocities which are one to two
orders of magnitude higher82, 83). The authors offer additional explanations for developmental
problems with their perfusion system including poor control over pH, and the likelihood that
potentially useful compounds from the embryo group were also washed away with waste.
Secreted growth factors are also removed which are believed to help regulate metabolism.
Similar studies have pointed towards the possibility of using pulsatile flow to mitigate these
shortcomings and more closely resemble dynamics of in vivo conditions. Preliminary
developmental results with this approach have been promising67, as indicated by the increased
percentage of embryos which successfully developed through to blastocyst stage in comparison
to a static control culture. Although, to avoid the difficulties in sample loading and isolation in
such work, open channels with millimeter scale dimensions were used67 (which could be argued
as poor usage of the term "microfluidics").
These studies provide a starting basis for additional work to be performed in dynamic culture,
but flaws exist in these early microfluidic approaches. First, the same media was utilized
throughout the culture period, while it is widely recognized in the clinical community that
sequential media is recommended 27 (by mimicking the composition and concentration in
nutrients present in the oviduct during the first three days of embryo development, and in the
uterine for the following two84). Second, it was not investigated whether continuous or periodic
fluid flow should be applied to the microenvironment, as the nutrient demands of a developing
embryo evolve over a culture period of up to five days. Also, only embryo morphology was
used as a measure of effectiveness for the microfluidic culture systems. Reiterating, morphology
alone is not sufficient to understand the implications on the health of cells and does not correlate
with latter developmental competence4 . To strengthen the conclusions of these studies, the
quality of blastocyst development should be supported with inner cell mass and trophoblast cell
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count data (discussed in section 3.4). Ideally, measurements of metabolic activity should also be
integrated to more accurately quantify the implications of dynamic culture. The devices used in
the aforementioned studies also lacked the flexibility to alter flow fields and do not enable the
option to recirculate media over embryos. In the present work, microfluidic approaches have
been conceived and implemented, to address some of these shortcomings and enable improved
culture flexibility.
3.2.2 Modeling Implications of Perfusion Based Culture
In reflection of dynamic culture systems, it is interesting to relate the dominant fluid flow in the
channel system to the potential nutrient uptake by a sample. In the aforementioned continuous
perfusion systems, the cell proliferation has not been related back to increased nutrient diffusion
resulting from advection. As a sample case, the potential uptake of glucose by an embryo in
media is modeled with the goal of providing some insights to the effects of advection with the
developmental period. To start, the diffusivity of glucose molecules in solution may be
estimated using Einstein's relation:
kT
Here, k is Boltzmann's constant (1.38E-23 J/K), T is the temperature of the solution (370 C =
310 K), t is the viscosity of the medium (-0.001 Pa s for water) and a is the effective radius of
the molecule (-0.43 nm for a glucose molecule). By this, D is approximately 5.3E-10 m2/s for
glucose in culture media. Now, consider the Sherwood and Peclet numbers for our system
consisting of an absorbing sphere in the presence of a flowing media. The Peclet number relates
the relative contribution of advection and diffusion in fluid flow:
UR
Pe = UR
D
Here, U is the fluid velocity, R is the sample radius (assume an embryo diameter of-100 iim)
and D is the previously calculated nutrient diffusivity. For the sake of this simple comparison,
we are interested to learning the potential increase in glucose uptake for the embryo when the
rate of adsorption is not diffusion limited. Thus we make the assumption that the concentration
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of glucose is zero at the surface of the embryo (a perfect absorber) - that is, this embryo will
absorb all glucose molecules which reach the surface by diffusion or advection. The Sherwood
number is used to calculate the enhancement in adsorption at a surface due to the effect of
advection. For a perfectly absorbing sphere, the Sherwood number is expressed as:
Sh = I1+ (1+ 2Pe)'
In the case of zero flow (Pe = 0), the Sherwood number is 1 and molecular flux is occurs by
diffusion only. This is the case of static microdroplet culture. For positive values of Pe, the
Sherwood number increases significantly for large radius samples such as embryos. In a flowing
nutrient stream, small (< 10 jim) absorbing cells do not benefit appreciably from fluid flow with
velocities (due to low Peclet and Sherwood numbers at small length scales). Samples with larger
diameters (- 100 jpm), however, can experience appreciable enhancement in nutrient adsorption
in the presence of flow due to their length scale.
For example, modeling of an ideal absorbing sphere of 100 jtm diameter in the presence of a
moderate 10 jim/s flowing stream of dilute glucose corresponds to a Sherwood number of -1.3
(that is, the total mass flux of molecules across the surface is 30% greater than that due to
diffusion alone). By the same scaling, mass flux across a 100 pm absorbing sphere doubles if
the average velocity approaches 100 jpm/s, while 10 tm spheres would only experience a
moderate -20% increase due to advection.
Though idealized, these scaling arguments suggest that embryos in continuous flow systems 26' 77
may have been provided a level of nutrients which is greater than what would be experienced
physiologically, ultimately distressing development. Unfortunately, it is difficult to quantify to
what effect the removal of secreted growth factors had on embryonic development in these
studies. Additional effects, including responses due to fluid shear stress on embryos and
unreported environmental fluctuations, certainly play a coupled role in metabolic regulation. As
such, future experiments in a controlled environment should be performed to accurately quantify
and understand the uptake of nutrients by samples resulting from dynamic culture.
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3.3 Open Microfluidic Chambers
With the first goal of moving towards static microfluidic culture in microliter volumes, an "open
channel" approach was designed and implemented. All early attempts to culture embryos were
performed using such PDMS channels, consisting of only one inlet and one outlet. While
primitive, these experiments and feedback driven design cycles were critical to identify and
resolve the most troublesome issues involved with microchannel culture.
Initial work involved finding methods to allow consistent loading and retrieval, as well as
circumventing the difficulties with manufacturing channels sufficiently large to accommodate
our embryos. It became apparent that the first major design change would involve the
microfluidic interconnect ports. Conventional 500 im diameter ports, created by punching
PDMS with a sharp biopsy tool, would not be acceptable for retrieving embryos from channels.
While working under a stereo dissecting microscope, it was nearly impossible to visualize an
embryo, or to fit a glass pipette to the bottom of a port to pick or place an individual embryo.
Several larger biopsy tools were tested, and 4 mm tools were found to be adequate. With these
large ports, it would be possible to deposit an embryo at the bottom of a well near the entrance of
a culture chamber using a mouth pipette. From there, a syringe pump (or small volume pipette)
connected at the exit port would precisely be able to draw the embryo into the chamber. In a
reverse manner, for collection an embryo could be gentle pushed back towards the input port,
and picked up.
Initial straight channels used for loading experiments, fabricated in PDMS using -100 pm tall
molds were found to be too constrictive for culture. Thus it was necessary to transition to a two
step photoresist process to achieve this channel height on molds using SU8 100 photoresist on
silicon wafers. Further, since embryos are non-adherent, it is also possible that embryos may
move around within their chamber due to pressure variations or capillarity from the interconnect
ports during loading. To prevent embryos from leaving their intended culture channel and
leaving via the exit well, constriction channels were placed near the far end of the channel
simplifying the oocyte gratings proposed by Suh23. The 50 p.m wide constrictions were
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fabricated using a 50 tm tall layer of SU8. The main culture chamber had 150 pm channel
heights.
The mold for the device was fabricated using a two step photolithography process. The base
layer of SU8 was patterned using a transparency photomask and cross linked. Another layer of
SU8 photoresist was then coated, and the second set of features on a complimentary photomask
was exposed using an alignment tool85. All features were developed in one step, leaving a mold
was distinct channel heights. An example of an open chamber device is presented in Figure 3.1,
with a nominal chamber volume of 1 pl.
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Figure 3.1: An open chamber device used to develop microfluidic embryo culture protocols.
Several varieties of such devices were tested to investigate and resolve the major issues in
sample handling, loading and retrieval. In addition, open channel devices were essential to
debug issue with device fabrication and toxicity. A) Schematic of a culture device with a nominal
1 pl channel volume. The blue andpurple regions indicate channel heights in distinct regions. B)
Image of a physical PDMS device, with a 4 mm diameter port on the left for loading of embryos.
The inset clarifies a sieve used to prevent embryos from accidentally flowing out the exit of the
device during loading. Scale bar is 500 ,um.
The device was cast using Sylgard 184 PDMS. Rather than bonding single layer devices directly
onto glass slides, it was decided that a PDMS bottomed device would more closely resemble the
assembly process used for the devices in Chapter Two. Further, by surrounding an embryo
sample with PDMS on all four surfaces, it would simplify the questions in determining whether
potential contamination is due to the PDMS device, or from the sealing surface. To achieve
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enclosed devices, a thick layer of PDMS containing channel features was first cast and punched
to create interconnect ports. It was then was bonded to a thin layer of PDMS (-100 pm) which
had been coated on a blank silicon wafer, using either thermal techniques or a plasma treatment.
The sealed devices could then be removed from the blank wafers, cleaned, then sealed to pre-
cleaned glass slides. Several generations of these devices with varying SAV ratios were
implemented over a 12 month period, with iterative improvements to the chambers design and
methods of fabrication based on the experience of culture trials.
3.3.1 Fabrication and Cleaning Protocols
Through numerous initial rounds of culture with murine embryos, mixed results were obtained in
the open chamber devices. Appropriate loading techniques were practiced using large 100 ptm
fluorescent beads, although first generation devices had large gratings that allowed smaller
embryos to slip through on occasion during loading. Most troubling during these early design
stages, embryos often would arrest within hours of being placed within channels filled with
media.
Numerous causes of this failure were suspected, owing to either mechanical or chemical stress.
The design of the channels had been already improved with wider inlet channels to prevent
collision of the embryos with PDMS walls or gratings, so this was dismissed as the primary
cause. More likely, interaction of the device surfaces was either introducing toxic byproducts
from the fabrication process into the media, or causing the depletion of essential nutrients from
the chamber. PDMS is gas permeable and semi porous, which makes it suitable for gas transfer
during culture. However, the porous nature makes PDMS susceptible to adsorption of small
molecules 86. The key causations and solutions for microfluidic device preparation that were
established in parametric culture studies are discussed below.
Silane and dummy casting:
While PDMS is generally considered non-toxic, silane-based release agents are often employed
in the process of replica casting of PDMS microfluidic devices using photoresist based molds25.
Release agents, such as chloro-trimethyl-silane or perfluoro-octyltrichloro-silane, may be
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evaporated onto silicon molds to assist removal of cured PDMS and extend the service life of
often-fragile photoresist features.
Unlike somatic cell lines used in routine biological research, gametes and embryos are
particularly sensitive to their surrounding environment23' 34. In particular, engineered
mammalian cell lines are often robust against chemical contamination during culture. Although
silane agents have not interfered with the growth of cells on chip in past studies36, it proved to be
fatal in all of the initial culture trials. To achieve successful culture, it was found necessary to
remove silane from the device fabrication process. It is believed that excess silane was being
absorbed by the bulk PDMS through the walls similar to other small molecules 86, and this silane
in turn may leach into the culture media. This poisoning would be exacerbated by long periods
(several days) of diffusion through static media culture, as opposed to dynamic culture, which
would remove toxins by advection.
From experience, high-aspect ratio photoresist features are prone to delaminating from the molds
during peeling if no release agents are utilized. The tradeoffs for using molds that have not been
silanized are a reduced service life, and an increase in the minimum feature size. Fortunately,
due to the large diameters of embryos, the minimum features were typically 50 tm or larger.
Further to the removal of release agents from the molding process, a "dummy" cast was
performed on newly fabricated SU8 molds. The first set of PDMS, that was cast over the
channel molds and blank wafers that would be used for sealing the bottom of the channels, was
tossed. This was found to improve the culture performance of subsequent cast chips, possibly by
removing residual photoresist products on the mold surfaces from the clean room.
PDMS Ratios:
The devices used in the present study consisted of two PDMS layers; the thick layer (-4-5 mm)
which contained the culture channels, and a thin layer (-100 tm) which sealed the bottom of the
channels. In standard MSL, these layers may be bonded thermally by varying the amount of
PDMS curing agent between the two layers 25. PDMS is nominally cured by mixing 10:1 /
PDMS based: curing agent. Standard MSL is performed by using 5:1 PDMS for the thick layer,
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and 20:1 for the thin layer, which can be used for thermal bonding of partially cured layers using
the concentration differential at mating PDMS surfaces. However, this method introduced the
suspicion that excess curing agent or base may interfere with culture. To remove this variable,
all PDMS was cast using the "stoichiometric" 10:1 ratio.
In the absence of a curing agent differential to perform interlayer bonding, the devices were
instead assembled using a plasma treatment. Thick layers were fully cured, interconnects were
punched and following a brief cleaning with ethanol and nitrogen, devices were plasma bonded
to blank cured sheets of PDMS. A 30 second air plasma treatment at low RF power (Harrick
Plasma, Expanded Plasma Cleaner) was found suitable for bonding PDMS surfaces. Devices
were removed from the thin layer molds, cleaned again, and then bonded to 1 mm thick glass
slides ready for culture.
Oven and PDMS curing time:
A shared laboratory grade gravity oven maintained at 900 C had previously been used for casting
of all microfluidic devices. However, this common resource used by many group members and
collaborators over the years to cast microfluidics and a variety of other unknown chemical
substances could have been subject to contamination. Devices cast on silicon molds were
observed to catch a yellow-colored tint if left uncovered in the oven. Residual odors were also
noticeable, likely from plastic Petri dishes which had been forgotten and melted in the oven. To
remove the variable of chemical contamination during PDMS curing, a clean new oven was
acquired which was reserved solely for casting devices for embryo culture. A separate oven also
prevented environmental contamination with other microfluidic molds which have been treated
with silane.
Studies were also performed to determine the minimum required curing time of PDMS culture
devices. Although 10:1 PDMS can cure to a solid rubber within 20 minutes of curing,
mechanical properties can continue to change even after hours or days of extended curing as
residual traces of uncross-linked monomer are cured. It was found that a minimum curing time
for devices was 48 h prior to culture, and that longer curing times were not detrimental.
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Pre-Equilibration:
After the extended bake time was complete, channels were filled with ethanol and soaked for 24
hours, followed by a rinse with water. This concept was a simplified version of multi-step
solvent extraction protocols that have been used to purify PDMS for temperamental biological
samples87 . To reduce osmolarity shifts during culture88, devices are then primed by soaking
channels in G embryo culture media for an additional 24 hours at room temperature before
culture. This was performed to saturate the walls with any small molecules which may be drawn
out of media in later cultures86, as well as hydrate the thick layer of PDMS to prevent
evaporation. The chips were finally refreshed with clean GI media and allowed to equilibrate
for pH and temperature in an incubator for at least 4 h immediately before loading embryos for
culture.
Final Protocol:
In summary, the recommended protocol for device preparation requires:
* Dummy casting of all new silane free molds with PDMS.
* Devices cast using 10:1 PDMS for both thick and thin layers, plasma bonded together.
* Devices bonded to glass slides with a total bake time of at least 48 h at 900 C.
* Solvent extraction for 24 h with ethanol followed by an equilibration for 24 h with media.
* Pre-equilibration with fresh media in an incubator for at least 4 h before loading embryos.
While it may be possible to reduce the suggested lengths of treatment, these were found to give
satisfactory results without necessitating excessive handing of devices. By using the techniques,
it became possible to culture zygotes through five days all the way to expanded blastocyst and
even hatching stages. Figure 3.2 illustrates the first experimental hatch observed in a 1 jtl
microfluidic channel, alongside control embryos performed in a 10 tl microdroplet.
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Figure 3.2: A comparison ofmicrofluidic and microdroplet culture. A) Two expanded
blastocysts cultured in a 1 ul microchannel. The top blastocyst has hatched, which is often a
sufficient, but not necessary, condition for an embryo to be considered a strong candidate for
implantation. Sieves towards the exit channel are visible on the right. B) The complimentary
controls for this experiment cultured in a 10 pl microdroplet. Scale bar indicates 100 pm.
3.4 Culture Results
With fabrication and preparation protocols set, microfluidic culture chambers were tested in
direct comparison to microdroplet controls in three rounds of experiments. To quantify the
performance differences between these formats, cell counts were performed on collected day five
blastocysts at the end of each culture cycle. The cell counts represent a total of the ICM (inner
cell mass, or embryoblasts) and TE (trophoblast) differentiated cell lines, of the blastocyst. The
trophoblasts which are located on the shell of the blastocysts later become the placenta in fetal
development, while the ICM eventually develops into the actual adult organism. For murine
embryos a total cell count from the mid 70's to low 80's (with an ICM count above 20) is
considered good (MTJ, personal communication). Fluorescent dyes may be used for
identification of these separate cell lines to simplify the process of manual counting.
In these culture experiments, performed over several weeks, fresh murine embryos were
collected following the methodology from Section 2.3.2. Briefly, female Fl hybrid mice were
superovulated with 5 I.U. pregnant mare's serum followed 48 hours later with 5 I.U. of human
chorionic gonadotropin and then immediately mated with Fl hybrid males. Zygotes were
collected from the oviducts 21 hours after mating. Embryos were washed using GMOPS buffer
(Invitrogen AB) then transferred into pre-equilibrated Gl media in either a microchannel or
microdroplet (volumes from 1 to 10 ±l) under paraffin oil in a Petri dish. Microfluidic devices
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were housed in covered Petri dishes under a few millimeters of water before being placed into
incubators at 370 C, 5% 02, 6% CO2. The additional water was necessary to combat humidity
control issues in the incubator, and did not enter the microchannels.
These experiments were performed at Fertility Labs of Colorado (Englewood, CO) with much
appreciation to Mark T. Johnson, David Potter and David K. Gardner. Complete cell count data
collected by D.P. at the conclusion of each experiment is presented in Appendix B.
3.4.1 Culture Set One
The first set of culture trials used a total of 21 embryos, with small groups of embryos being
cultured in four individual microfluidic devices and the remainder cultured as control samples in
microdroplets. The results of the five day long experiment are summarized in Figure 3.3.
Complete details of the experimental conditions are presented in Appendix B. On some devices,
sequential G2 media was flowed into the microchannels after the embryo had reached the eight
cell stage (around day three of culture). Similarly, in the control experiments, some embryos
were transferred to new microdroplets of G2 to implement the sequential media.
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Figure 3.3: Results of Culture Set One. A) Cell counts on chip were consistent with microdroplet
controls, although cell counts rarely exceeded 70. B) Embryo images from three different devices
at day five appear morphologically similar to those cultured in C) microdroplets.
This culture experiment was regarded as highly successful benchmark. Numerous expanded
blastocysts were developed in the microchannels, including several hatches (in three of six
separate devices). On average, embryos cultured using microchannels performed on par with the
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microdroplet controls, although total cell counts were rarely over 70. The difference in cell
counts due to sequential media protocols is not markedly different in this set of devices. As this
was the first set of experiments necessitating a media changeover while samples remained inside
of microchannels, it is possible that the flushing may have been too abrupt, or introduced
excessive fluid velocities to the samples. With practice and refinements to this process, further
improvements to cell counts in the microfluidic chambers were expected.
3.4.2 Culture Set Two
Before proceeding to additional experiments with sequential media, additional experiments to
assess the device preparation process were performed. In this experiment, two devices were
prepped using an ethanol extraction, and two devices were extracted with ethanol for 24 h
followed by an overnight equilibration in media. It is evident that the ethanol extraction of
microfluidic devices promotes improved embryo culture, as summarized in Figure 3.4.
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Figure 3.4: Results of Culture Set Two. The six embryos which were culture in devices which
were both extracted with ethanol and pre-equilibrated with media outperformed those in devices
which were not ethanol extracted. All four microfluidic devices outperformed the microdroplet
controls.
These data support the necessity of thoroughly cleaning the PDMS channels prior to use. There
may be alternative extraction protocols worth exploring to either reduce the 24 h treatment time,
or improve the microchannel biocompatibility even more. Fortunately, solvent extraction with
readily available ethanol is simple to carry out and highly effective with a minimal amount of
labor.
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3.4.3 Culture Set Three
A third set of culture experiments was completed using 12 embryos in four separate devices.
Sequential media was applied to two of the devices, which the other two used only G1 media for
the entire culture period. Consistent with the previous trials, the microfluidic channels yielded
higher cell counts on average, compared with the microdroplet controls. The results of this
culture trial and sample images are presented in Figure 3.5.
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Figure 3.5: Results of Culture Set Three. A) On average, the microfluidic devices produced cells
counts greater than the microdroplet controls. In both systems, the use of sequential mediaprovided superior culture results (*counts were only available on three of the six microfluidic
embryos in this case). B) The morphology of the blastocysts in channel on day five compares
well with the controls in C).
Unfortunately in this round, cell count data was lost from an additional three blastocysts which
also hatched in a microchannel (this data set is marked with an asterisk, and noted in Appendix
B). In contrast to the first formal set of experiments, it is evident that the microfluidic results
have improved relative to the microdroplet controls. This can be attributed in part to the operator
learning curve, as with practice, transfer of embryos into microchannels becomes easier and
reduces additional handling time.
In previous microfluidic culture trials in the literature, concerns were acknowledged about the
sub-optimal quality of microdroplet control samples. Specifically, controls in past studies used
large 30 ld microdroplets of non-sequential media 68, 80, although it is generally accepted in the
clinical community that microdroplet culture is improved with higher embryo density culture in
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smaller volumes (on the order of 0.5 - 2 gl) 75. Thus, the improvements in microchannel culture
relative to "standard practices" may have been overstated. In these studies, murine embryos in
the microdroplet controls were performed using clinical expertise, with protocols and reagents
consistent with the state of the art (it is also noted that the Fertility Lab of Colorado has been
recognized for producing the highest IVF pregnancy rates in the U.S.). Thus, improved cell
counts relative to controls in the present studies are considered noteworthy. At the same time,
only a limited number of embryos were available in these studies, and larger scale trials must be
pursued to demonstrate statistical significance.
The open channel culture device has yielded many new insights to the embryo culture process,
and to some of the logistical issues which may be faced by embryologists using microfluidics in
the future. The microfluidic environment offers environmental protection to the embryo by
dampening changes in temperature or gas exchange. It was demonstrated that in well defined
microfluidic geometries, it is possible to perform embryo culture with total cell counts that
compare with, if not outperform, standard microdroplet culture on average. With further
refinements to the fabrication and loading process, microfluidic culture should consistently
outperform microdroplet culture, and a clinical study would be warranted to pursue this
opportunity.
3.4.4 Transition to Closed Chambers
With the protocols and designs in place for embryo cultures in microfluidic devices, the
challenges of sample transport on media collection were to be addressed. With the intent of
developing culture methods compatible with metabolic profiling, it would be advantageous if it
were possible to separate embryos into closed chambers on chip to retain all metabolites in spent
media. In the open chambers, nutrient diffusion from the inlet and outlet ports may interfere
with the metabolite levels in the vicinity of the embryo, and subsequent metabolite analysis on
spent media samples would provide inaccurate measurements of actual nutrient utilization and
waste production. To enable a device which can load and store embryos into closed
microchannels, it was necessary to engineer a new class of microfluidic valves compatible with
both embryo culture, as well as existing microfabrication techniques.
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It has been hypothesized that numerous variables associated with laboratory culture systems
(including accumulation of metabolites, such as lactate and ammonia and depletions of necessary
nutrients, namely glucose and pyruvate) are related to the low yields of viable embryos in vitro.
In vivo, the female reproductive tract is constantly active, resulting in movement of the embryo
down towards the uterus. This movement also washes the embryos through constantly changing
fluids in the uterus, possibly maintaining a gradient for the supply of necessary nutrients and
oxygen, and the removal of waste products26 . As the in vivo environment is dynamic, it is
suggested that the use of an active system may be beneficial for in vitro culture. A concept for a
recirculation culture system is presented in Figure 3.6.
Figure 3. 6: Schematic of an open loop culture device modified to include a recirculation pump.
Flow lines would enable the collection of spent media for later metabolic analysis, as well as
allow new media to be refreshed automatically. Three valves actuated as a peristaltic pump are
used to recirculate media over an embryo which remains in the culture channel. The scale bar
indicates 5 mm. The left-most valve near the inlet must be capable ofpassing an embryo, as well
as fully seal a microchannel 150 Im in height. These specifications were beyond the capabilities
of MSL valves.
Several devices were designed to enable greater control of the fluidic environment and capability
for automatic media sampling. The culture channel dimensions were based on those successfully
used in the open channel system, fabricated using SU8 based molds. Additional flow channels,
compatible with integrated valves, were fabricated using positive photoresist. Unfortunately,
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when loading embryos from the input well to the culture chamber it is necessary that an embryo
(diameter -100 pm) must traverse past at least one multilayer soft-lithography valve, typically
limited to -50 tm in height by availability of positive photoresist. There are a multitude of
microfluidic valves which have been presented in the literature, but none of which could be
easily integrated with the computer controlled microfluidic devices and open channel culture
protocols developed thus far. It was therefore necessary to revisit the microfluidic design
options available, and examine solutions to the embryo valve problem.
3.5 Development of Microfluidic Megavalves
In order to enable culture in closed chambers, it was necessary to develop of a new class of
integrated valves suitable for safely loading and retrieving embryos from microfluidic devices.
The most simple closed culture device would consist of an embryo culture channel (similar to
those already demonstrated), with valves implemented on the inlet and outlet. The motivation of
closed culture defined by valves was to isolate a sample from the surrounding environment, from
other embryos located on the same device, or to enable fluid manipulation such as automatic
collection of media samples for chemical analysis. Culture within a defined volume allows
retention of critical growth factors and all metabolic byproducts that could otherwise diffuse
away from culture chamber.
3.5.1 Assessment of Valve Alternatives
While multilayer soft-lithography valves are straightforward to integrate and control, they are
typically limited to channels which are 10 to 50 jtm tall. Besides the preferred MSL technique, a
wide variety of alternative approaches have been developed in the microfluidics field specifically
for the purpose of flow control in larger channels 89 . Alternative valve designs with potential for
embryo culture may be classified by the method of actuation. These groups include pH
responsive90, thermal91, 92, mechanical 93-96, magnetic97, 98, pneumatic99-102 or hydraulic 103
There is likely no limit to the size of channels which can be sealed using pH responsive
microgels 90, and there are potentially interesting applications in embryo culture in which flow of
fresh media is triggered in response to decreases in media pH in a culture chamber. Practically
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speaking, however, such materials cannot be computer controlled in the same manner as MSL
valves, and there is concern regarding biocompatibility with embryos in microchannels.
Phase change valves, using plugs of wax which can be repeatedly melted and solidified in situ,
have been used to seal arbitrarily shaped channels 9 1' 92. These valves have the advantages of
having a default "closed" state, but require the fabrication of heaters in the device to melt wax
and permit fluid flow. There is also a concern of heat shocking of embryos by local heating of
microchannels.
Very large mechanical valves have been developed in a variety of forms. Torque valves with
ball screws have been cast directly into PDMS channels, but must be sealed using a screwdriver
on top of the device 95. PDMS "flap" check valves have been demonstrated to regulate flow in
channels up to 500 jtm wide, but require a positive back pressure to ensure a complete seal96
Computer controlled Braille pins have been used to seal microfluidic channels, but devices must
be mounted directly on Braille displays which hinders sample observation 94. The specialized
fabrication process which was developed to make large "bell shaped" channel structures
compatible for actuation by Braille pins, however, may find useful applications with MSL
microfluidics.
Numerous pneumatic valves have been created using flaps of PDMS, sandwiched between two
pieces of etched glass or silicono' 0'. These diaphragm valves are large enough to
accommodate embryos, but the fabrication of these devices is not trivial. Operation of these
membrane valves requires use of negative and positive pressures to realize the open and closed
states, respectively. While these valves require an involved assembly process, they can be
computer controlled and made to be chemically inert 02.
In light of such related alternatives, it is evident that the ideal valve would be a variation of the
standard MSL valve to avoid complications involved with new control schemes and device
materials. The limiting factor in creating MSL valves with larger dimensions is in the molds
used for casting PDMS channels with rounded cross sections. To address this design challenge,
a new class of large scale MSL valves (dubbed "Megavalves") was engineered.
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3.5.2 The Megavalve Concepts and Development
Multilayer soft-lithography valves require a rounded flow channel profile for closure2 5 ' 60, but the
positive resists used to create rounded channels are generally only 10-75 pm thick'0 3 . To
accommodate large samples in microfluidic channels, it is herein demonstrated that it is possible
to combine several photoresist steps to create a "megavalve", with flow mold heights of 100 pm
or even greater with readily available resists. These megavalves can be readily integrated with
devices also utilizing standard sized valves. Large scale MSL valves are advantageous as they
are fabricated using the same process as the open channel system, and the valves are actuated
using the same microsolenoids as the microfluidic metabolite detector.
Molds for creating rounded channels are conventionally created by patterning a positive
photoresist on a substrate followed by a "reflowing" process to melt the resist beyond its glass
transition temperature. During the reflow process, the originally rectangular cross section
minimizes free surface energy in the molten state, resulting in a continually semicircular shape.
The key challenge is obtaining channels that are 150 ptm or taller, which have a continuously
smooth cross section. Any sharp transitions or edges in the channel geometry prevent MSL
valves from fully sealing, and pressurized fluid will leak through the channel.
Early attempts to fabricate a deep channel with rounded cross section simply consisted of
numerous layers of thick positive photoresist. For example, a layer of 50 tm could be spun coat
on a silicon wafer, partially baked, and followed by application of a second layer of photoresist.
Ideally this would provide a channel with a height of 100 pm. Unlike SU8 resist used to create
the 150 tm culture channels, positive resist is nearly opaque. It was difficult to sufficiently
expose the resist through deep layers to define channel patterns. Even with extended photoresist
development steps, it was difficult to remove all the excess photoresist from the mold surface,
and the intended channel resist was also observed to deteriorate by excessive submersion in
developing solutions. In some cases, very thick layers of photoresist were developed for more
than 30 minutes without removing the excess resist. It was necessary to explore other routes to
obtain tall valves, preferably with one application of positive resist which could be properly
developed.
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Another approach to providing sufficient channel height was to stack positive resist on top of
underlying SU8 structures. In this method, readily processed SU8 with rectangular cross
sections could provide the foundation, and the positive resist could be patterned over top with the
intention of creating a continuously smooth channel cross section. This concept is presented in
Figure 3.7.
A)
RI
Figure 3.7: A conceptual three layer photoresist process is used to create tall channels with a
rounded cross section. A) A base layer of 50 um SU8 is followed by B) an additional layer of 100
pm SU8. C) Positive photoresist is aligned and patterned over the base structures, then reflowed
to yield a rounded cross section. Note that the positive resist must extend beyond the foundation
structures all the way to the mold substrate.
In this process, two layers of SU8 are used to achieve a flow channel with a height of-150 jpm
similar to the open channel culture chips. In a third photoresist step, a positive resist is coated
and patterned in alignment with the base structures. To round the final layer of positive
photoresist, the microfluidic mold can be placed onto a hotplate or into an oven after the
photolithography and development steps. Epoxy based SU8 photoresist does not reflow after it
has been patterned and cross linked, which ensures that the base channels maintain their height
and dimensions. The photoresist reflowing step is crucial. When in the molten state, surface
tension across the resist surface tends toward smooth continuous profiles to minimize free
surface energy, and this profile solidifies when the wafer is cooled back to ambient temperature.
The positive photoresist must be gradually heated beyond its glass transition temperature to
prevent out gassing residual solvent. If the correct processing parameters are determined that
enables such a channel section to be fabricated, then it will be possible to enable MSL valve
closure in the largest channel heights reported to date by multilayer soft-lithography. The
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proposed assembly process for a complete device consisting of a complementary flow and
control layer is presented in Figure 3.8.
A)
Flow
Control
B)
Figure 3.8: Soft-lithography fabrication of a microfluidic device containing megavalves. A) Two
molds are required, one for the flow channel and one for the control valves B) The thick layer
and thin layers are both cast using 10:1 PDMS, thus are plasma bonded together in step C). D)
After the layers have been bonded by plasma, they are removed from the control mold as one,
interconnects are punched, and devices can be bonded as usual to glass slides. This fabrication
technique is compatible with conventional MSL, and regular valves can be included on the same
chip with this process.
A variety of flow and molds were fabricated using the aforementioned process, using the
pyramid SU8 approach coated with one layer of AZ 50 XT resist (Clariant, MA). AZ 50 XT was
the most suitable resist available for valve fabrication since it is specifically designed for
fabricating features with thicknesses of 25 - 70 tm. For reference, the processing of AZ 50 XT
involves five steps:
1. Spin coating resist onto the wafer (-1400 rpm for 45 s for a thickness of -50 gm).
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2. A pre-expose bake (either -30 min in a humid 900 C oven, or ~3 min @ 850 C + 10 min @
115 0 C on hotplates).
3. Mask alignment and exposure, at least lh hour or more following the prebake (- 6
intermittent exposures, -1 min each).
4. Development (submersion method with agitation, 400K developer diluted 1:3 in water).
5. Reflow patterned resist (on a hotplate ramped to -120 0 C over 3 hours).
These steps were rough guidelines only, and it was found that shorter prebakes or increased
exposures could improve pattern fidelity over SU8 structures. Several three layer test molds
were designed, and the first successful prototype is presented in Figure 3.9.
Figure 3.9: The first working "megavalve" based on a three layer photoresist process. The
spine of the channel due to a tall photoresist is visible in both A) open and B) closed states.
Valve and channel widths are 500 ~m and 1000 pum, respectively.
Unfortunately, yield of defect free molds and reliably sealing devices during prototyping was
intolerably low. Although the device casting and mold cross sections are intuitively
straightforward, the interaction between different photoresists through complete processing
cycles was particularly difficult to troubleshoot. Several fabrication issues commonly arose,
such as the formation of bubbles in the photoresist during baking, cracking of the positive resist
during reflow and, in general, the non-uniformity of channel heights. These defects would yield
channel cross sections that were not continually smooth and prevent valve sealing. As observed
in Figure 3.9, a sharp "spine" transition near the thickest SU8 layer was the most common failure
point of valves. The PDMS membrane could not sufficiently deflect to prevent fluid flow along
pronounced spines, as confirmed in microfluidic experiments with 1 pm fluorescent flow tracers
which could easily leak past the "closed" valve.
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For practical implementation with already challenging embryo culture, it would be important to
develop a robust fabrication process and set of design rules such that these megavalve features
could be readily integrated into a variety of microfluidic devices by others in the future. A
parametric fabrication study was devised to investigate how to fabricate these features
consistently.
3.5.3 Fabrication Parametric Study
To debug fabrication issues and identify process parameters for megavalve fabrication, a simple
culture device was designed based on the open channel culture concept. Megavalves were
implemented on the inlet of the culture chamber, and a regular MSL valve was located on the
exit port as illustrated in Figure 3.10.
5mm
"Megavalve" Standard valve
Figure 3.10: A 1 ul culture device with channel heights of 150 on integrating a megavalve on
the inlet port. This simple architecture would be used for optimization offabrication and
development of design rules for integrating megavalves on embryo culture devices.
The effect that the underlying SU8 structure has in the patterning of AZ was not well understood.
It was therefore decided to test a variety of SU8 foundations in the parametric study, summarized
in Figure 3.11. A pyramid-like layout of underlying SU8 was modified to support AZ resist
during the reflow process. The cross section width of AZ in this experiment was 1000 ptm.
During the reflow process AZ resist may deform and contract slightly on the substrate. It is
necessary to avoid any sharp transitions in the cross section of the final channel, either between
the AZ and substrate, or between the AZ and SU8 structures, so ensure the MSL valve seats
properly.
An interesting "splashing" effect was observed when spin coating thick positive resist over
existing SU8. After spin coating, significant waviness of AZ is apparent over the much taller
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SU8 features, and due to the viscosity of photoresist, the non-uniformity does not necessarily
flatten under gravity. To also investigate the effects of this splashing effect, devices were
patterned onto a wafer with various orientations.
A) B)
'/, nmv.2
MV type 1:250um mv.3 mv.1 mv.3
MV type 2:um - --- ", -/
MV type 2:500um
I- 3I I\ mv.2
MV type 3: 750um
Figure 3.11: Three different megavalve profiles tested. A) The width of the base SU8 in the
megavalve structure was varied to determine which design would provide the most consistent
channel cross section in fabrication. The total SU8 height in all cases was 150 mon B) Patternlayout on the wafers for the fabrication study. This layout on a 3" wafer would allow the study
of variations in channel fabrication that may be dependent to feature orientation in photoresist
spin coating. The flow mold consists of a three photomask process (two SU8 layers followed by
one AZ), and the control mold was fabricated from a single layer of SU8.
It was determined that the orientation of the tall SU8 features was in fact an important
consideration during spin coating of the final AZ photoresist for reflowing. Devices oriented
radially outwards from the center of the wafer allowed the resist to coat both sides of the tall SU8
channels equally. Asymmetric features resulted if features were not radially oriented with the
direction of material spreading during spin coating, as determined by examination of channel
cross sections. This effect was further exaggerated when thinner layers of AZ were tested.
Using flow molds fabricated with various thicknesses of 50XT resist, devices were cast using
PDMS and cross sectioned to assess channel quality. To test for valve closure, chips consisting
of a flow and control layer were assembled using megavalve types one, two and three. It was
found that molds with 50XT thickness greater than 50 jtm yielded valves which could be sealed
with sufficient control line pressures. Type two designs provided the smoothest channel cross
- 80-
sections, as sharp transitions were occasionally observed with types one and three. Typical
results of the channel mold measurements are presented in Figure 3.12.
A) 0 - C)
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Figure 3.12: Selected results of the megavalve fabrication parametric study A) PDMS Devices
were cast using the flow molds and cross sectioned in three sections B) The cross sections of the
channels corresponds to the dashed lines in part A). The "splashing" effect during spin coating
is apparent in two off-center devices in section (iii). C) Photoresist asymmetry in spin coating
may be attributed to the feature locations on the wafer, where material is removed radially D)
Devices were fabricated as per Figure 3.8 to test valve performance. This device corresponds to
the center sections in B). The valve channel is 500 pm wide.
Type two megavalves were robust, and the reflow process resulted in a channel section that was
almost perfectly round. As observed in Figure 3.12, the underlying SU8 is almost invisible
below the AZ for the center channel, but transitions are evident on the neighboring channels.
This was a result of asymmetric spin coating, since these channels were not radially aligned with
the direction of material removal in spin coating. With the centerline device, it was possible to
seal the megavalves with applied pressures of 5-6 psig, which is in the standard operating range
of MSL control lines.
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Based on this parametric study, for large displacement megavalves produced using a single layer
of positive photoresist, channel geometries consistent with type two patterns were used. Also,
channels encompassing megavalves were to be oriented on the molds in a radial direction if
possible, to provide symmetry in the final AZ resist
3.5.4 Implementation of megavalves for culture
Using the protocols and design rules resulting from the parametric study, a new design for
parallel embryo culture was ultimately developed. The channel design and fabrication steps are
presented in Figure 3.13.
A) C) "
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SU8:50 um m AZ50XT:50 um 5 mm
1 SU8: 100 um m SU8: 100 um (control mold)
Figure 3.13: Mask layout and fabrication process for closed volume culture devices A) the base
layer of SU8 encompassing the sieve channels was patterned to a height of 50 pm followed by B)
an additional 100 um to create the culture channels. C) AZ50XTphotoresist was patterned to
create the exit channels and megavalves. D) Control valves were patterned on a second mold.
The final device contained six embryo culture chambers, which could be sealed using four MSL
valves. Concept designed with David Potter of FLC.
The channel spokes were arranged on the silicon molds to ensure radial symmetry. In this way,
all megavalves would be nearly symmetric. Further, a larger splash guard of SU8 (on the right
hand side of the patterns) was used on later revisions to allow a more uniform positive
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photoresist distribution in spin coating. Chambers in the closed volume device were nominally
125 nl, 250 nl and 500 nl, each in duplicate. Channels cast using the "6-legged" concept are
illustrated in Figure 3.14. The smooth megavalves profiles, and exit sieves are clearly visible.
There is also good consistency between neighboring valves (in contrast to Figure 3.12), due to
the radial symmetry of the design.
Figure 3.14: Using the fabrication protocols developed in the parametric study, it is now
possible to integrate valves with the earlier open channel designs. A) Detail ofa single culture
chamber consisting of two layers ofSU8, with a megavalve on the left and waste channel to the
right. The first SU8 layer with sieve patterns is 50 pm, followed by an additional 100 umn in
regions for housing embryos. B) Parallel culture channels from a common loading port.
Development of integrated, large displacement valves was a crucial turning point to enable
culture in truly closed volumes. With valves on both the inlet and exit, embryos would be
cultured in irrefutably the smallest microchannel devices to date.
3.6 Closed volume culture
Combining the design rules for microfluidic megavalves, and the cleaning protocols developed
previously, it was now possible to culture embryos in sub-microliter confined devices.
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3.6.1 A device for closed volume cultures
Consistent with the open channel systems, all newly fabricated silane free molds were dummy
cast with 10:1 PDMS at least once before producing culture chips. PDMS on both flow and
control molds was baked for 48 h before assembling the device with a plasma treatment. Devices
were ethanol extracted and soaked with culture media, each for 24 h, in preparation for culture.
Rather than water, embryo culture media was back filled into the control lines to prevent
osmolarity shifts across the PDMS valves into the culture chambers during the course of five day
experiments.
Since PDMS devices were being cast off wafers without silane treatments, cured devices had to
be peeled very carefully to prevent damaging the megavalve photoresist, and the PDMS valve
membrane. Several instances of membrane tears were experienced on the first sets of chips,
which was remedied by removing sharp corners from the profiles of the control lines, as well as
increasing the valve membrane thickness to at least 35 p~m (-600 rpm 10:1 PDMS spun coat over
100 tm thick control molds). Typical closing pressure of the valves of these culture devices
ranged from 10 - 15 psig.
A custom control manifold operating off a portable air pump was set up adjacent to the embryo
incubator to allow manual control of the device valves. The manifold was connected to
individual culture devices with several feet of Tygon tubing, so that control lines could remain
pressurized at all times during culture. To assure complete sealing of channels, dyes were tested
in the devices as per Figure 3.15.
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Figure 3.15. Demonstration of chamber isolation using the megavalves. Megavalves are used on
the right hand side of the chambers, whereas regular valves on used on the exit port. Holes
punched directly on either side of the chambers were used for volume calibration purposes, such
that water containing a volume tracer could be isolated within individual chambers when the
valves were sealed. The scale bar indicates 5 mm.
3.6.2 Closed culture results
Cultures were completed using the architecture presented in Figure 3.15. In parallel to murine
embryos cultured individually in channels of three separate devices, controls were also cultured
in various volumes of microdroplets. Microdroplet media volumes less than one microliter were
dispensed as accurately as possible with glass constriction pipettes (Figure 2.1). Group cultures
were also performed in large 20 pl droplets. As with open channel trials, samples were removed
from incubators once daily for optical inspection.
Embryos in two of the three devices produced blastocysts, while some samples were degenerated
at the two cell stage in one of the chips. During device preparation, air bubbles were not
completely purged from the megavalve channels, which passed through the PDMS membrane
into some culture chambers. In the other devices, no air bubbles were observed and culture was
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not compromised. Morphological results of the microfluidic and microdroplet trials are
presented in Figure 3.16.
A) Device B) Microdroplet
culture
2 chambers
exit
ports valves
Figure 3.16: Culture results in sub-microliter microfluidic chambers. Embryos wereindividually cultured in six chambers of microfluidic chips, and controls were cultured in
microdroplets of various volumes.
In both the device and droplet cultures, the cleavage rates of the day four embryos are lagging
compared to those cultured in larger volumes. The cleavage rates of samples in 250 nl and 500
nl microchannels appeared to lead those performed in microdroplets. Cell counts (ICM and TE)
were not performed on these initial trials using closed chambers, although qualitatively, the
results are very promising and appear consistent with experiments refined in 1 tl open channels.
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Trials are being currently underway with larger embryo populations using the closed chamber
architectures to explore the affects of culture in sub-microliter volumes, and to quantify the
benefit of microchannel culture. These experiments demonstrated that it is possible to culture
embryos through to the blastocyst stage using the smallest microfabricated volumes to date.
Integration of large scale MSL valves which accommodate embryos and do not interfere with
culture represents a significant milestone in metabolomics for IVF, and opens avenues for
integrated profiling.
3.7 Conclusions and Contributions
In this chapter, we developed the expertise necessary to culture embryos in static microfluidic
systems, with the goal of enabling integration of downstream metabolic profiling. In contrast to
previous static microchannel systems of other groups, using hybrid glass channels with PDMS
bottoms, our devices were entirely produced using replica cast PDMS. Our open channel
systems allowed us to debug issues with embryo handing, and fabrication toxicity. Through
several culture trials, it was demonstrated that blastocyst cell counts obtained from embryos in
microchannel systems were on par with, if not better, than samples cultured in conventional
microdroplet formats.
Development of integrated, large displacement valves was a crucial turning point to enable
culture in truly closed volumes, and to provide unprecedented regulation of flow in culture
systems. While a multitude of microfluidic valve techniques have been presented in the
literature, none were suitable to accommodating embryos in our microfluidic systems. As such,
a new class of "megavalves" were engineered which could be operated in the same methods as
standard MSL valves, yet operate on channels greater than 150 ptm in height.
Microfluidic embryo culture using tools similar to those introduced in this chapter will be
applicable to pursue open questions in the field of embryology. For example, it will be of
particular value to determine if there exists an optimal volume for static culture in
microfabricated systems, and whether that volume is limited by metabolite depletion. Also,
since in vivo environment is dynamic, it could be studied whether gentle agitation or
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recirculation of media using integrated pumps improves overall culture. Regiments for
replenishing spent media could potentially be automated and reduce the need to manipulate
samples manually within incubators. With microfluidic channels with integrated valves that
have been demonstrated to be compatible in culture, these devices are a major step towards
enabling integrated metabolite analysis.
-88-
Chapter Four - Integrated Microfluidic Culture with
Metabolomics
4.1 Introduction
In the previous chapters we have developed competencies for non-invasive metabolic profiling
and embryo culture using microfluidic constructs. Individually these accomplishments should be
of utility to clinical embryologists by their own merits. Looking forward, an end-to-end solution
for unattended embryo culture and metabolic profiling in real time would combine both of these
functionalities to a single device. The objective of this chapter is to develop such a platform,
capable of supporting cell culture while performing non-invasive measurements for metabolites
of interest.
The tools introduced in this chapter provide a proof of concept for integrating culture and
detection capacities in a scalable manner beyond techniques available in the literature. While it
was not possible to utilize embryos for the present work due to availability of samples, the
architectures and infrastructure designed provide the groundwork for devices with integrated
embryo culture and analysis in the future.
A variety of engineering challenges are addressed to enable sustainability of cell cultures on a
chip with non-invasive fluorometric measurements. The goal is to develop an approach which is
general enough to satisfy the requirements, of not only embryologists, but also of biologists
interested in cellular metabolism. Such a platform should accommodate many samples in
parallel, offer the freedom to modify upstream culture conditions, and allow various metabolites
to be examined without constraints on reagents or protocols. These are distinct advantages of the
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approach conceived in this chapter which differentiates it from alternative tools previously
reported in the literature.
4.1.1 Potential Applications of Integrated Culture
Several microfabricated devices have been previously demonstrated providing either discrete or
continuous monitoring of specific metabolic products in cell culture. However, many of these
techniques are invasive and none have demonstrated the flexibility to modify culture conditions
in an automated manner based on the outcome of measurements.
Eklund et al developed a macro scale "cytosensor physiometer" with four custom fabricated
electrodes capable of detecting changes in extracellular glucose, lactate, oxygen and pH53
Electrodes are coated with either glucose oxidase or lactate oxidase that creates hydrogen
peroxide in the presence of the respective metabolite. Hydrogen peroxide can be measured
amperometrically and the electrical current can be related to concentration. This system has the
benefits of non-optical readout, but suffers from difficult calibration (appropriate signals are on
the order of nA), lack of compatibility will all media types due to electrochemical compatibility,
and the flexibility to measure additional substrates of interest. Leegsma et al also used oxidase
based sensors for continuous sensing of glucose and lactate from cell culture contained in a
customized enclosed chamber52 . The sensor was capable of simultaneously detecting glucose
and lactate concentrations requiring media flowrates of- 1 l / min, although the system was
opaque hindering morphological inspection, it could not be extended to sensing of other
metabolites and was subject to noisy calibration. Shiku et al developed scanning electrochemical
platinum sensors for oxygen consumption, and used these probes to measure the oxygen
consumed by single bovine embryos directly within culture 54 . While the method is "non-
invasive" it does require manual holding of an embryo while a 4 tm diameter probe traverses
within 5 tm of the surface. The authors did correlate higher oxygen consumption to the
developmental potential of bovine embryos, although widespread use of this technique may be
hindered by the complex instrumentation and need to manipulate every embryo for
measurement. Finally, Ciobanu et al furthered the use of scanning electrochemical glucose
oxidase and lactate oxidase probes to be compatible in a wider range of culture media, and
demonstrated their instrument could create surface maps of metabolite concentrations
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surrounding single mammalian cells at a certain point in time55 . In many assays, however, such
detailed information is overkill and difficult to interpret. Rather, endpoint measurements
averaged over longer windows may be more useful to infer the average nutrient utilization of a
cell, or group of cells. Many of the aforementioned studies focus on instruments used to detect
specific metabolites, which necessitate non-trivial electrochemical calibration. They also lack
scalability to analyze additional samples in parallel, and the ability to adapt culture conditions
based on feedback of current measurements.
An interesting approach to cell culture would be the integration of feedback driven protocols
based on metabolic measurements. For example, if nutrients were depleted, or by-products were
produced, beyond predetermined thresholds then media could be replaced. If regulation of
metabolic activity was desired, cells could be either physically or chemically perturbed to
varying degrees in order to achieve a desired metabolic output. A single microfluidic device
may be capable of supporting cell culture, periodically performing metabolic assays, and
replacing or even generating new media formulations on demand upstream of culture.
Beyond the overdue embrace of metabolomics in the IVF community, there are many fields of
cell biology where metabolic profiling plays a critical role. Directed evolution, drug toxicity and
cancer treatment are some of the most pressing research fields where microfluidic tools for
metabolomics may be particularly valuable.
A key challenge in cancer therapy is the development of treatments to preferentially kill cancer
cells without undo harm to healthy tissues, and metabolism may offer opportunities to new
strategies. An area that has received much attention is the potential regulation of metabolic
activity of cancer cells through glycolytic inhibitors. Although all causes are not yet understood,
it is widely observed that most cancer cells exhibit altered metabolic profiles in comparison to
normal adult tissues, and in particular increased levels of glycolysis35' 39. Cancer cells depend
almost solely on this metabolic pathway to generate ATP as their main energy source, which is
known as the Warburg Effect (observed more than 75 years ago by Otto Warburg). The excess
of lactate produced by cancerous cells, which may be considered a first order indicator of
overactive glycolysis, is known to rapidly decrease the pH of surrounding medium to acidic
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levels 55. The net reaction for glycolysis (the process by which one molecule of glucose is
catabolized to two molecules of pyruvate with a net gain of two molecules of ATP) is:
Glucose + 2 Pi + 2 ADP + 2 NAD+ - 2 Pyruvate + 2 ATP + 2 NADH + 2 H+ + 2 H20
Pyruvate is utilized through the tricarboxylic acid (TCA) cycle and oxidative phosphorylation in
mitochondria in healthy cells to generate ATP, but if these cycles are dysfunctional, pyruvate is
converted directly to excess lactate by lactate dehydrogenase (LDH). ATP generation by the
glycolytic pathway is far less efficient (2 ATP per glucose consumed) than alternative pathways
(36 ATP per glucose by oxidative phosphorylation), thus cancer cells consume far more glucose
to generate sufficient ATP for metabolism and proliferation 35. This increase in aerobic glycolysis
and dependency on this pathway for ATP generation in malignant transformation suggests the
fundamental importance of this mechanism and suggests possibilities to kill cancer cells by
therapeutic inhibition of this pathway35. Mitochondria of normal cells are able to adapt to
alternative sources to generate ATP, such as amino or fatty acids, rather than depend on
glucose35
An automated approach for studying the effectiveness of various inhibitors on tissue and cell
lines (or even combinations of inhibitors for simultaneously addressing different pathways) in a
streamlined platform could be very powerful. Most of the microfluidic protocols required for
microfluorometric analysis have been studied and understood in previous work. To demonstrate
the potential of an integrated analysis approach, a device is devised which is capable of
metabolic profiling of mammalian cell cultures in a parallel manner.
4.2 An Integrated Device for Parallel Processing
A platform was developed to enable culture of small populations of mammalian cells lines in
separated chambers, each of which is equipped with a downstream mixer for monitoring
metabolism non-invasively.
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Previous parallel architectures for bacterial culture and processing of nucleic acid from single
cells have been previously developed32' 104, 105. In recent work, a parallel architecture was
developed capable of supporting cell culture in 96 separate chambers for a period of weeks with
on demand replenishment of different types of culture media'
0 6
. These devices demonstrate the
scalability and automation enabled by microfluidics, as well as the advancements in supporting
cell culture on chip. In many of the previous studies, optical inspection of growth quality was
performed directly within of culture chambers, while for non-invasive metabolic profiling, it will
be necessary to periodically transport samples of media from the cell culture chambers for assays
with metabolite cocktail. A layout with modular culture chambers and assay chambers was
designed for this purpose.
4.2.1 Utilization of Cell Sieves
In order to seed and grow uniform cell populations on chip, previously characterized
microfluidic designs for trapping cells are implemented36. These cell sieve designs are easily
integrated with standard microchannels. Numerous "C" shaped sieves with open slits of- 8 ptm
are positioned within a culture chamber, and are used to catch mammalian cells with diameters
of - 10 p.m from a flowing solution as illustrated in Figure 4.1. Following the removal of excess
cells by a wash with fresh media, adherent cells are allowed to culture within the chamber.
cell loadingI
s)
0
2
100 PM
Figure 4.1: A microfluidic cell sieve for delivering highly repeatable populations of cells to
culture chambers on chip. These modules are used for containing cell cultures within the
implemented device. Figure adapted from M. Kim et al (2008).
Typical diameters for the cells culture chambers are between 400 and 800 ptm, with heights in
the range of 20 - 25 pm. Approximately 100 cells are seeded per chamber, as governed by the
size and number of sieves. The advantage of using microfabricated geometries to trapping cells
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is that the number of cells loaded into the sieve tends to an asymptotic value with loading time,
which reduces uncertainty in loading due to initial cell density.
4.2.2 Device Architecture and Operation
Using modular cell culture and metabolite detector mixer elements (Chapter Two), a scalable
architecture was designed. Assay operations, such as sample metering, loading of metabolite
cocktails, and assay mixing can be performed simultaneously across multiple analysis lanes. A
schematic of the integrated chip is presented in Figure 4.2
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Figure 4.2: A microfluidic architecture with eight culture chambers for parallel processing of
metabolic measurements (Figure adapted from software interface, JPU). Reagents including
enzymes, washes and standards are located on the left which can be directed to the detection
rings. The top four inputs are reserved for cell seeding and for supply offresh media. Mixing of
all eight reactions occurs at the same time using common control lines. A motorized microscope
stage enables unattended fluorometric measurements of all reactions.
This architecture contains two independent sets of multiplexors. One set regulates the flow of
inputs, and the second is used to select the outlet channels between the mixing rings and the
waste port. In this manner, different compositions of media and cells can be directed to each of
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the eight individual culture chambers, while analysis can be completed in parallel. Flexibility of
this architecture is demonstrated in Figure 4.3, where custom mixtures of media were prepared in
six neighboring chambers. While many experiments will only involve a single cell and media
type, an advantage of the dual multiplexor approach is that the media can be replenished on
unique schedules for each chamber.
Figure 4.3: The integrated architecture contains an additional set of multiplexors on the output
channels, to combine the flexibility of independently addressable sample chambers with the high-
throughput strategy ofparallel sampling. Here, mixtures offood coloring are metered to culture
chambers to yield a rainbow pattern. Cell chambers are 800 pm in diameter.
In the context of inhibition assays, it is now possible to deliver different formulations of media to
individual cell cultures, yet perform automatic metabolic analysis in parallel. Further, this device
was designed to be scalable. As such, only minimal changes to control and flow networks are
required to accommodate, 16, 32 or even more chambers for profiling.
4.2.3 Device Functionality
The device was developed with the goal metabolic profiling in a non-invasive manner, similar to
the approach that would be implemented for embryo measurements. With this in mind,
fluorometric assays on samples of spent media would be performed in reaction chambers
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downstream of culture, and the necessary mechanisms for sample collection would have to be
designed. It was important that metabolite enzymes never contact the cell cultures.
The integrated assays were separated into three steps. First, samples would be cultured within
well defined volumes of media, with known initial concentrations of metabolites. Second, after a
predetermined amount of time, used media from the culture chambers would be drawn
downstream into dedicated mixer. In the final step of the assay, the sample of media would be
mixed with a metabolite cocktail and fluorometric measurements would be recorded in a manner
identical to the standalone detector'0 7 . These mechanisms are illustrated in Figure 4.4.
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Figure 4.4: Primary operating modes of the integrated metabolic detector. Yellow, blue and red
lines represent culture, flow and control channels, respectively. For scale, channels are 100 Pm
wide. A) In the culture mode, peristaltic pumping may be used to gently circulate media over a
population of cells inside of a closed loop. This ensures that metabolites and growth factors are
retained and homogeneous throughout the culture media to be sampled. B) The culture loop
design enables two different media sampling modes to be used. Samples may be peristaltic
pumped from either the culture chamber, or the bypass channel, to the top right of the assay
chamber. C) In the assay mode, metabolite cocktail is loaded to the left side closed mixing loop
and mixed with the sample. The purple outline indicates the imaging region.
A recirculation loop approach for the culture chamber was chosen to ensure that sampled media
has a uniform concentration of metabolites for measurements. The bypass chamber also allows
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new reagents to be directed towards culture chambers, while preventing cross contamination of
upstream reagents over the cells. Each chamber is expected to contain - 100 cells during
experiments, with some stochastic variation due to the loading process and exact mold
geometry 18, with corresponding changes in metabolite levels expected to be on the order of
-mM per hour (discussed in detail in section 4.4).
With this non-invasive approach, there is a tradeoff in sampling rates for metabolic profiling. If
samples are drawn frequently, higher resolution profiles may be determined although the cellular
environment may be perturbed more frequently. Longer culture periods between samples would
lessen the effects of measurement noise and allow more accurate time averaged metabolism to be
reported. It may be necessary to experiment in both these regimes to also determine how the
media refresh rates will affect nutrient utilization. With this operating strategy in place, it was
necessary to implement the remaining infrastructure necessary for parallel fluorometric imaging.
4.2.4 Device Fabrication and Platform Control
Devices were fabricated using either bottom-up valve configurations with RTV 615 PDMS.
Flow molds 25 jim tall were fabricated using a two step photolithography process as per Chapter
Two, with rounded channel sections of positive resist (AZ 50 XT, 3100 rpm) compatible with
valves, and rectangular channel sections (SU-8 10, 1200 rpm) for cell trapping and fluorometric
detection. Control molds were also fabricated with a two step process using layers of 25 Im
thick SU-8, also following the design rules from Chapter Two. Chips were cast using standard
MSL procedures from the molds treated with fluorinated silane, baked for a minimum of 36 h,
and plasma bonded to 1 mm thick glass slides. Prior to use, channels were soaked with ethanol
for several hours, and dried using nitrogen.
Computerized valve control and connections of all reagents are as previously described for the
single chamber detector. Typical control pressures were - 15 psig, and sample inputs were
maintained at - 4 psig. Rather than water, it is critical that sterile PBS was backfilled into
control channels to prevent adverse osmolality shifts of media during culture due to transport
through PDMS membranes.
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To enable parallel fluorometric imaging of all eight mixing chambers, control of a motorized
stage (Prior H117) on the microscope (Olympus IX-71) was integrated with the BioStream
JAVA software. A "zero" position was declared over chamber 0 (the mixing chamber on the left
hand side of the device). All chambers and mixing rings were identified with nominal (X, Y)
coordinates in a driver file, which were referenced by the image acquisition commands. Further,
to account for devices which are not perfectly parallel with the glass slides during plasma
bonding, coordinate transformations were used to translate nominal (X, Y) locations to actual
(X', Y') positions. The coordinate transformations were of the form X' = X cos 0 - Y sin 0 and
Y' = X sin 0 + Y cos 0, where 0 is the angle of skew in radians. An example series of corrected
images is presented in Figure 4.5.
Figure 4.5: Automatic images acquired from parallel lanes of the microfluidic device. A) A
subtle -4' rotation is evident in the device, introduced during the manual plasma bonding of the
chip to the glass slide. Since chambers one and eight are -1 cm apart, this can lead to imaging
discrepancies if direct lateral translation is used for imaging (y error = tan (40) * 0. 01 m = 700
pm). B) Coordinate correction of the nominal skew angle allows images to be acquired at
identical locations for each detection channel, to improve quality of measurements. Channels
are 100 pm wide, imaged at 20X
With the imaging mechanisms automated, it was straightforward to perform fluorescent analysis
sequentially across all chambers in a matter of seconds. The automated scanning routines could
also be used to regularly inspect the cell morphology within culture chambers.
4.3 Device Calibration
Based on the experience of developing and troubleshooting the serial metabolic detector device,
it was straightforward to identify the key issues that would have to be calibrated on the integrated
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platform. With the serial standalone device, sample throughput and repeatability was 
of primary
importance since only one mixing chamber was in operation. In management of parallel analysis
channels, not only should results be repeatable on a single channel, but they must be repeatable
chamber-to-chamber for the purpose of comparing metabolic results. By these criteria,
uniformity between all chambers is more important that absolute speed. For example, it may 
be
possible to draw samples from all chambers for metabolic analysis in under one second, but
slower, regulated sampling will ensure similar volumes are used for all eight reactions. As 
there
are eight parallel reactions, the throughput of data is still appreciable even when individual
operations are performed at a reduced rate. It was also desirable to ensure consistent treatment
across all separate samples being cultured on chip.
Calibration trials were completed on each of the three operational modes outlined in Figure 4.4
to ensure uniformity between chambers, as well as to minimize operating time and sampled
volumes. In these trials, inputs of food coloring were used as mock inputs. Example calibration
trials and images of sample isolation are presented in Figure 4.6.
Figure 4.6: Typical images used for loading, sampling and mixing calibration. Key areas of the
device are annotated
In the following sections, important performance parameters are discussed for each of the
circulation, sampling and assay operating modes.
4.3.1 Culture Media Circulation
To initiate a metabolite assay experiment, fresh media with known metabolite concentrations
would be supplied into both the culture chamber and bypass channels. Cells would be allowed to
culture within their chamber, and periodically peristaltic pumps would be used to circulated
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media around the chamber to ensure that all nutrients are made available to the cells, and also
that the media is homogeneous prior to sampling. A calibration panel is presented in Figure 4.7
for the recirculation pumping trials, where performance of different peristaltic pumping duty
cycles was assessed.
Figure 4. 7: Calibration of culture recirculation operations. Peristaltic pumps are used to
circulate media within the eight closed loops over the cells to ensure uniform metabolite
concentrations for sampling. A) Initially fluid samples were docked in the bypass chamber. B)Fluid was pumped for 10 seconds at various pump duty cycles, from 10 to 100 ms. Some non-
uniformity is observed for very fast pumping, while the most uniform pumping across all
chambers for duty cycles of 50 ms or slower.
While it was possible to rapidly circulate media around the chamber, differences in valve
performance become apparent at high pumping frequencies. Thus more uniform recirculation
operations across the device were ensured by using longer duty cycles, which may also prevent
adverse effect on culture due to reduced fluid shear stresses.
4.3.2 Sample Metering
Experiments were completed to identify the conditions by which identical volumes of media
from the eight culture chambers could be sampled. It was found that while this operation could
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be completed very quickly, uniformity would suffer as observed in Figure 4.9. If too much
sample is drawn from a single chamber, the bypass chamber or sieve could be exhausted of
valuable sample before profiling is completed.
t=ls 2s 3s 4s
Figure 4.9: Calibration panel of the media sampling operation. Peristaltic pumps in the lower
mixing ring are used to draw media from the culture sieve or bypass loop, using various duty
cycles (rows) and total metering times (columns). The rate ofpumping plays an important role in
metering uniformity. For duty cycles 50 ms or less, significantly more media was drawn from
some chambers than others (e.g. 25 ms cycles for 3 s). Ideal metering is achieved for duty cycles
of 100 msfor total cycle times of three or more seconds.
The channel volume between the culture chambers through the enzyme mixers is nominally 3.3
nl, while the volumes of the sieve and bypass channels are 12.6 nl and 11.2 nl, respectively.
Unfortunately with this device configuration and sampling scheme it will not be possible to
complete a nominal seven or more (- 23.8 nl / 3.3 nl) metabolic measurements. Since the
existing culture volumes are replaced with fresh media during sampling, diffusion will dilute the
existing media of interest. Taylor dispersion will also work to accelerate the dilution process,
since fresh media introduced to the chambers traverses the centerline of the channels
approximately twice as fast as the average flowrate of the remaining fluid. The meandering
bypass channel was designed with a longer path length specifically for these reasons of diffusion
and sample transport.
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As a result of this parametric calibration study, it should be possible to draw as many as four or
more media samples from the bypass and sieve chambers for replicate metabolic measurements
before it is necessary to completely replace the media. If additional replicate measurements are
desired, it would be straightforward to scale up the length of the bypass channel to generate
larger samples of spent media. Increasing the volume of this channel would come at the expense
of changes in metabolite concentrations that may become more subtle to detect, although as
demonstrated in Chapter Two, the microfluidic device can be tuned to detect micromolar
concentration changes or less without difficulty.
4.3.3 Cocktail Mixing Operation
The third mode of operation to be characterized was the assay mixing operation. Again, it was
determined that slower pumping duty cycles provided more uniform fluid transport across all
chambers. The calibration panel for the assay mixing operation is presented in Figure 4.8.
Initial position
25 ms
50 ms
S 7I ms
SI 100 s
Figure 4.8: Calibration ofparallel mixing operations to combine media samples and enzymecocktails. Peristaltic rotary pumping is used on circular mixing rings, each with a volume ofapproximately 10 nl (Inl media sample, mixed with 9 nl enzyme). A) In the calibration study, acolored marker was docked in the sample portion of the mixer. B) Uniformity ofpumping wasassessed at different pumping duty cycles, after a total pump time often seconds. Non uniformityof sample mixtures was observed for fast pumping (duty cycles < 50 ms), while pump cycles of100 ms appear suitable for slightly slower, but highly uniform mixing.
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Based on extensions of similar calibration trials , it was decided that pumping should be
performed using duty cycles of at least 75 ms, for 30 seconds or more. Fortunately, unlike the
recirculation and sampling operations, it is not critical that all assays are performed consistent
among one another. It was more important that performance of an individual chamber was
consistent from run to run, since every assay chamber would be fluorometrically calibratied
separate from one another.
4.4 Cell Assay Design
With the device infrastructure, imaging routines, and fluid operations well characterized, the
device would then be primed for performing cellular metabolic profiling. To transition to
integrated assays, it was necessary to calculated metabolism estimates for our mammalian cell
line, create custom blends of culture media suitable for fluorometric assays, and perform
fluorometric calibration trails. Further, since these experiments will use mammalian cells as
opposed to embryos, consideration was given to the problem of culturing adherent cells on
PDMS surfaces.
4.4.1 Predictions of Cellular Metabolism
In order to determine the adequate concentration of metabolites to utilize for fluorometric
calibration of media, it was desirable to know the expected consumption of glucose and
pyruvate, and the production of lactate due to cell culture. Rates of changes in these metabolites
are highly dependent on culture media compositions, temperature, pH and general culture
technique, thus any predictions would have to be used as guidelines only when adapting these
results to a microfluidic based construct.
In particular, relevant metabolism measurements reported by Barton were performed in macro
scale dishes, and may not apply to cells cultured in confined volumes 109. Across a range of
culture media pH between 6.8 and 7.5, glucose consumption and lactate production values for
HeLa cells were measured to lie anywhere in range of 0.2-0.8 mg / 1E6 cells / 24 h, and 0.1 - 0.4
/ 1E6 cells / 24 h, respectively 8 ' 110. DMEM media which will be used in these studies also has a
range of pH values depending on the formulation and buffer strengths, but if we assume a
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midrange pH of 7.2, approximate glucose and lactate changes are 0.41 mg / 1E6 cells / 24 h, and
0.16 mg / 1E6 cells / 24 h, according to Bartonl 9
The cell sieve structures in the integrated device accommodate approximately 100 cells each36
Thus we may expect that -1.7E-6 mg glucose will be consumed, and that -6.7E-7 mg of lactate
will be produced every hour, in each chamber. On a molar basis, these hourly differentials are
equal to 9.42E-12 moles glucose, and 6.0E-12 moles of lactate. Further, the total available
media volume is -25 gl within the combined culture and bypass circuit. This suggests that the
glucose concentration will drop by -0.37 mM / h, and the lactate concentration will increase at
-0.24 mM / h. These metabolic rates were reported using a different culture media and
approach, but provide a starting point to determine the sensitivity requirements of our detector.
In the serial metabolite detector from Chapter Two, expected physiological changes in
metabolite concentration in embryo media samples were in the range of 0 - 0.5 mM, and the
microfluidic platform was capable of detecting changes in the gM range. This resolution
therefore should be sufficient for measuring the changes in nutrient levels of mammalian cells
populations after even minutes of culture. Conversely, it would be possible to reduce the
numbers of cells per culture chamber, with the tradeoff that it may that it may take longer to
generate sufficient concentration changes in the media which can be measured. Perhaps with an
optimized microfluidic system, it could be possible to use these fluorometric assays for single
mammalian cell metabolic profiling in the near future.
4.4.2 Cell Media and Calibration
With approximations of metabolic rates completed, it is possible to compute and prepare a range
of calibration standards suitable for on chip assays with culture periods from 0 to 24 h. The
nominal concentrations of glucose, lactate and pyruvate in conventional high-glucose DMEM
media are 25 mM, 0 mM and 1.25 mM. Custom media was prepared based on a formulation of
low glucose media (Invitrogen, 11054-020) which was free of lactate and phenol red pH
indicator (which would interfere with fluorometric measurements). For culturing purposes,
glucose was supplemented to original DMEM levels of 25 mM glucose. A range of standards
with known glucose, lactate and pyruvate concentrations based on the phenol red free media
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would be used for fluorometric calibration. Contents of the four calibration standards are
provided in Table 4.1. Since it was not possible to obtain DMEM media which did not contain
phenol red without also including pyruvate, it was necessary to use an extrapolation calibration
scheme. A linear calibration curve would be calculated for concentrations greater than 1.25 mM,
although pyruvate will actually be consumed during metabolism.
As with previous metabolite specific assays, glucose, lactate and pyruvate were combined into
single standards to reduce the number of required fluid input to the device. After reagents had
been added and mixed, all media was passed through a 0.22 ptm syringe filter prior to
refrigeration.
Nominal STD 1 STD 2 STD 3 STD 4
glucose 25 20 15 10 mM
[180 g/mol] 225.00 180.00 135.00 90.00 mg/50 ml
lactate 0 2.5 5 10 mM
[112 g/mol] 0.00 14.01 28.02 56.04 mg/50 ml
pyruvate 1.25 1.50 1.75 2.00 mM
[88 g/mol] 5.50 6.60 7.70 8.80 mg/50 ml
Table 4.1: Metabolite concentrations in the media standards and fitted values
To assess sensitivity of the detector as well as develop analysis routines, numerous calibration
assays were performed. Replicate assays were performed for the three metabolites of interest,
across the aforementioned media standards. Each assay of a single calibration standard for a
particular metabolite required approximately ten seconds for metering samples, 60 seconds for
mixing, and another ten seconds to automatically image all eight chambers. An example
calibration panel from an assay routine is presented in Figure 4.10.
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Figure 4.10: Montage offluorometric images acquired during the detector analysis routines.
Four calibration standards are assayed for glucose, lactate and pyruvate. The channel widths
are 100 ium. While obvious fluorescence is only apparent in the glucose set of images, the 16 bit
CCD camera used to acquire these images has a large dynamic range and acquires sufficient
signalfrom all the channels. In all cases, the fluorometric measurement reported is the
difference in intensity between inside the microchannel and surrounding background.
Due to the difficulties in obtaining sub milligram accuracy in adding G, L and P to aliquots of
culture media, some discrepancies from nominal concentrations were experienced. Following
several rounds of calibration, a correction scheme was used to determine which actual
concentrations of metabolite are necessary to generate linear curves, as per Figure 4.11.
A) Glucose - Uncorrected
12.5 15.0 17.5
B) Glucose - Corrected
20.0 22.5 25.0
Avg R 2 = 0.996
10.0 12.5 15.0 17.5 20.0 22.5 25.0
Concentration (mrnM) Concentration (rnM)
Figure 4.11: Correction of nominal to actual glucose concentrations in the calibration standards
accounts for inaccuracies in metering sub milligram amounts of metabolite. The linear
coefficient of determination averaged across all eight chambers is significantly improved.
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In all cases, nominal values of metabolite in the media as received were not modified. Similar
correction schemes were also tested for both the amount of lactate and pyruvate in media
standards. Corrected values are summarized in Table 4.2.
Concentration (mM) STD 1 STD 2 STD 3 STD 4 Avg R2
Glucose - nominal 25 20 15 10 0.96
Glucose - corrected 25.64 21.02 16.92 10 0.99
Lactate - nominal 0 2.5 5 10 0.98
Lactate - corrected 0.00 3.59 5.01 9.72 1.00
Pyruvate - nominal 1.25 1.50 1.75 2.00 0.97
Pyruvate - corrected 1.25 1.52 1.78 1.97 0.99
Table 4.2: Nominal vs. corrected concentrations and resulting linear fits averaged over all eight
assay chambers.
4.4.3 Culture Surface Treatments
A known challenge in microfluidics is the ability to culture adherent cell lines directly on PDMS
surfaces. To circumvent these difficulties, "push down" valve geometries are most often used
with mammalian cells such that culture in microchannels can occur in contact with a glass
substrate. Since the performance of the device was found to be more repeatable using "push up"
valves, it was decided that cell growth should be attempted directly on PDMS surfaces. It was
also desirable to maintain use of the "push-up" valve geometries with the integrated device, since
this was the same approach used for embryo culture with megavalves from Chapter Three.
As adherent cells are not capable of growing directly on PDMS, it is necessary to introduce an
interstitial protein matrix, which can adhere to both the surface, and to cells22 . The most popular
adhesion layer is gelatin due to the simplicity of application 36, while more specialized matrices
have been suggested specific to different cell lines. To assess suitability of various surface
treatments, culture trials were performed with various culture dishes which were coated with a
thin layer of 20:1 RTV PDMS. After complete curing and prior to surface treatments, all test
plates were thoroughly rinsed with ethanol and dried at 900 C. In total, seven surface conditions
were tested in replicate, using combinations of gelatin (GE), fibronectin (FI) or poly-L-lysine
(PLL). Solutions of G, F and P were prepared in either DMEM media or PBS, and these
solutions were spotted to the PDMS bottomed plates with a pipette. Gelatin was diluted to 2%
by volume. Fibronectin and poly-L-lysine were both applied using concentrations of 20 gg / ml.
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After a 12 h incubation period, the spot treatments were briefly rinsed with fresh media, and
HeLa cells were then added in solution. The effectiveness of cell adherence in various regions of
the culture plates was assessed several hours later, and the results are presented in Table 4.3. As
a control, a PDMS coated device with no surface treatment was also tested, with no adhered cells
observed.
PDMS Plate Plate morphology Plate Plate morphologytreatment "pbsl" "pbs2" comments "medial" "media2" comments
GE 25% 30% acceptable 0% 0% n/a
PLL 15% 20% marginal 5% 10% poor
Fl 75% 75% very good 25% 20% acceptable
GE + PLL 30% 40% acceptable 0% 10% poor
GE + Fl 75% 75% very good 10% 10% acceptable
Fl + PLL 30% 10% poor 0% 20% poor
GE + Fl + PLL 35% 30% poor 0% 0% poor
Table 4.3: Approximate percentages of cells adhered to PDMS after 2 h using various surfaces
treatments. Two plates were tested for PBS based treatments, and two for media based Each
test spot was approximately 1 cm in diameter on a PDMS coated culture dish. Percentages were
approximated by analyzing cell morphology in phase contrast images from each test spot.
It is evident that media based treatments are not appropriate. Likely, the complex media
mixtures contain many additional small molecules which preferentially adsorb to the PDMS,
interfering with intended treatments. Either PBS based fibronectin, or fibronectin mixed with
gelatin, both supported excellent cell growth directly on PDMS.
These treatments were then tested in situ, using spare detector devices. Ethanol cleaned devices
were filled with mixtures of either gelatin, or gelatin mixed with fibronectin and incubated
overnight. Devices were then rinsed with fresh media and allowed to equilibrate in the incubator
for about 2 - 4 h prior to cell seeding. The contrast in cell proliferation when using two of these
different treatments is presented in Figure 4.12.
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Figure 4.12: Cell culture on chip using two different surface treatments, approximately 2 h after
seeding. The difference in morphology is apparent between A) non-adhered cells on gelatin vs.
B) adhered cells onfibronectin treated PDMS. The diameter of the cell sieves is 800 um.
With the protocols in place for establishing reliable cell culture in the devices, it would now be
possible to combine detection and culture capabilities for metabolic profiling in a single device.
4.5 Cell Assays
Metabolic assays of HeLa cell lines were performed using the parallel device to assess accuracy
and demonstrate utility of this platform. Control channels were all filled with sterile PBS to
prevent osmolality shifts of media, and all devices were cleaned using an overnight soak with
ethanol before use. Culture channels were treated with PBS based fibronectin for an additional
night, followed by an equilibration period with fresh DMEM media for several hours before
loading cells.
4.5.1. Cell transfer and device preparation
HeLa cells for assays were grown in 25 cm 2 culture flasks using filtered DMEM media
supplemented with 10% FBS and 1% penicillin-streptomycin for several days in preparation for
experiments. For harvesting, cells in the flask were first rinsed with warm PBS buffer to remove
dead cells then incubated with 0.5 ml trypsin for at least five minutes. Although only two
minutes of trypsin is usually required to passage the cells, a longer release treatment was helpful
to prevent cell aggregation during loading without adverse affects on cell growth. Trypsin was
neutralized and cells were resuspended by adding 2 ml pre-equilibrated DMEM media. To
increase the density of cells for seeding, the cell suspension was transferred to Eppendorf tubes
and centrifuged at 1000 g for 1 minute. The supernatant media was removed, and cells were
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resuspended in approximately 250 pl media. Using sterilized Tygon tubing and stainless steel
tubing, this suspension was transferred by a syringe and input to the microfluidic device for
seeding. Control lines on the microfluidic device were actuated to select the desired input
channel, and to isolate columns from one another (valve 13, Figure 4.2) during seeding. This
ensures a direct flow of media containing cells from the input port, through all of the sieves, and
then towards the waste port. Gentle pressure was manually applied on the syringe to ensure cell
velocities did not exceed - 1 mm/s, and after about 3 minutes, most of the sieves in the culture
chambers contained an adequate number of cells. Excess cells were removed with a rinse of
clean media, and in some cases, a rinse with trypsin directed around the culture chambers. Care
was taken to prevent the introduction of air bubbles into input wells on chip. After seeding, the
entire device was placed back into an incubator to allow for the cells to adhere to the fibronectin
treated PDMS and grow. Long gel loading pipette tips containing for media were placed at the
input wells of the device to allow a slow gravity driven perfusion of media to feed the cells
during culture in the incubator.
In some cases, profiling experiments were initiated several hours after seeding. In other trials,
cells were cultured on the device for at least one or two days prior to experiments (it was
established in culture trials that cell viability could be maintained for periods of more than a
week on chip, providing media was refilled daily in the pipette tips). To perform experiments
the device containing cells was transferred to a portable incubator on an inverted epifluorescent
microscope (see Appendix D). Fluidic inputs for rinse buffers, enzyme cocktails, calibration
standards as well as fresh pre-equilibrated media in Tygon tubing were connected to the device
(following Chapter Two). All valve control lines were reconnected to external microsolenoids
and the rotation correction for the motorized stage was established for automatic imaging.
The microscope incubator was used to maintain an environmental temperature of 370 C, and a
sub chamber was placed directly over the device to provide premixed gas with 5% CO 2 and 21%
02, ideally at 100% relative humidity. The microscope incubator and humidifier greatly
improves the sustainability of cell culture on chip, but due to inherent system leaks and
environmental fluctuations over the course of the experiment, the best culture was still achieved
when devices are located in a real incubator. Nonetheless, the morphology of the on chip cells
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was deemed suitable for proceeding with experiments using the current system. Cells were often
mounted on the microscope for 12 h periods or longer during the course of assays routines.
Along with the fluorometric imaging required for metabolic profiling, the cell sieves were
periodically imaged to check the status of the cell samples.
4.5.2 Proof of principle glucose measurements
Using the integrated device, glucose measurements were performed on separate cultures of HeLa
cells grown on chip. Cells were allowed to adhere on chip for at least six hours after seeding,
then cultured in phenol red free media ("STD 1", Table 4.1), which was loaded into both the
sieve and bypass channels. Software routines were written to periodically recirculate media over
the cells in the culture chamber, for 30 seconds every five minutes. This arbitrary recirculation
was used to ensure a homogeneous concentration of metabolites throughout the chamber,
although it may be necessary to revisit the effects of perfusion on metabolism in future studies.
Four point glucose calibrations were performed using standards one through four, immediate
prior to, and following, assays performed on cells. Typical results of glucose assays are
presented in Figure 4.13.
Figure 4.13: Glucose consumption of HeLa cells, reported as decrease in average glucose
concentration in the chamber media, and the effective rate of substrate uptake. The quantitative
results qualitatively agree with cell density. Measurements were performed in 90 minutes after
replenishment with fresh DMEM media containing 25 mM glucose, 1.25 mM pyruvate and 0 mM
lactate.
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In this device there was some heterogeneity in cell density due to the seeding process, although
this effect was useful for evaluation of results. The absolute values of glucose uptake alone were
less meaningful than relative metabolism measured between chambers. As evident in Figure
4.13, the qualitative density of HeLa cells corresponds closely with the measured rate of glucose
uptake. Each uptake measurement represents the average of two measurements taken after 90
minutes.
Degradation of enzyme generated fluorescence was observed over the course of routines, due to
the warm incubator environment. This degradation was not a concern when using the standalone
detector at ambient temperature, where it was possible to use the same cocktail overnight in long
calibration experiments. As such, the normally refrigerated metabolite reagents were replaced in
the Tygon tubing several times through the course of the long experiments. There exists a
tradeoff between maintaining a warm device for cell culture, along with the use of temperature
sensitive enzymes for assays. It was still possible to generate linear calibration curves even
when the enzymes had been connected to the device for several hours, although the slope of
calibration curves decreased continually, which introduces measurement uncertainty. This
degradation reinforces the importance of frequent fluorometric calibration. Fortunately,
calibration routines were fully automated in the software, and linearity could be verified
regularly. In future work, it may be worth investigating approaches to either reduce the
sensitivity of cocktails to temperature degradation, or in ways to keep reagents cool in tubing
when attached to the incubating chip.
Some degradation in cell morphology was also observed over the course of extended
experiments. Time lapse images from eight cell chambers over the course of a 22 h experiment
are presented in Figure 4.14.
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Figure 4.14: Cell culture in eight parallel sieves over the course of an extended metabolic assay.
The labels on the left indicate the number of hours since cells were seeded onto the chip.
Changes in cell morphology are illustrated in the insets. Diameter of individual cell sieves is 800
jPm.
As observed in the images, changes in cell morphology occurred over the course of experiments.
Degradation in cell culture conditions may be due to a combination reasons, including excessive
driving pressure or fluid shear, and imperfect culture conditions on the microscope incubator.
Every time that media was drawn from the chambers for assays, fresh media was provided to the
chambers at a pressure of 3 - 4 psig, which may have stressed the adhered cells. During culture,
and also prior to assays, media was regularly circulated through the culture sieve and bypass
using the parallel peristaltic pumps, with fluid velocities in excess of 100 ptm/s in the bypass
channels. It is possible that the cells were adversely affected by frequent pressure fluctuations
and it may be necessary to dampen the affects of mechanical agitation on biological samples by
using either smaller valves, or longer bypass channels. Modification of device geometry may be
useful to reduce necessary driving pressures for fluid transport. Alternatively, circulation and
metering pumping protocols could be reexamined to reduce average fluid velocities over
biological samples. Fortunately, the cell lines utilized in this research are robust and can
withstand some adversity in culture conditions.
Further, the volumes sampled from the culture chambers were approximately 25% of the total
available culture volume (-6 nl of a total -25 nl in the culture loop). Thus it was necessary to
perturb most of the fluid within the chamber for every sampling operation, and the discrete
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actuations of peristaltic pumps displace a lot of fluid every cycle relative to this culture volume.
If this integrated approach was adapted for embryo culture, the relative fraction of media
sampled to total culture volume should be much lower. For example, if - 250 nl is used for
embryo culture, it should still only be necessary to displace - 6 nl of media for measurement. It
is believed that with adequate modifications of both culture channel geometry and protocols used
for sampling, similar architectures can be deployed for integrated embryo assays, while also
ensuring robust culture conditions.
Another approach which may be worth exploring is the addition of a sample staging area. In this
approach, spent media could be transported to a downstream chamber all at once using gentle
pressure as to not disturb the primary culture. Assays could be then performed in replicates
using standard high-throughput protocols from this staging chamber, reducing the potential of
disrupting cells or embryos with frequent microfluidic pumping. For future embryo culture, this
may be the most desirable and least invasive approach.
4.5.3 Metabolic inhibition assays
Beyond simple consumption measurements, this architecture can also be utilized for studying the
metabolism of different cell types or culture parameters in parallel. The multiplexor on the outlet
of the device allows culture chambers to be addressed individually with custom media inputs.
As a proof of this flexibility, metabolism of cancerous HeLa cells cultured on chip using
standard media was contrasted to those cultured in media containing one of the most common
glycolysis inhibitors, 2-deoxyglucose (or 2-DG) 35, 111, 112. In these experiments the relative
difference in glucose uptake and lactate output by use of inhibitor agents would be measured.
The conversion from glucose to pyruvate and ATP involves several intermediate steps. Consider
the initial mechanisms of glycolysis in Figure 4.15, in the conversion of glucose to glucose-6-
phosphate (G-6-P), followed by the conversion to fructose-6-phosphate.
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Figure 4.15: Glycolytic pathway (Adapted from Pelicano et al, 2006). Ofspecific relevance for
the inhibition by 2-deoxyglucose are the phosphorylation of glucose to G-6-P by hexokinase
(HK) and conversion of G-6-P to fructose-6-phosphate by phosphoglucose isomerase (PGI).
The ATP-dependent conversion of glucose to G-6-P is the rate limiting step in glycolysis,
catalyzed by HK. In competition to glucose, when 2-DG is transported into a cell, it is
phosphorylated by HK to 2-DG-P. However, unlike the phosphorylated version of glucose, G-6-
P, 2-DG-P cannot be metabolized by PG135, 1ll. 2-DG-P is accumulated in the cell and the result
is a decrease in cellular ATP by this pathway. In inhibition experiments, since less HK is now
available to convert standard glucose, it is expected that less lactate will be generated by the cells
and this should be reflected in the microfluidic measurements.
The clinical effectiveness of this particular inhibitor is still under clinical investigation 35. The
effectiveness of 2-DG cannot completely offset the native physiological presence of glucose, and
there are some side effects which need to be considered during high concentration inhibition
treatments. Cancer cells are surprisingly robust, and cellular studies with 2-DG alone have not
exhibited the full cytotoxic response in vivo as expected 112 suggesting that treatments using
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multiple inhibitors to address multiple pathways simultaneously may be more effective.
Conversely, it has been possible to detect changes in glycolytic activity from cell populations in
vitro treated with such inhibitors, and most notably, a reduction in lactate output113 . Thus,
inhibition of glycolysis with treatments such as 2-deoxyglucose on cervical cancer HeLa cells
should serve well as a proof-of-principle model for an integrated metabolomics tool.
In these experiments, cells were seeded on the device and grown overnight on chip in the
standard incubator. The following day, the device was transferred to the microscope incubator
for monitoring, and reservoirs were connected containing either standard DMEM media, or
media supplemented with 5 mM 2-deoxyglucose (D6134-1G, Sigma Aldrich). Media was
addressed individually to each culture chamber to initiate inhibition. To ensure cell viability and
uniformity, four of the eight chambers on chip were treated with a live / dead cell stain (L-3224,
Invitrogen) at the onset of the experiment, while four were reserved for post experiment
counting. The cell densities on chip are presented in Figure 4.16.
Figure 4.16: Live/dead stain was utilized at the initiation of the inhibition culture experiment to
assess cell quality and density uniformity across chambers (live = green, dead = red). Only four
of eight chambers were treated with stain before the experiment. In this experiment, alternating
pairs of chambers were cultured using either regular DMEM media, or DMEM with 5 mM of 2-
deoxyglucose.
Culture was performed for four hours on chip, with intermittent recirculation every several
minutes (slow 250 ms duty cycle peristaltic pumping for 60 seconds, once every 10 minutes).
Assays for glucose and lactate were performed by sampling media from the bypass and sieve
channels, with four point calibration performed immediately before and after media assays. The
results are summarized in Figure 4.17.
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Figure 4.17: Results of glycolytic inhibition experiments. Glucose and lactate measurements
were performed on four cultures which were cultured in DMEM media in contrast to two others
cultured in media supplemented with 5 mM 2-deoxyglucose. Error bars represent one deviation
on duplicate measurements for each chamber. After four hours, the average glucose uptake is
approximately equal, but the production of lactate has been hindered. This indicates that
glycolysis had been moderated by 2-DG.
These measurements of glycolytic inhibition of HeLa cell lines by 2-deoxyglucose are in general
agreement with the reported observations of Barban and Schulze"'. In their work, media
containing equal concentrations of glucose and 2-deoxyglucose (both at 5 mM) was found to
hinder lactate production almost immediately, while glucose uptake did not lag in 2-DG media
until approximately 12 hours of exposure. Had measurements been performed several days after
culture, significant decreases in both glucose uptake and lactate production would be expected.
These results also verify the specificity of metabolite measurements using the integrated
platform. Roughly speaking, it was also noted that the overall glucose uptake was slightly lower
than in the previous studies on a per cell basis. The average glucose uptake may have been
reduced by including some measurements from cells treated with live/dead stain prior to the
experiment. Further, the one entire day of culture on chip to settle cells before starting inhibition
experiments may have resulted in culture with slightly lower metabolic requirements. This
alludes again to the importance of being able to run many cultures in parallel on a single
platform, such that relative differences can be characterized carefully, even when absolute uptake
values may vary between cell populations. The ability to seed approximately equal cell numbers
on chip for integrated assays by the use of sieves is also critical10 8, and in future experiments, it
may be necessary to refine loading protocols further to yield similar populations for every
experiment, avoiding the necessity of counting cells every run to normalize results.
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There are a wide variety of alternative agents suitable for use in future inhibition studies, which
would also serve as interesting test cases for the integrated metabolomics device. Potential
inhibitors include phloridzin to regulate glucose uptake, alpha-chlorohydrin to modify glycolysis,
or pentachlorophenol to stunt oxidative phosphorylation. As the fluorometric reaction of glucose
in this research is converted using hexokinase (Appendix A), however, it may be necessary to
perform additional trials to confirm the linearity of calibration, since hexokinase may
inadvertently be depleted by converting inhibitors as well (i.e. 2-DG to 2-DG-P).
4.6 Conclusions and Contributions
In this chapter, the essential functionalities for culture and detection required for a microfluidic
metabolomics tool were combined to a single platform. The architecture developed was
scalable, and allowed several cell cultures to be assayed in parallel using a variety of media
inputs and metabolite reagents. The advantages of automatic fluorometric calibration and
sensitivity were adapted directly from the standalone microfluidic detector of Chapter Two. The
lessons learned from embryo culture in Chapter Three provided a systematic basis debug culture
issues early and provide support of standard mammalian cells.
While several approaches for monitoring changes of glucose and lactate have been demonstrated
by a number of research groups in the past, none have offered the flexibility of this integrated
device. Previous microfabricated approaches often used metabolite specific electrodes for
detection either dipped directly into culture media containing samples, or near an outlet port of
the culture which necessitates constant bleeding of media for detection. Technically these
systems do provide dynamic measurement of growth conditions, but none offer the flexibility of
studying multiple metabolites in parallel, or demonstrated the capability to modify culture
conditions upstream based on current metabolic conditions. The non-invasive approach
demonstrated in this chapter open avenues to implement feedback driven culture, and can
support many different cell lines on a single chip.
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All of the infrastructure, including software and imaging routines, were developed to ensure this
platform is tractable to use in standard cell research. Arguments were provided to ensure that
detection limits and sensitivity covered the physiological range of interest for the cell
populations that would be contained on chip. Scaling up this integrated device in the future, to
accommodate larger culture volumes or many more culture chambers, is simple based on the
architecture proposed in this work.
Using the integrated device, glucose profiles were first captured from parallel cultures of HeLa
cervical cancer cell line, with qualitative cell densities correlating closely with reported nutrient
uptake values. As a further proof of applicability for this device in the fields of cancer research,
metabolic inhibitors were utilized to modify the nutrient utilization of these cancer cell lines. It
was possible to detect reductions in lactate generation when glycolytic pathways were regulated
using low concentrations of 2-DG. As many replicate experiments would be required to
determine the effects of different inhibitor concentration and application strategies, the
economies of scale through parallel processing with the proposed architecture is evident. There
are many avenues for research with an integrated microfluidic tool, and the goal of transitioning
to hands off embryo metabolomics in the future should be possible with this unprecedented
approach.
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Chapter Five - Vertically Integrated Microfluidic
Architectures
5.1 Introduction
Although state-of-the-art microfluidic devices contain complex channel networks with hundreds
or thousands of channels, designs are inherently planar due in part to the fabrication process of
soft-lithography. In this chapter, a new design paradigm is described which will allow for
unprecedented assay densities in microfluidic constructs. The concept is based on enabling
numerous individual planar microfluidic networks to be operated in parallel within integrated
vertical stacks.
5.1.1 Limits of Existing Architectures
To accommodate more features in a microfluidic construct, a designer must either increase the
footprint of the device, or decrease the size of individual features. Unfortunately, there are
fundamental limits to both of these routes. As the spatial area of devices increase, it becomes
difficult to monitor multiple channels or samples in parallel. Motorized stages on microscopes
have alleviated this limitation for the most part in the microfluidics community, so allow
simultaneous monitoring of multiple regions beyond a fixed field of view. Chips with footprints
greater than several inches in length, however, necessitate specialized optical readers, such as
those used for fluorescent analysis of high density 384 or 1532 well plates. Device footprints are
also limited by the means of fabrication. Microfluidic molds used for soft-lithography replica
casting are most commonly prepared using photoresist patterned on 3" or 4" diameter wafers. It
is certainly possible to cast larger devices, although manual manipulation of larger chips
increases potential for defects or debris during assembly, compromising performance.
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There are also limits to the miniaturization of microfluidic features. In the semiconductor
industry, photolithography resolution governs the smallest features (such as transistors gate
widths on a processor) which can be reliably fabricated. The ability to form small features in the
microfluidics field is not the limiting factor; PDMS replica casting is capable of reproducing
features accurately to the molecular level. For example, Hua et al have demonstrated PDMS
casting fidelity off individual carbon nanotubes with diameters of 4 nm for nano imprint
lithography 14. However, there are three important reasons which limit extreme miniaturization
of channels for higher density assays.
First, hydraulic resistance increases dramatically as channel dimensions decrease, and the
necessary driving pressures for obtaining desired flowrates becomes prohibitive. Analogous to
Ohm's law, an expression for pressure driven flowrates can be expressed as AP = QR, where AP
is the driving pressure differential through a length of channel, Q is the fluid flowrate and R is
the hydraulic resistance. For a simple case of a square channel (width = height = L), the
resistance term increases with L-4. Halving the dimensions of a square channel decreases the
flowrate by a factor of 16 for a given input pressure. This is a well known tradeoff in
microfluidic systems. Fortunately, fluids driven by electro-osmosis (EO) do not suffer this
setback, and the use of electric fields to transport fluid increases in efficiency with
miniaturization 5 -119 . At the same time, not all samples can be transported using EO or
alternating current electro-osmosis (ACEO) 15' 117, 120. EO requires high voltages, on the order of
-kV per centimeter of channel length, which can result in adverse hydrolysis or Faradiac
reactions in solutions of high electrolyte strength. Thus EO is not suitable for routine analysis of
many biological fluids (inherently strong electrolytes) and this remains a reoccurring technical
barrier with these fluid transport options.
The second limiting factor involves the integration of sensors or actuators in microfluidic
channels. Many valve strategies (Section 3.5.1), and in particular those fabricated using
multilayer soft lithography, do not scale well with miniaturization due to high actuation
pressures60, 121. The PDMS membrane between the flow and control channels may be considered
as a dually supported beam undergoing deflection due to application of a uniform pressurel 21
Based on a deflection model developed by Kartelov, necessary sealing pressures for a valve
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increases quickly with smaller channel widths, as presented in Figure 5.2. For reference,
common valve widths in many microfluidic devices are -100 pm, used for sealing a -100 pm
wide channel.
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Figure 5.2: Approximate actuation pressure scaling as a function of valve geometry. For a valve
with equal lengths and width used to seal aflow channel, the required control pressure increases
dramatically with miniaturization. This valve scaling model was developed by Kartelov et al
(2007). In this calculation, dimensions of the flow channel height and interlayer PDMS
membrane are each 20 pum.
While valves have been fabricated with dimensions less than 10 jtm wide, the actuation pressures
required become very high and increase the potential for device rupture. In addition, standard
microsolenoids used to control microfluidic devices are often rated to -20 - 25 psig.
With sufficient pressures for valves, and ability to transport fluid in nanometer scale channels,
there are no limits to microfluidic miniaturization. However, the third limiting factor to channel
scaling involves physical dimensions of the samples of interest. It is certainly possible to
produce submicron scale channels with existing technology, but these will not be suitable for
accommodation all biological samples of interest. Selected examples include bacteria (-1 tm),
yeast (-3-5 jtm), mammalian cells (-10 jtm), or even embryos (-100 jtm). In certain devices,
such as those used for the separation of DNA and protein solutions, miniaturization of channels
is necessary and increases efficiency of these systems' 22 123. For the remaining microfluidic
networks used for studying cellular biological systems (particularly in this thesis) channels must
remain on the scale of the samples.
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5.1.2 The Concept
Vertically integrated devices increase density of microfluidic assays while avoiding the
aforementioned limits to miniaturization. These architectures can conserve use of "large"
channels as well as limit the necessary footprint of devices. To achieve increases in device
complexity, individual planar networks of channels are assembled above one another within the
volume of a microfluidic chip. New approaches to addressability and optical readout enable the
planes of a stacked microfluidic system to be addressed individually. In colloquial terms, the
transition would to the new design technique be analogous to performing experiments in
apartment buildings as opposed to standard bungalow chips.
It is possible to layout microfluidic devices comprised of multiple flow networks that share
common flow and control inputs to significantly scale up channel capacity without requiring a
larger device footprint or excessive devices connections. Interconnects to actuate control lines
are common through all layers, such that only one port must be punched when assembling
PDMS chips, and only one control line must be connected to pressurize all valves arranged
above one another. Vertical multiplexors can be arranged to enable layer by layer addressability,
similar to the way that planar control multiplexors allowed an exponentially large number of
control lines to be controlled with a minimum of control valves. While control valves for planar
multiplexors are identical throughout the stack, vertical multiplexors are unique on every layer to
provide addressability. This concept is illustrated in Figure 5.2.
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Figure 5.2: Schematic of an eight layer vertical multiplexer, each with a corresponding set of
control lines. Control ofN channels requires 2log2N control lines as with standard multiplexers,
but networks may be designed in more compact devices. The above configuration, for example,
allows 64 channels to be controlled in afootprint of only 8 channels. Only one interconnect
from the left is required to the chip to access all 64 lines.
There are several advantages in increasing the channel density of devices by using vertical
integration. First, the manufacturing process is more robust against fabrication errors. On a
device consisting of several cm2, the possibility of experiencing a point defect on a photoresist
mold increases. If there are several thousand channels on a single layer, one or two defects on a
layer may render a device unusable. Using a stack of several slightly less complex devices, clean
castings are easier to select or reject from subsets of larger molds when building up vertical
structures. The tradeoff is that precautions are necessary to avoid introducing debris between
layers of the chip during assembly.
In long term cell and bacteria culture experiments, more samples can be contained in a single
device. For example, an eight layer device can contain the samples previously studied using
eight separate chips. Containing more samples on multiple layers of a device can potentially
alleviate concerns whether all samples were cultured under identical conditions, and improve
consistency in comparing experiments. It would, however, still be worthwhile to quantify spatial
environmental variations that could adversely affect culture through the depth of the PDMS, by
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the use of heat and gas transfer models. Further, if many different chips are cultured
concurrently, control lines would have to be reconnected from device to device to run
experiments, while with vertically integrated architectures, control lines remain connected to the
same substrate at all times. The only tradeoff in complexity is the additional control valves used
to address fluid samples to appropriate layers, while designs of all flow layers is unchanged.
Additional functionality could be introduced with internal interconnects to transfer or merge
fluid between adjacent layers in arbitrary locations throughout the assembly 24 . It would also be
possible to increase the throughput of multilayer soft-lithography peristaltic pumping, by
merging several parallel streams towards a single channel or connection port.
5.1.3 Optical Considerations for Vertical Microfluidics
As numerous networks are stacked above one another within transparent PDMS substrates, it
may become more challenging to resolve and monitor individual samples within a stack. With
the use of appropriate device design and optical instruments, it should be possible to alleviate
these difficulties and monitor samples independently from one device layer to the next.
Confocal microscopes are specifically designed for performing three dimensional optical scans
through thick samples, and to resolve features independently at different focal depths. This
would be a particularly valuable tool for observing experiments simultaneously through the
depth of a device with N device layers, each separated by a distance dz. However, even a
standard microscope used in most research labs with a decent selection of objectives should be
capable to resolve features independently on different layers. An ideal microscope objective
would have long working distance (LWD) and a high numerical aperture (NA). The working
distance allows observations to be made several millimeters deep into a transparent (presumably
PDMS device), and the depth of focus (DOF) is inversely related to high NA values 25 . A
shallow DOF ensures only those features of interest are in resolved in the field of view. For
example, a high quality 20x objective (Olympus) with -7.6 mm LWD and 0.45 NA has a
nominal DOF of - 3-6 tm for collecting fluorescence in the range of -550 nm. If the layers are
separated by several hundreds of microns, vertically integrated microfluidics should be ideal for
independent fluorometric assays even for lower values of dz. There are additional optical
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analysis tools, such as confocal reconstruction and simple background subtraction, which can be
used to improve fluorometric assays in a three dimensional space.
Another option to further improve observation between individual chambers is to purposely
offset successive layers during assembly. In this manner, samples contained in chambers on a
lower layer will not interfere with observation through to channel above, either using fluorescent
or brightfield observations. The principle of offset alignment is presented in Figure 5.3, where,
for example, four sample types are loaded into four chambers on unique device planes.
load chambers overlapping alignment offset alignment
(4 samples, 4 layers)
Figure 5.3: Offset alignment may be used to simplify the observation of samples in stacked
storage chambers. Here, blue outlines represent aflow channel, and red outlines represent
control valves used to isolate samples within the chambers. Since PDMS is transparent,
chambers containing four different cell types may appear to occupy the same section of channel
when observing with a deep depth offocus. This ambiguity is resolved to an extent by offsetting
pairs offlow and control lines during assembly of successive layers.
With high NA objectives, it would be possible to resolve which sample is stored on individual
planes, but the offset technique may be useful for further reducing background (such as
fluorescence emitted) from samples in adjacent layers. Since the offset required (- 100 tm), is
small relative to the typical punch diameters used to create interconnect ports for fluids to the
chip (- 500 pm), there is some tolerance in alignment of adjacent flow layers which maintaining
connectivity to all layers.
5.2 Applications of Vertical Architectures
There are fields of microfluidic research which increase in utility with the ability to manage
more samples in parallel. Application such as protein crystallization, emulsion based
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microfluidics and high-throughput screening are examples which often necessitate complex
device networks, and may benefit in scalability from vertically integrated architectures.
5.2.1 Protein Crystallization
One of the most difficult and perennial problems in structural biology is to identify the structure
of proteins. Significant computation progress has been made to predict the most likely
configurations which proteins are folded. Most of the work to identify or verify the true
structure (and thus protein function) is still performed experimentally. One of the most popular
approaches is X-Ray diffraction, which may be used to examine the protein structure of pure
protein crystals. However, discovering the necessary conditions to nucleate and grow crystals
from microliter volumes of highly purified protein solutions for diffraction studies is far from
trivial. Little information is usually known in advance of the appropriate buffers and
complementary salts required to be mixed with a protein to yield a crystal, which is why high-
throughput trial and error experimentation is commonplace.
Microfluidics has made fundamental contributions to structural biology in this regard, and is
arguably one of the most prolific success stories of implementing microchips in pharmaceutical
settings 126,' 127. Devices have been demonstrated which perform multiplexed reactions of
different buffers with purified protein. Hundreds and thousands of conditions may be tested
without user intervention, either serially or in parallel, to identify likely conditions to nucleate
protein crystals. The growth of proteins also favors chambers of small length scales, where
delicate sample are protected from the outside laboratory environment and in particular, fluid
turbulence' 28 , 129. Diffusion limited mixing allows proteins to grow, either during incubation on
chips or in external capillaries, for days or even weeks'28 130. To accommodate additional
parallel reactions and enable a wider array of screening conditions, the current generation of
devices is limited only by available storage cells' 2 8' 131. VLSI may be aptly suited for these high-
throughput screening applications. In addition to simply screening for protein crystallization
conditions, there are opportunities for kinetic optimization of growth rates by controlling osmotic
shifts through the numerous interlayer PDMS membranes during incubation 2 7 129. Conversely,
if there are concerns about water or solvent diffusion between samples located on separate
planes, it is possible to increase the interlayer thickness, or coat the PDMS surfaces with
impermeable barriers such as Parylene.
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5.2.2 Droplet based microfluidics
Miniaturization of chemical reactions and biological assays into emulsion formats has been a
rapidly developing area of interest in recent years22 , 83, 132, 133. Aqueous reagents may be
dispensed into an immiscible oil phase as droplets to separate reactions in many containers. This
avoids cross contamination of reaction products, and may allow rare samples of interest to be
amplified and sorted from bulk library solutions. In addition, microfluidic emulsion technology
has been realized as a valuable route for particle and microgel synthesis where monodispersity
and dimensional control is of primary importance' 34' 135. A key limitation of these microfluidic
processes is the production rate of emulsions depending on fluid properties of both fluid phases,
operating conditions and device geometry. For a given set of conditions, there is a limit on
microfluidic water-in-oil droplet production (typically - 100 - 1000 Hz) before the onset of
instabilities leading to polydispersity or droplet coalescence. It has been suggested that
bottlenecks can be overcome by operating several separate devices in parallel, although this
requires user multitasking to set up more chips, and additional hardware such as syringe pumps
to pump fluid for each devicel36
Several options have been developed to circumvent limitations in production rate. By using a
microfabricated manifolds bonded on top of a microfluidic device, parallel droplet production
was demonstrated from four inline droplet nozzles with good monodispersity 3 7. This allows
essentially four microfluidic droplet devices to be driven at one using single input for aqueous
and oil phases. Pseudo three dimensional methods have been proposed for microfluidic
emulsification by sandwiching two patterned slabs of PDMS together in order to flow focus an
aqueous stream into a surrounding oil phase which effectively lowered overall fluidic resistance
while still enabling small emulsions to be produced 13 8. A circular three dimensional droplet
nozzle has also been fabricated using etched silicon which was found to enable higher droplet
rates by more than an order of magnitude 88 . Impingement devices with droplet nozzles arranged
in symmetric bicycle spoke patterns have also been used to produce many droplets in parallel 39
Vertically integrated architectures may also be useful for increasing droplet production rates.
Rather than producing emulsions with one planar set of channels, it may be possible to prepare
stacks of nozzles within a microfluidic device. Common ports for inputs and droplet collection
- 129-
reduced the number of external connections required. It remains to be seen whether
monodispersity can be ensured from one layer to the next due to subtle differences in hydraulic
resistance, although design of larger connection wells relative to channel dimensions can reduce
this issue.
5.2.3 Microfluidic LSI
One of the fundamental advantages of vertically addressable architectures is the capacity to
increase feature density on chip without requiring a prohibitively large device footprint. General
resources to store and retrieve multiple fluid samples on chip is useful for screening applications,
and allows more experiments to be prepared on a single chip while reducing the time spent in
configuring multiple smaller chips in parallel.
Consider the pioneering device which was used to demonstrate microfluidic large scale
integration (LSI), where 1000 fluidic storage chambers were located in an area of -20 mm x 20
mm, while the total device footprint was about -25 mm x 25 mm. As a rough approximation, to
increase this feature number by eight fold conserving a similar architecture would require a
footprint of -3425 mm2, or edge lengths of -59 mm (approximately the largest device which
could be cast using a 3" wafer, a typical mold substrate for casting devices). With a 16 fold
increase in the number of features, the edge lengths approach -81 mm. Over such large areas,
the possibility increases of introducing a point defect in either the mold, or in the device.
Further, many instruments such as microscope stages, cannot accommodate samples with edge
lengths exceeding two or three inches. The use of vertical multiplexers could be used to obtain
ten-fold or more increases in the numbers feature, while maintaining conventional postage stamp
sized footprints if desired. For reference, the original microfluidic LSI is reproduced in Figure
5.4, as well as some simplifications to the geometry used in the present research.
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Figure 5.4: A) Example ofa complex microfluidic storage architecture utilizing planar
multiplexors (Adapted from "Microfluidic Large Scale Integration ", Thorsen et al, 2002). Thedevice contains 1000 storage chambers in an area of approximately 25 mm by 25 mm. B)
Modified geometry based on LSI suitable for integration with vertical multiplexing. Serial
architectures allow samples to pass through storage bins when column valves are open.
Chamber dimensions are 200 pm x 300 pm.
Again, consider the eight layer device, which may have necessitated a total footprint of-3425
mm 2 (59 mm x 59 mm). By implementing vertical multiplexing, this complexity could also be
achieved while conserving the original (25 x 25) mm2 total device footprint and the same feature
sizes.
Another interesting application is the use of VLSI to create high resolution microfluidic displays.
If pixels are offsets from one layer to the next (similar to Figure 5.3), there will be no apparent
empty space between storage cells, and the total display will appear to be continuous is colored
dyes are used in every cell. Rather than monitoring an apparent 16 x 32 storage array through 4
levels, for example, offset alignment allows all 16 x 32 x 4 (2048) "pixels" to be observed at
once in a 32 x 64 grid. Further, with vertically overlapping pixels, there is the option to mix
complex combinations of colors. A chamber filled with yellow, backed by a chamber filled with
blue, may appear green when backlit. This is not intended to suggest microfluidic devices would
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ever replace LCD displays, but only illustrate the interesting side effects when working with
complex transparent devices.
5.3. Manufacturing Process
To realize vertically integrated microfluidics, it is necessary to create a single composite device
from many individually patterned layers of PDMS. There are several options available to
bonding these layers together, each with particular advantages and drawbacks in terms of
robustness and required time.
Limitations of existing PDMS assembly techniques have prohibited the previous development of
such systems. If standard techniques had to be used, the assembly time scales linearly with the
number of layers, and as such, a ten layer device would take at least ten times as long to
manufacture. The last thing microfluidic researchers desire is more time spent fabricating
devices. In this section, a unique thermal-plasma approach is devised, where the forgiving
nature of thermal bonding is combined with the parallel processing nature of plasma bonding, to
allow the fabrication of vertically integrated microfluidic systems with PDMS.
5.3.1 Thermal Bonding for Assembly
Thermal bonding is the most common approach of bonding separate flow and control layers to
one another in MSL microfluidics 25 . Thermal bonding has the advantages of forgiving
processing for high accuracy alignment, but is slow for creating devices consisting of multiple
layers. In standard thermal bonding, complementary layers, one containing an excess of PDMS
curing agent, and the other a deficit, are partially cured on separate molds (typically for -15
minutes at -80 0C). After this initial cure, the thick layer containing the top channel network can
be removed from the first mold, and aligned to the second layer of PDMS. To promote bonding,
the two layers are then baked for several hours to create a single device containing two channel
networks. The thick layer is normally cast two - 5 mm thick to simplify handing and to allow
sufficient engagement for tubing to be plugged into the chip. Alignment error of alignment
between flow and control layers is generally < 25 jim, and often < 10 jtm for researchers
experienced with PDMS assembly. Since bonding is not initiated until two separate layers have
been baked together, this process is forgiving if adjustments between layers must be made during
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the alignment process. However, there is dependence on total PDMS curing time which
complicates assembly for vertically integrated devices.
With careful control of process parameters, it is possible to repeat this step to bonds with a third
layer, and so on. In this technique, the first two layers are subsequently baked for a short period
(- 15 minutes at 800 C) while a third layer of PDMS is also cured on a separate mold.
Alignment is performed again, before a subsequent bake. This thermal technique requires a
unique mold for every layer, and the assembly time linearly increases with the number of device
layers. With a minimum of 20 minutes required per layer pair (baking + alignment time), it
would be intractable to use this technique for a very complex VLSI device.
5.3.2 Plasma Bonding for Assembly
Plasma bonding is also an attractive method for multilayer bonding 9' 36. Traditionally, plasma
bonding is reserved for the final assembly process to seal a PDMS device to a glass slide, since
this process yields a covalent bond between mating surfaces, and is irreversible. In this process,
a sample is placed inside of a vacuum chamber and exposed to a reactive radio frequency (RF)
air or oxygen plasma. The cleaned sample surfaces are rendered hydrophilic and can be readily
bonding to treated glass 9. Plasma can also be used to bond together separate layers of PDMS, but
is simply unforgiving for novice microfluidic practitioners, since the alignment between critical
features must be perfect on the first try.
Plasma bonding is a serial process, although large plasma chambers are capable of
accommodating multiple samples at once. Treating and bonding of already cured PDMS
surfaces to one another requires only several minutes (- 1 min to pump down the vacuum the
plasma chamber + 30 sec plasma treatment + - 1 min for alignment). Unlike the thermal
bonding approach for vertically integrated architectures, a unique mold would not be required for
every microfluidic layer. The multiple device patterns could be arranged on a single mold with
several plasma steps used to combine the separate levels together.
With plasma bonding, wafers for flow and control features were coated with PDMS and fully
baked in the oven overnight. For device assembly, a blank piece of PDMS was used as a master,
and successively bonded to features on the flow and control wafers to build up the device height.
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With additional layers, alignment was increasingly difficult and it became challenging to
visualize complementary features through the master.
There are several concerns when using a plasma treatment to assemble all layers of a vertically
integrated device. Every time that a sample must be transported into a vacuum chamber, treated
and aligned, the potential for introducing debris to the devices increases. Since the plasma bond
is permanent, care must be taken to work in a clean environment and remove any potential debris
(with a nitrogen flux, or similar) immediately prior to bonding. The strength of the plasma bond
can also introduce difficulties. To create MSL valves, the interstitial layer of PDMS between
flow and control layers is typically -15 - 20 pm to facilitate valve deflection at low actuation
pressures. In plasma bonding, if is possible to inadvertently collapse this membrane to the
adjacent PDMS layer, sealing the channel and rendering the valve and device unusable. It may
be necessary to increase the thickness of valve membranes at the expense of low valve operation
pressures if plasma bonding is used to assemble an entire device.
5.3.3 Hybrid Thermal-Plasma Assembly
Using either the thermal or plasma assembly approaches, it was possible to assemble prototype
vertically integrated devices. Unfortunately, it was difficult to find a balance among all the
parameters which govern device performance. The thermal bonding approach accurate, but
extremely slow, and the resulting bonding between uppermost layers was not robust. The plasma
bonding approach was rapid, but it was difficult to ensure correct feature alignment, and to
prevent collapse of valves and channels it was necessary to increase PDMS thickness to the point
that some valves could not close.
A preferred protocol was developed to significantly improve the assembly process, combining
benefits of both thermal and plasma bonding. Thermal bonding would be used as the first step to
ensure accurate and forgiving alignment between complimentary flow and control layers. As an
example, consider a device featuring four flow layers, and four control layers. The control mold
used for such a four layer device with a vertical multiplexor is pictured in Figure 5.5.
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Figure 5.5: Control mold layout for a single VLSI device patterned on a 4" quartz wafer. A) The
patterns for all four layers are identical with exception to the annotated regions. B) VMUX
valves (in green) are selectively connected to enable individual layer addressability using
common ports in the final assembly.
With bottom actuated valves, a set of flow layers would be spun coat to - 500 p~m thick (-130
rpm for 60 seconds, 5:1 PDMS), partially cured, and bonded to a control wafer containing the
valve features (20:1 PDMS). Layers which are several hundreds of microns thick are delicate,
but can still be picked up and aligned by hand to the second wafer. After all four films have
been aligned to their respective features on the second mold the control wafer is baked for least
several hours at 900 C to complete bonding of the flow and control layers. This process creates
essentially four sub-assemblies of a complete vertically integrated device, which can be removed
from the mold individually. Next, a plasma treatment would be used to bond these four sub
assemblies together. A simple rack for the plasma vacuum chamber was prepared which would
allow both sides of a sub-assembly to be treated by plasma at the same time, pictured in Figure
5.6.
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Figure 5.6. A "bed of nails" holder for plasma treating both sides of a PDMS sub-assembly. In
this manner, it is possible to assemble an entire device consisting of multiple layers using only
one rate limiting plasma step. For scale, the slide is 25 mm x 75 mm. Double sided tape is
suitable for holding tacks in place.
Using this approach, all sub-assemblies of PDMS could be loaded into the plasma chamber and
treated simultaneously. Following the treatment, they could be aligned to one another under a
microscope. The alignment tolerance of this secondary step is more forgiving, since all critical
alignment has been completed in the thermal stage. It is only necessary to align the sub-
assemblies within - 100 !tm on one another, such that a common interconnect punch (-500 pm
diameter) would make contact through all the layers. The assembly process is presented in
Figure 5.7.
A) hlan B) b+4+3+2+1
plasma4f+4c
3f+3c . C)
2f+2c.
lf+1 c
Figure 5. 7. Assembly schematic for a vertically integrated device. A) Sub-assemblies consisting
of complementary flow and control layers (shown in blue and red, respectively), as well as a
blank layer ofPDMS are all exposed to plasma (The base assembly "lf+ lc" is placed on a glass
slide in this step ensuring only the top surface is treated, while the remaining assemblies are
placed on the bed of nails from Figure 5.6). B) The sub-assemblies are sequentially aligned to
one another under a microscope, resulting in permanent bonds C) Interconnects are punched in
one step, and the device is bonded to a clean glass slide with afinal plasma treatment.
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An eight layer device would require eight flow and eight control designs. The design
modifications necessitated on every control layer are minor, but bookkeeping is required during
mask layout and chip fabrication. This complexity issue is inherent in the addressability
approach, but the additional work to fabricate one or two extra molds is not significant.
Also, there are some limitations to manual assembly; most notably that alignment becomes
progressively more difficult as the number of layers is increased. Alignment problems could
also be compounded by previous errors on lower planes. It may be necessary to reduce the
density of features and increase the spacing between adjacent features to ensure consistent
assembly for every layer.
The hybrid thermal-plasma process was found to be the most direct way to assemble vertically
integrated devices using standard equipment available in most microfluidic laboratories. At the
same time, it may be possible to further improve and automate this process to reduce the
potential for defects or valve failure. Alternative bonding approaches using corona RF systems
have recently been investigated to take advantage of the strength of reactive plasma treatments
with the forgiving nature of thermal bonding 40 , and these may find application with vertical
assembly. To improve alignment, semi-automatic PDMS bonding systems integrating optical
feedback have also been demonstrated, which could be used for both thermal and plasma
processes36, 141. These examples illustrate the range of approaches available to create complex
stacked devices, and may help simplify high-throughput assembly of vertically integrated chips
devices in the future.
5.4 VLSI - Vertical Large Scale Integration
To demonstrate the ability of vertical architectures to enable unprecedented sample
addressability in microfluidic constructs, several storage arrays were designed and tested. An
example VLSI device is presented in Figure 5.8. This design was motivated by the original
microfluidic LSI device of Thorsen et al containing 25 x 40 = 1000 chambers with a footprint of
approximately one inch squared66
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Figure 5.8: Schematic of a stacked storage device (VLSI 1 = 2048 chambers) realized by vertical
multiplexing. Repeated levels ofstorage chambers may be successively stacked on top of one
another to yield significantly more complex devices with multiple planes while utilizing common
interconnects. A) The vertical multiplexer (or Z mux) is denoted in green. Flow and control
channels are in blue and red, respectively. B) Schematics offour or eight layer multiplexors to
enable layer by layer addressability. C) Sample manipulation within a storage array. Red food
dye was loaded into storage bins, with dimensions of 200 pm x 300 pm.
To demonstrate VLSI, two different architectures (denoted "VLSI 1" and "VLSI 2") were
developed of varying complexity while conserving approximately the same device footprint (-25
mm x 25 mm). VLSI 1 contained a total of 16 rows, 32 columns and 4 layers, for a total of 2048
individually addressable chambers.
Flow channels were 25 ptm tall, and 100 jlm wide. The control wafer was fabricated using a two
step photolithography process, with a base layer of 10 tm hard baked positive photoresist to
create rounded channels, followed by a layer of 10 itm tall SU8 to create valves. All molds
were treated with fluorinated silane prior to casting, and devices were prepared using RTV 615
type PDMS. This architecture was particularly useful for debugging fabrication protocols of
vertical devices, as well as some of the operational issues for a three-dimensional storage array.
It was found that interlayer thicknesses of greater than several hundred microns are preferable for
sample resolution as well as for alignment in thermal bonding.
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After of the assembly and operational issues had been experienced and resolved using VLSI 1, a
more complex architecture was devised. VLSI 2 featured 32 rows, 64 columns and 8 layers for a
total of 16384 independently addressable chambers, illustrated in Figure 5.9.
lock down a
open all .
column toggle .
run routines .
input delay = 3000ms
13 151 17 19 21 331
Xmux Ymux Cell Valve
Figure 5.9: Software interface for VLSI 2. The device contains a total of 32 rows, 64 columns
and 8 layers, for a total of 16384 individually addressable chambers with a total footprint of less
than 25 mm x 25 mm. Valves used for vertical addressability are in green. Flow and control
channels are in blue and red, respectively.
Interestingly, introduction of this architecture follows growth rates postulated by a co-founder of
Intel Corporation, Gordon Moore, commonly known as "Moore's Law". According to Moore's
Law, the storage capacity of silicon-based integrated circuits doubles approximately every 18
months, a trend which has persisted since around 1970. Since the arrival of the original LSI
device in 2002, the storage capacity should have doubled four times, and this is precisely the
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case. Only, instead of miniaturizing features to accommodate the complexity as is the case in the
semiconductor industry, the designs are been fabricated using vertical integration. The VLSI 2
device is presented in Figure 5.10.
Figure 5. 10: The VLSI 2 device A) An isometric view of the device bonded to a glass slide withB) separate planes visible. The total device thickness is approximately 5 mm. C) Multipleplanes after plasma bonding of sub-assemblies, prior to punching interconnect ports D) A sideview of a vertical multiplexor, with three of eight layers assembled E) The chip connected to 33external control lines for operation.
A VLSI 2 device contains 34104 valves, and is the most complex device reported to date in the
literature with fully addressable storage.
5.5 Vertically Integrated Cell Assays
Beyond demonstrating the capability to increase the fluidic storage capacity of microfluidics,
vertical integration was also applied to pertinent biological applications. Specifically, new
microfluidic architectures are implemented for cytotoxicity assays on multiple, independent
planes. Such applications are intended to demonstrate the applicability of vertical integration for
fluorometric measurements and management of cells within a multilayer construct.
There are several reasons to perform cellular assays in a vertical device. First, it is possible to
perform replicate runs of an experiment on a single device without requiring additional
hardware. By repeating protocols and measurements from one layer to the next, it is possible to
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support quantitative data with statistically information. Without vertical integration, it may be
necessary to repeat experiments using several different devices. Another advantage of vertical
integration is that replicate samples can be contained on a original device, ensuring all samples
were treated under identical conditions.
By performing cytotoxicity assays in stacked, it is demonstrated that this approach is not only
feasible, but may find several applications for scaling up the complexity of biological and
chemical assays. In this chapter, we develop two approaches to using vertically integrated
microfluidics for cell assays. In one approach, we extend a well characterized planar system for
toxicity assays, and in another, we demonstrate a convergence of the addressability of VLSI with
cell culture.
5.5.1 Non-planar Row/Column Cytotoxicity Screening
Recently, high density channel arrays were demonstrated for cell toxicity assays using multilayer
soft lithography36 . With this architecture (Figure 5.11), it was possible to culture different cell
lines in parallel then expose each to a variety of stimulants or toxins. The affect on cells was
assessed at the endpoint of the experiment with standard live/dead fluorescent dyes.
toxins/stimulants
rail lin 1
H L H L L H L H L live/dead
'Z screen
Figure 5.11: A microfluidic device with 24 x 24 = 576 chambers for high-density cell toxicity
assays. Cells are seeded into chambers across rows, and integrated valves allow the delivery of
toxins to individual columns. Using a live/dead cell screen (live = green, dead = red), the
toxicity of chemicals can be characterized in parallel. Figure adapted from Z Wang et al (2007).
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Cells are seeded into chambers using the sieve traps previously described 0 8 (also refer to Figure
4.12), and MSL valves were arranged to direct flow along rows or columns. Motivated by these
effective assays designs, a vertically integrated approach to row column assays was developed as
presented in Figure 5.12. These devices were fabricated using bottom actuated valves using
RTV 615 PDMS, and assembled using the hybrid thermal-plasma method.
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Figure 5.12: Two row/column architectures for cell toxicity screening, motivated by the assays
demonstrated by Wang (2007). Both devices use only seven control lines to direct
stimulants/toxins to cells on four independent device layers. Control lines used for vertical
addressability appear in green. Valve five is used for cell seeding, valve six for toxin screening
and valve seven for device pretreatment. These scalable architectures are also designed with
row/column spacing equal to the diameters of the cell sieves, to enable offset alignment during
assembly.
While these proof-of-concept devices contained less samples that the architectures demonstrated
by Wang, the density of assays per device area could now be increased substantially without
reducing the size of the cell culture chambers. Since these devices contained only four flow
layers, standard valve arrangements were used rather than vertical multiplexors to provide
addressability.
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Returning to earlier discussion regarding optical independence between layers, it was necessary
to first assess whether cytotoxicity screening could be confidently completed using fluorescent
dyes without affecting the results in adjunct levels. A simple fluorometric study was thus
performed with a row column device. In this experiment, a strong fluorescent sample (0.1 mM
Rhodamine 6G) or water was flowed into cell culture chambers. While imaging on one plane, it
would be interesting to determine whether the presence of a fluorescent sample out of the focal
plane would affect intensity measurements. Imaging trials from within intermediate layers using
either dye or water as mock samples was performed, and the results are summarized in Figure
5.13.
E) Sample in other layer:
Eo same M different Top
8000
-1 mm
6000
2000 Btm
0 - F = fluorescent dye
Top (F) Top (W) Bt r (F) Btm (W) (0,1 mM Rhodamine)
Image location (Cell contents) W = water
Figure 5.13: Assessment offluorometric independence. Fluorescent dyes were imaged in cell
culture chambers at 20x magnification (0.2 second exposures) with either A) dye, or B) water in
the adjacent chamber. Similarly, water was imaged in chambers when either C) dye, or D)
water was stored in behind. E) by subtracting the background contribution of intensity, it is
shown that the fluorescent signal from within a culture chamber is essentially independent of a
same either in front or in behind. It is also noted that samples located deeper into the stack may
exhibit lower intensity. As such, quantitative calibration offluorescence should be performed for
every plane. Culture chambers are 400 pm in diameter, and -25 pm deep.
Fortunately, the measurements of Figure 5.13 represent a worst case scenario for potential
fluorometric assays for several reasons. The sample chambers covered almost the entire camera
field of view, and contained a concentrated solution of Rhodamine 6G. Images were acquired
manually with an inverted epi-fluorescent microscope, and background was subtracted manually
during post processing with ImageJ software. Confocal systems (specifically designed to
remove background noise between optical planes) would be expected to provide superior results.
To improve signal to noise ratio, it is straightforward to increase the interlayer thickness between
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flow layers in future devices. Further, these cell chambers were located directly above one
another, whereas the "offset" approach (Figure 5.3) could also alleviate intensity interference
issues, particularly with detection chambers with smaller volumes. Nonetheless, under these
experimental conditions, it was demonstrated that it is possible to perform measurements in
overlapping planes independent of the sample contents in the neighboring layer. In the case of
cell assays, only cells would be dyed, resulting in significantly lower background fluorescence.
Fluorescence in these assays will also be used for binary cell responses (live vs. dead), and
quantification of intensity is of secondary importance.
For cytotoxicity assays, four layer devices ("4x4x4" of Figure 5.12) were prepared using the
thermal-plasma approach. The distance between sample layers was approximately 500 tm. To
promote biocompatibility and cell adherence, channels were cleaned with a 24 h soak in ethanol,
followed by a 24 h treatment with fibronectin/PBS solution. This was necessary for enabling cell
growth on PDMS surfaces, as described in Section 4.4.3. HeLa cells were grown to confluence
in culture flasks for several days, collected, and seeded into the device sieves. Software control
of the layer valves allowed cells to be seeded one layer at a time. After seeding, cells were
incubated for at least 6 h prior to cytotoxicity experiments, with a gentle perfusion of fresh
media.
Proof of principle assays were performed a challenge of a dilute solution of histamine flowed
through the device, which had the intended effect of killing a fraction of cells. Histamine at a
concentration of 0.1 mM in PBS was input to chambers containing cells on all four layers, and
incubated for 20 minutes. Cells were then treated with a live/dead stain (L-3224, Invitrogen),
prepared with calcein AM and ethidium homodimer-1 (EthD-1), both at 2 tM in PBS. The 16
individual chambers on each layer were automatically imaged one at a time using routines
written in JAVA to synchronize the camera and motorized stage. Fluorescent scans were
performed twice for each layer, once for live cells under a FITC filter set, and once for dead cells
using a RHOD set. For multiple layers, the microscope is refocused between scans (it is possible
to automate this step on microscopes with motorized focus features). The results of the cell
assays are presented in Figure 5.14.
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Layer 1/4 - 16 images Layer 1/4 - 16 images
Array (brightfield) Compilation
Layer 1/4 - 16 images
Figure 5.14: Live/dead cell assays performed using a vertically integrated architecture. A) The
cell chambers contained HeLa cells which were treated with a histamine solution. 
Each offour
layers contains 16 cell chambers. Live and dead images were captured through 
FITC and
RHOD filter sets at 20X magnification, with exposure times of 0.2 seconds. B) The fluorescent
results from one layer to another are independent.
The viability stains indicated that approximately half of the cells in the chambers 
had been killed
by this particular histamine treatment. To preclude the possibility that some cells 
may have been
dead prior to the assays, due to the seeding process or sub-par culture conditions, 
a live/dead
stain could also have been preformed prior to the application of toxins, although 
these stains can
adversely affect the health of the cells over several hours (this represents another advantage of
vertical integration - if desired, it would be possible to perform pretreatment viability 
assays on a
spare layer). Images from one layer to another did not exhibit interfering fluorescence. The
results of this assay demonstrate that it is possible to increase the density of microfluidic 
toxicity
assays using the concept of vertically integrated architectures. While high density 
cytotoxicity
screens have been performed using planar devices in the past, the stacked device 
allows
additional assays to per performed without necessitating additional hardware or 
handing on
control lines. In the future, a wide variety of biologically relevant substrates and 
cell lines could
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be combined on a single device, and replicate experiments on separate layers can be used to
explore the effects of different treatment times.
5.5.2 Independently addressable chambers in three dimensions
By combining the ability to culture and assay cells in a three dimensional construct, with the
addressability of VLSI, new architectures were conceived to extend the capability of
microfluidic toxicity assays. Such devices extend the flexibility of row/column cytotoxicity
protocols, by providing independent addressability of cell culture chambers.
In row/column assays, it is not possible to direct toxins to a specific culture chamber, and it is
necessary to flow reagents over all cells in a row. Rather than connecting all cell chambers along
a single flow channel, culture channels may be patterned containing bypass lines, as illustrated in
Figure 5.15. This approach prevents cross contamination enables individual addressability.
A R
closed open
Figure 5.15: A serial method for storage chamber addressability, in contrast to the parallel
architecture utilized for previous large scale integrated devices. Although this concept requiresslightly more area, it is advantageous for cell signaling as cross contamination between
chambers can now be avoided with adequate flushing of reagents. A) When chamber valves areactuated together (in red), flowing fluid passes around a chamber by via symmetric bypasschannels (in blue). B) In the open state fluid will still flow though bypass channels, but due theratios of hydraulic resistance, the majority offluid flow will be directed through the storage cell.Typical widths for bypass channels are 25 pm, while the centerline flow channels are 100 pm.
In the row/column device, an entire column was dedicated to use of a specific reagent. It was not
possible to rinse out this well for application of a second reagent without additional
contamination of samples. By providing bypass channels, cross contamination between reagents
is avoided, which is particularly useful if channel multiplexors are used to manage inputs. Using
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this cell sieve design with bypass channels a modified VLSI device was implemented, illustrated
schematically in Figure 5.16.
8 x 8 x 4 cells Zmux
5 mm
Figure 5.16: A cell toxicity device architecture utilizing both VLSI and the serially addressable
chamber techniques. The device contains a total of 8 rows, 8 columns and 4 layers, for a total of
256 individually addressable chambers with a total footprint of less than 12 mm x 12 mm. Cell
sieves (denoted in orange) have diameters of 400 pum. Valves used for vertical addressability are
in green. Flow and control channels are blue and red, respectively. B) Detailed view of
fabricated cell sieves. Shadows from out ofplane features can be observed. C) Photograph of a
two layer device during assembly, placed next to a U.S. dime for scale.
In this design, 256 independently cells could be observed in an area of approximately 7 mm x 7
mm. Fluid addressability and sample management is controlled using BioStream software
routines (in a similar manner to the devices described in Chapters 2 and 4). The union of VLSI
and cell culture offers unprecedented assay densities. While this architecture has been driven by
the objective of cytotoxicity screening, there are other key applications including metabolic
profiling and protein crystallization which can benefit from this new scalability.
5.6 Conclusions and Contributions
In this chapter a new paradigm for microfluidic device engineering has been introduced to
implement unprecedented feature densities on chip which circumvents previous limitations with
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device size and miniaturization. The concept of vertically integrated microfluidics could have
utility in a wide variety of applications where it is necessary to increase the capacity of parallel
assays on a single device. The key challenges of vertical addressability, layer fabrication, and
optical readout were reviewed and solutions were proposed.
Design and fabrication rules were developed to allow vertically integrated microfluidics to be
manufactured using variations of existing PDMS processing steps, with widely available
equipment. These processing steps were devised to ensure that the fabrication of vertical devices
is practical, and that the fabrication time does not prohibitively scale with the number of layers in
the device.
High density storage devices were developed using the concept of vertical multiplexing. Device
leveraging vertical multiplexing to yield independently addressable storage chambers in three
dimensions represent the most complex example of integration reported to date. These devices
used standard valve and channel sizes, while maintaining a device footprint of approximately one
inch squared. Interestingly, the increase in complexity was found to scale closely with the rate
predicted by Moore's Law.
Finally, vertical integration of microfluidics was proposed for several biologically relevant
applications. The first three dimensional cytotoxicity screening devices using a row & column
format were demonstrated, with optically independent results between layers. New architectures
for independently addressable cellular assays have also been provided. Non-planar devices were
found to be biologically compatible and will allow replicated data sets to be acquired on a
device, while avoiding the complications of setting up many separate chips. It is believed that
the concept of vertical integration will play a major role to manage complexity as more
ambitious microfluidic challenges are addressed in the future.
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Chapter Six - Conclusions and Outlook
6.1 Contributions
This thesis has addressed a wide range of technical challenges necessary to apply the benefits of
microfluidic technology for metabolic profiling of biological systems. Both application-driven
and fundamental design contributions to the engineering field were developed, which should be
of interest to a broad audience in the areas of automation, device design and cell culture.
First, the flexibility of multilayer soft-lithography was applied to automate the process of single
embryo profiling, in the form of a scalable and high-throughput microfluidics-based tool. Such
approaches should simplify the non-invasive acquisition and analysis of critical data in culture
studies to better understand the relationship between nutrient utilization and sample viability.
Continued efforts to simplify measurement techniques may increase adoption of metabolism-
based embryo selection metrics to a wider community in assisted reproductive medicine.
It was demonstrated that it was possible to resolve biocompatibility issues and successfully
perform embryo culture in microfluidic environments by revisiting existing microfabrication
processes. To date, the conditions necessary to sustain healthy embryo culture in closed
chambers on chip have not been documented. In contrast to previous microchannel systems, our
devices were produced entirely with PDMS. Development of the largest displacement MSL
valves to date was crucial to achieve culture in sealed volumes, and to provide unprecedented
regulation of flow in culture systems. Microfluidic embryo culture with tools similar to those
introduced in this thesis will be applicable to pursue open questions in the field of embryology
by enabling precise control of media volume and composition.
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Microfluidic channels with integrated valves, that have been demonstrated to be compatible in
embryo culture, were a major step towards integrated metabolomic analysis. To establish the
feasibility of an end-to-end solution for IVF, the functionalities of culture and detection were
combined to a single platform for mammalian cells. A microfluidic device and supporting
instrumentation was automated to support multiple cell cultures in parallel while performing
non-invasive metabolic assays. Automatic, real time metabolite monitoring may enable the
ability to dynamically modify and optimize culture conditions in vitro. By moving towards
single embryo culture and real time analysis with a single platform, parameters affecting embryo
viability may be studied and understood with unprecedented accuracy.
As an extension to the culture and detection methods developed in this thesis, a new paradigm
for microfluidic device engineering was presented which will allow an unprecedented number of
assays per chip to be performed. Vertically integrated microfluidics ensures more features on
chip without undesirable miniaturization of channels while also minimizing the necessary
footprint area of a device. The key challenges of vertical addressability, layer fabrication, and
optical readout were reviewed and solutions were proposed. Leveraging vertical integration, the
largest number of independently addressable chambers on a device was demonstrated. In the
context of biological relevance, the first three dimensional cytotoxicity assays were performed.
It is believed that the conception of vertical integration will play a major role to manage
complexity as more ambitious microfluidic challenges are addressed in the future.
6.2 Future work
There is a significant breadth of studies which can be pursued in both the metabolism and
microfluidic fields using the tools developed in this thesis. In this section, potential short and
long term projects are overviewed with the desire to initiate discussion for research by others.
For the microfluidic metabolite detector, with the fundamental operation already established,
adoption by other groups may be accelerated by efforts to make the devices more accessible and
easier to use. Next generation devices should also be scaled up to accommodate more samples.
By adding two or four more control lines, it would be possible to increase the number of fluidic
-150-
inputs from 16 to either 32 or 64. While calibration would be required to determine the new
minimum sample size for analysis, the advantages of throughput would be significant. It would
also be worthwhile to revisit image analysis routines (currently based on ImageJ through
BioStream JAVA software) to automatically compute linear regressions and slopes. By
implementing more frequent calibration, it should be possible to implement error checking
routines to ensure the metabolite enzymes have not degraded through the course of long
experiments. Looking forward, application of this detection platform to analyze hundreds of
culture samples could play a key role in illuminating the relationship between nutrient utilization
and developmental viability.
With regard to embryo culture, it is important to pursue continued experiments to compare
microdroplet culture with closed volumes on chip. Although several rounds of cell count data
have been obtained using the open channel microfluidic devices, no groups to date have
demonstrated sub-microliter embryo culture in microfabricated environments. A trial with at
least 50 embryos cultured in each of the 125 nl, 250 nl and 500 nl chambers, corroborated with
cell count data, would provide further insights to advantages and disadvantages of microfluidic
culture in contrast to existing microdroplet techniques. The outcome of these trials would also
provide importance information in the push for integrated metabolomic analysis of embryos.
Work should be continued to streamline the operation of the integrated detector device.
Preliminary metabolic results from HeLa cell lines has been very promising, particularly the
results obtained with metabolic inhibition. The architecture developed in the present work
utilized eight parallel chambers. To demonstrate the economies of scale with this integrated
metabolomics approach, it may be necessary to scale up the capacity further to accommodate
additional cell lines and culture protocols. Currently, the -25 nl recirculation chambers allow
only about three or four measurements to be measured before all the media must be replaced. On
future designs, these culture volumes may be increased to enable additional non-invasive assays
to be performed every measurement cycle. The sensitivity characterized using the standalone
detector suggests that dilution of metabolite signals should not adversely affect accuracy of
fluorometric assays. To improve longevity of cell lines during long term assays, the widths of
valves used for peristaltic pumping over cell cultures should be decreased to reduce flowrates
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and minimize shear stress on cells. Beyond the investigation of metabolic inhibitors with
different cell lines, it would be interesting to integrate the mixers necessary to formulate custom
compositions of fresh media upstream of culture in response to current metabolic measurements
in cell chambers. This would minimize the number of external inputs to provide different
compositions of media for all chambers, and also prove as a proof of principle experiment for
feedback driven cell culture.
With respect to vertically integrated microfluidics, only a limited number of experiments have
been completed to date to fully convey the strength of this design approach. It was reviewed that
one of the key applications demanding expanded storage densities was for protein crystallization.
It would be interesting to revisit this field with vertically integrated devices to assess how well
crystals can be observed through various channel layers. Using a microscope with a motorized
focus, it would also be of interest to utilize vertical integration for metabolic measurements. In
this approach, it is conceivable that integrated metabolite analysis devices can be operated in
parallel on separate layers of a single device.
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Appendices
Appendix A - Reagentsfor metabolic assays
Enzyme Cocktails. Metabolite specific enzyme cocktails were prepared following Gardner and
Leese13' 14. All reagents in this research were purchased through Sigma-Aldrich unless noted
otherwise.
Standards for glucose, lactate and pyruvate were prepared by adding known amounts of the
particular metabolite to either water or media formulations.
Single use glucose and pyruvate aliquots were stored at -200 C, and lactate cocktails were
prepared fresh immediately prior to experiments.
Stock solutions:
* 5 mM DTT (DL-dithiothreitol) (Sigma, D-5545, Ig, 40 C); 7.72 mg in 10 ml H20
* 37 mM MgSO47H20 (Sigma, 230391-25G); 91.2 mg in 10 ml H20
* 10 mM ATP (Roche, 10519979001, ig, 40 C); 30.3 mg in 5 ml H20
* 10 mM NADP (Roche, 10128031001, 100mg, 40 C); 39.4 mg in 5 ml H20
* 5 mM NADH (Roche, 10128015001, 500mg, 40 C); 17.73 mg in 5 ml H20
* 4.76 mM NAD+ (Roche, 10127981001, 1g, 40 C); 31.58 mg in 10 ml H20
EPPS buffer:
* 2.25 g EPPS (Sigma, E-1894, 25g, RT)
* 10 mg penicillin (Sigma, P-8721, 10MU, 4'C)
* 10 mg streptomycin (Sigma, S-9137, 25g, 40 C)
* 200 ml H20
* balance to pH 8.0 with 1M NaOH
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Glycine-hydrazine buffer:
* 7.5 g glycine (Sigma, G7126-100G)
* 5.2mg hydrazine (Sigma, 215155-50G)
* 0.2 mg EDTA (ethylenediaminetetraacetic acid) (Sigma, ED-100G)
* 50 ml H20
* balance to pH 9.0 with IM NaOH
Glucose Cocktail: Individual 1.2 ml [or 24 ml] aliquots of cocktail contained:
* 0.75 ml [15 ml] EPPS buffer
* 0.1 ml [2 ml] 5 mM DTT
* 0.1 ml [2 ml] 37 mM MgSO 47H 20
* 50 il [1 ml] 10 mM ATP
* 150 l [3 ml] 10 mM NADP
* 50 jil [1 ml] hexokinase/G-6-PDH (Roche, 10127825001, 15mg/5ml, 4°C)
Aliquots were frozen at -800 C in Eppendorf tubes, and thawed prior to use.
Pyruvate Cocktail:
Individual 0.735 ml [or 14.7 ml] aliquots of cocktail contained:
* 0.7 ml [14 ml] EPPS buffer
* 15 dtl [0.3 ml] 5 mM NADH (Roche, 10128015001, 500mg, 40 C)
* 20 ptl [0.4 ml] LDH (Roche, 127 876, 25mg/5ml, 4'C)
Aliquots were frozen at -800 C in Eppendorf tubes, and thawed prior to use.
Lactate Cocktail:
Individual aliquots of cocktail contained
* 75 pll 4.76 mM NAD+
* 400 pl H20
* 450 ptl Glycine-Hydrazine buffer
* 25 l LDH
-162 -
Aliquots of NAD+ were frozen at -800 C in Eppendorf tubes, and the remaining reagents were
mixed prior to use.
Using NAD(P)H linked reactions, a variety of substrates can be studied fluorometrically with the
appropriate choice of enzyme cocktails. Lowry has described recipes for measuring hundreds of
unique substrates46. The following reactions are of particular relevance for metabolic profiling.
Pyruvate Assay:
Lactate Dehydrogenase
Pyruvate + NADH + H+ --+ Lactate + NAD +
Lactate Assay:
Lactate Dehydrogenase
Lactate + NAD+ Pyruvate + NADH+ + H+
Glucose Assay:
Step 1:
Glucose + ATP
Hexokinase
--> glucose-6-phosphate + ADP
Step 2:
Glucose-6-phosphate Dehydrogenase
Glucose-6-phosphate - 6-phosphogluconate + NADPH + H+
Glutamine Assay
Step 1:
Glutaminase
Glutamine + H20 Glutamate + NH3
Step 2:
Glutamate Dehydrogenase
Glutamate + H20 + NAD+ - a - ketoglutarate + NADH + NH4+
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Appendix B - Microfluidic Embryo Culture Supporting Data
Summaries of these murine embryo culture trials appear in Figures 3.3
performed by David Potter at the Fertility Labs of Colorado.
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Appendix C - Culture Device Volume Characterization
It was believed that volume variance between nominally similar microfluidic devices was due in
part to the PDMS curing time. To address this concern, a study was completed where
dimensions of culture channels were measured periodically over an extended curing process.
Volume discrepancies based on prior measurements indicated that actual channel volumes were
often 10-20% smaller than nominal, and at times, even devices cast off the same mold exhibited
several percent variation.
Thick layers cast using 5:1 PDMS in conventional soft-lithography are known to contract after
removal from molds. A nominal shrinkage ratio of 100/101.7 is therefore accounted for when
preparing multilayer soft-lithography devices, to ensure detailed features from the thick layer
will register with those on the thin layer during alignment. However, this empirical shrinkage
factor ratio is based on 5:1 PDMS for very short cure periods. To ensure successful embryo
culture, it was found necessary to cure chips using a 10:1 PDMS ratio for a minimum of 48 hours
prior use. No prior studies were identified which have presented data regarding the effects of
extended cure times on PDMS shrinkage.
Flow and a control layer of the embryo culture devices in this research were fully cured
separately before using a plasma treatment for assembly (Under normal MSL assembly it be
possible to assemble the layers using thermal bonding, but since the same ratio of PDMS was
used for both flow and control channels, sealing was found to be superior with plasma bonding).
Due to scheduling difficulties when devices were prepared, the actual curing time used for
device fabrication often ranged anywhere from 50, to more than 60 hours, since longer bakes
were also considered adequate for embryo culture. For this reason, it was necessary to
characterize culture device shrinkage as a function of time and determine whether this process
parameter was to blame for volume variations in channels.
Key questions to address were: 1) What is the typical linear and volumetric shrinkage expected
for such culture chambers during extended curing protocols, 2) What is the expected variation, if
any, from devices cast off the same molds under identical conditions, and finally, 3) Whether the
curing time is the cause of significant discrepancies between measured and nominal volumes.
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Twelve devices were cast from two different culture device molds containing the same channel
pattern. The same batch of 10:1 PDMS was used for all devices to avoid variations in polymer
mixtures. Initially 20 minute bakes were completed at 900 C until the devices were sufficiently
cured that they could be removed from the molds and cross sectioned. Initial images of two
culture channels were captured using an inverted microscope at 10X before returning samples to
the curing oven. The device design used and a typical cross section are presented in Figure C1.
During the bake periods, PDMS chips were placed channel side up on a tissue to allow
unrestricted device contraction if shrinkage were to occur. Once a day, cross section images
were acquired for every sample and channel measurements were performed using ImageJ
software. For reference, nominal values of channel height and width were 150 gm and 667 p~m,
respectively.
A) B)
Figure Cl: Cross sections used for shrinkage characterization. A) Channels 3 and 4 were cross
sectioned on six identically prepared culture chips. B) The height and width of channels were
measured for every sample over a one week cure period.
It is difficult to ensure that manually cut sections were precisely perpendicular to channels. As
such, the width may differ slightly from expected values. Nonetheless, we are interested in
examining the effect of bake times on dimensions relative to initial size of the channel.
Additional parameters such as photomask resolution and lithography exposure may result in
channel mold widths which differ from nominal values.
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Over an extended cure time of more than 100 hours, minimal shrinkage was observed for PDMS
samples. Results of width and thickness measurements are summarized in Figure C2. Large
error bars are the result of difficulties in identifying clean channel edges for dimensioning (these
difficulties were alleviated slightly when using sharpened images). Within the limits of
measurement resolution, however, it is evident that channel heights contracted by almost 2%,
while the channel widths actually widened by less than 0.5% when the results are averaged over
all twelve channels. No significant variation chip-to-chip was observed in six separate chips
used in this study.
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Figure C2: Channel height and width measurements averaged over twelve channels. Error bars
represent one standard deviation oferror.
This indicates that during contraction of the elastomer device (in this case a block of
approximately 4 mm x 20 mm x 20 mm) dimensions of the original chip play a role in distortion
of features. It is likely that the entire PDMS block was contracting at a uniform strain ratio.
Distortion through the 20 mm lengths may have been minimal as a percentage, but absolute
values may have been significant working to pulls the channel walls apart from only another. By
conservation of mass, this larger absolute strain in the lateral direction (sw/Ewo) would have
increased the thickness of the device, counteracted slightly by the strain through the thickness of
the device. This hypothesis is supported by the fact that the average ratio of strains in this
experiment, sw/sh, is -0.22, similar to the aspect ratio width to height of the elastomer chip
(4/20 mm). In any case, further characterization of PDMS distortion as a function of cure time is
beyond the scope this concise study.
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These measurements eliminated the possibility that that observed culture volume variations on
the order of 10% or greater were not primarily the result of baking time. Through examination
of numerous cross sections, however, many obvious variations in height were observed which
identified the mold manufacturing as the main cause. Uncertainties in the lithography process,
namely photoresist solvent content and proper leveling of hotplates during pre-bakes, are most
likely the culprit of variations. These factors have been a previous concern in fabricating thick
(> 50 rpm) features from SU-8. Width variations on mid-resolution (3386 dpi) lithography masks
used to prepare these samples were also observed on the channel cross sections. As a result of
this questions raised in this study, higher resolution masks were obtained for future devices, only
newer bottles of SU-8 was used for fabrication of such tall molds, and the dimensions of all
features were verified using an interferometer prior to casting.
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Appendix D - Example BioStream routine for metabolic profiling
BioStream is an open source programming environment for microfluidics first developed by Bill
Thies of MIT CSAIL, which has been used for controlling all the microfluidics in this thesis.
Beyond management of microsolenoids used to actuate on chip MSL valves, the BioStream
environment has since been extended for control of additional external hardware including
motorized stages, microscopes and cameras. Due to the powerful and intuitive nature of this
software, is highly recommended to others working in this field.
The following routines written in JAVA were used to complete the integrated assays in Chapter
4. These routines are extensions of the subroutines used to complete sample analysis with the
microfluidic detector in Chapter 2. Example lines of code, for calibration of fluorometric
standards and measurement for glucose concentration in spent media, is provided to demonstrate
the flexibility of our approach.
public static void runRoutine ()
for (int i=0; i<6; i++){ //routine reps - about (1.5 + 1.5) hours each
// GLU ASSAY
// refresh bypass and cell chamber with fresh media, then allow to culture
Oocyte9Driver.doInputToCultureBypassPumpTimed(Oocyte9Mapping.MEDIAl, 60000);
Oocyte9Driver.doInputToCultureSievePumpTimed(Oocyte9Mapping.MEDIAl, 10000);
Oocyte9Driver.doTimedMix (2, 30000);
// culture routine with periodic circulation - about 6 x (5 min) = 30 mins
for (int j=0; j<6; j++) {
Oocyte9Driver.wait(240000); // allow culture
Oocyte9Driver.doTimedMix(2, 30000); // circulate culture
for (int p=0; p<4; p++) { //calibrate - stds 1 through 4
runStandardTest(p, Oocyte9Mapping.GLUCOSE);}
Oocyte9Driver.doTimedMix(2, 30000); // circulate media prior to assays
for (int a=0; a<3; a++) ( // assay from sieve and bypass - 3x each
assayCocktail(Oocyte9Mapping.MEDIA1, Oocyte9Mapping.GLUCOSE);
for (int p=0; p<4; p++) { //calibrate - stds 1 through 4
runStandardTest (p, Oocyte9Mapping.GLUCOSE);
Details and downloads of BioStream are available at http://www.cag.csail.mit.edu/biostream/.
Also refer to Urbanski6 2 and Thies63 .
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